Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,41758,-0.135185223426241,0.00471320851081009,-0.144423112107429,-0.125947334745053,1.50933635240651e-175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41465,-0.321887648443076,0.0130141611377046,-0.347395404272977,-0.296379892613175,5.48548314122245e-132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,41689,-0.213589897850501,0.00927263855434512,-0.231764269417017,-0.195415526283984,4.03947307074396e-115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,41905,0.302828729461617,0.0134114440662447,0.276542299091778,0.329115159831457,8.15515529205625e-111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39633,-0.0913558902943035,0.00411641024304225,-0.0994240543706664,-0.0832877262179407,8.52202740215574e-107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39250,-0.224959149796194,0.0105999146416051,-0.24573498249374,-0.204183317098648,6.17616513430683e-98
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39308,-0.111182288696741,0.00538170629751717,-0.121730433039874,-0.100634144353607,5.17346865266738e-93
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,39625,-0.187166691905963,0.00913201035189811,-0.205065432195683,-0.169267951616242,1.18745898315525e-91
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,41786,-0.178222764943613,0.00903336081483958,-0.195928152140699,-0.160517377746528,2.04742481605405e-85
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,41765,-0.131300350750083,0.00669421380081798,-0.144421009799686,-0.11817969170048,1.87614489419789e-84
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,39655,0.0529480924594485,0.00273024606206044,0.04759681017781,0.058299374741087,2.0462625732801e-82
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,39655,0.116648231817993,0.00614963472427026,0.104594947758423,0.128701515877563,5.56125502532064e-79
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,41802,0.066903159254394,0.00353279589779991,0.0599788792947062,0.0738274392140818,6.18022930942508e-79
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,41703,-0.0838222575368817,0.00443397045879839,-0.0925128396361265,-0.0751316754376368,1.16111739714345e-78
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41521,-0.15776281264667,0.00869072597520242,-0.174796635558067,-0.140728989735274,9.71637439059001e-73
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,41712,-0.190028554044579,0.0109755171305545,-0.211540567620466,-0.168516540468692,2.02205999663656e-66
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,41911,-0.052865324693736,0.00311081981383321,-0.0589625315288491,-0.0467681178586229,4.30558046397995e-64
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39581,-0.156220229781386,0.00922811397978517,-0.174307333181765,-0.138133126381007,1.75845855464102e-63
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,41740,-0.15036405168248,0.00904283063155097,-0.16808799972032,-0.13264010364464,1.85346551469608e-61
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,39625,-0.158468307509802,0.00967610174037994,-0.177433466920947,-0.139503148098657,1.40024872006583e-59
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,41877,-0.0641624691390323,0.00393689703396992,-0.0718787873256134,-0.0564461509524513,3.83790117247891e-59
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,41805,0.0502378797086629,0.00308945648599181,0.0441825449961189,0.0562932144212068,6.95291403432086e-59
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,41813,-0.058104658168257,0.00361835209839658,-0.0651966282811143,-0.0510126880553997,1.74777066701492e-57
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,41758,0.0541558349451283,0.00342305904253292,0.0474466392217638,0.0608650306684928,7.30310456358261e-56
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41411,-0.0916423894119117,0.00584808740527839,-0.103104640726257,-0.0801801380975661,7.76691379766819e-55
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,41862,-0.200226774267364,0.0128203810655072,-0.225354721155758,-0.17509882737897,1.68169281836891e-54
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,41877,-0.10211933958725,0.00669381226880195,-0.115239211634102,-0.0889994675403986,4.16550409707719e-52
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,41911,-0.0817954368127615,0.00540986258416316,-0.0923987674777213,-0.0711921061478017,3.196825061984e-51
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41521,-0.0883133765399516,0.00584532503416311,-0.0997702136069113,-0.0768565394729919,3.8964956849262e-51
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41689,-0.0595323408747526,0.0039662704817737,-0.067306231019029,-0.0517584507304761,1.66947528384649e-50
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,41809,-0.0522911227605997,0.00352590568365382,-0.0592018979005612,-0.0453803476206382,2.3183674501738e-49
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,39655,0.0737099565811547,0.00501143778306829,0.0638875385263409,0.0835323746359686,1.63562863791775e-48
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41559,0.0847273032823565,0.00577759687877245,0.0734032133999625,0.0960513931647505,2.63991951369201e-48
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,41765,0.0751482248786039,0.0051271732712959,0.065098965266864,0.0851974844903439,2.92159234949512e-48
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,40881,-0.0640585292463656,0.00442758079914308,-0.072736587612686,-0.0553804708800451,4.69722146788316e-47
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39633,-0.053695880006172,0.00371621922198197,-0.0609796696812566,-0.0464120903310873,6.80308465336412e-47
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,41802,-0.0505682394857749,0.00352791249694149,-0.0574829479797802,-0.0436535309917696,2.99297213502166e-46
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,39600,-0.11538883172374,0.0081381569875772,-0.131339619419391,-0.0994380440280887,3.10199477650864e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,41689,-0.117775897818761,0.00832014283441398,-0.134083377774212,-0.101468417863309,3.71712981341944e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41465,-0.115972047420627,0.00826577446567964,-0.132172965373359,-0.0997711294678953,2.1571309189232e-44
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41689,-0.127347893362023,0.00910556155137233,-0.145194794002713,-0.109500992721333,3.95725628929185e-44
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,41758,-0.0788836267832649,0.00568476551885877,-0.090025767200228,-0.0677414863663017,1.78392823553979e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39408,0.0450154439237267,0.00329224659097513,0.0385626406054155,0.051468247242038,3.29407635105909e-42
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,39650,0.100318484413967,0.00734911322007139,0.0859142225026268,0.114722746325307,4.40119178664033e-42
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39401,-0.0710072302114611,0.0052139196359999,-0.0812265126980209,-0.0607879477249013,6.86280833283437e-42
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39408,-0.111368017568116,0.00819308358713128,-0.127426461398894,-0.095309573737339,9.71090028603198e-42
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41534,-0.119031510968,0.00884776426184866,-0.136373128921223,-0.101689893014776,5.55286443321332e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39589,-0.0806452261084333,0.00604991162157211,-0.0925030528867146,-0.068787399330152,3.17861556818494e-40
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,41903,0.0852431905724183,0.00646667956254579,0.0725684986298285,0.097917882515008,1.97017625150841e-39
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39448,0.254775267212433,0.0195316126035782,0.216493306509419,0.293057227915446,1.33660579893715e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39408,-0.069558020473185,0.00535371166877899,-0.0800512953439918,-0.0590647456023782,2.61158241215015e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,41865,-0.200082995777305,0.0155157829597904,-0.230493930378494,-0.169672061176116,8.05584704927551e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,41689,-0.0768164060316943,0.00603164894485318,-0.0886384379636066,-0.0649943740997821,6.21320820908201e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41466,-0.0718776600966494,0.00564657329454687,-0.0829449437539613,-0.0608103764393376,6.77237756011637e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,41750,0.238074726622052,0.0190205008444178,0.200794544966993,0.27535490827711,9.66350914246631e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,41740,-0.0704890278746669,0.00565053558205098,-0.0815640776154869,-0.059413978133847,1.62899065835665e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,41777,0.025588821615877,0.00205448761176598,0.0215620258968157,0.0296156173349384,2.07606306211693e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,41758,-0.0510748605751745,0.00413593244603156,-0.0591812881693964,-0.0429684329809527,7.68510305236292e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41689,-0.106575780069683,0.0086378680521541,-0.123506001451905,-0.0896455586874612,8.80105859308717e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,41877,0.0482727804323467,0.00393377086545988,0.0405625895360453,0.0559829713286481,1.9825270484387e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,41840,-0.063544323286748,0.00521790659571529,-0.07377142021435,-0.053317226359146,6.17334222822128e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,41821,-0.0866563974263108,0.00712163581957263,-0.100614803632673,-0.0726979912199485,6.97950953839842e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39308,-0.0822601521709277,0.00675768671985735,-0.0955052181418481,-0.0690150862000073,7.25860953438383e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41836,0.0499204465304301,0.00412402779458779,0.041837352053038,0.0580035410078222,1.49840296020168e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,41765,-0.0440395607788419,0.00364959228893871,-0.0511927616651617,-0.036886359892522,2.3665888685281e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41534,-0.0703721897071703,0.00584039403024031,-0.0818193620064413,-0.0589250174078993,2.9501566401127e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39334,-0.059704608443431,0.00495780013641422,-0.0694218967108029,-0.0499873201760591,3.4722969675902e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39308,-0.0809610287263526,0.00673024775862414,-0.0941523143332559,-0.0677697431194493,4.06746569402862e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,41856,-0.040624523543509,0.00340106974805745,-0.0472906202497016,-0.0339584268373163,1.01934055503373e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,41911,-0.0389842796710536,0.00327510955468932,-0.0454034943982447,-0.0325650649438626,1.66491950610057e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,41758,-0.0500561914661053,0.00423601002816793,-0.0583587711213144,-0.0417536118108961,4.64047655068282e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,41925,-0.0636101458042244,0.00539865302216878,-0.0741915057276752,-0.0530287858807735,6.90833877517544e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41465,-0.0825231339105514,0.00701327671596708,-0.0962691562738469,-0.068777111547256,8.43281921027025e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41376,-0.126024158685224,0.0107358779847125,-0.147066479535261,-0.104981837835188,1.17495355770876e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41617,-0.0906047513221688,0.00772020282957724,-0.10573634886814,-0.0754731537761974,1.20208578480617e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,39633,0.0720427367203291,0.00614903474005855,0.0599906286298144,0.0840948448108439,1.61974976485016e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41521,-0.114720325989171,0.00982699018638412,-0.133981226754484,-0.0954594252238584,2.4859656291893e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,41877,-0.15435912593143,0.0132431823613936,-0.180315763359761,-0.128402488503098,3.04470679693271e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,41689,-0.0487183500160176,0.00420130505423982,-0.0569529079223276,-0.0404837921097075,6.11552117514111e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,41862,-0.0523025246077413,0.00452190350784547,-0.0611654554831184,-0.0434395937323642,8.56137579404091e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41449,-0.0733574277540858,0.00635215447222126,-0.0858076505196395,-0.0609072049885321,1.06560111490573e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,41734,-0.0640831478904776,0.0055544232661209,-0.0749698174920745,-0.0531964782888806,1.20197330989125e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,41758,0.0332853167131908,0.00288787744728604,0.0276250769165101,0.0389455565098714,1.37018288804114e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,41820,-0.0846194674246507,0.00737863413235403,-0.0990815903240646,-0.0701573445252368,2.65139293315657e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,41740,-0.0405555759865708,0.00354270844010725,-0.047499284529181,-0.0336118674439606,3.36030006525573e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,41877,-0.031972206263493,0.00280875307091773,-0.0374773622824918,-0.0264670502444943,6.98637166708505e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,41744,-0.0687760545248057,0.0060558900630941,-0.0806455990484702,-0.0569065100011413,9.43206973746637e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39334,-0.152692569606038,0.0134542221251766,-0.179062844971384,-0.126322294240692,1.10658065727062e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,41877,-0.0342825483163879,0.00302507272735811,-0.0402116908620098,-0.028353405770766,1.23496165224813e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41455,-0.0594999903029991,0.00525680025232441,-0.0698033187975549,-0.0491966618084432,1.463655960677e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,41689,-0.0791995231319707,0.00704468453328499,-0.0930071048172093,-0.0653919414467321,3.43262035278425e-29
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,41829,-0.0727910036473581,0.0065370378164537,-0.0856035977676074,-0.0599784095271088,1.13427013430428e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39308,-0.0687966246268455,0.00618463680123757,-0.0809185127572711,-0.0566747364964198,1.37802540381329e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,41802,-0.0645004352380537,0.00581866626543001,-0.0759050211182965,-0.0530958493578109,1.97820498498839e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41540,-0.098148834241477,0.00894001302699139,-0.11567125977438,-0.0806264087085738,6.4316393152204e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39153,0.0491379424548285,0.00450868617698646,0.040300917547935,0.0579749673617219,1.64168645066619e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,41911,-0.0381568375740276,0.00353798365238817,-0.0450912855327084,-0.0312223896153468,5.2448461951531e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41614,-0.0598049097056199,0.00554855483857421,-0.0706800771892254,-0.0489297422220145,5.65492651279132e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,41689,-0.0404340034328438,0.00376552703551953,-0.0478144364224621,-0.0330535704432255,8.73091899304168e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39625,-0.0324227260338612,0.00302275850550234,-0.0383473327046458,-0.0264981193630766,1.0384626305437e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,39655,0.0564520647450888,0.00530251817642378,0.0460591291192982,0.0668450003708795,2.43420183980041e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,41819,0.0322940663209982,0.00303529786350083,0.0263448825085366,0.0382432501334599,2.49398234262334e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,41877,-0.0381635949716508,0.00361612599969563,-0.0452512019310543,-0.0310759880122474,6.18464898725026e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,41703,-0.0349094576649449,0.00336571407990728,-0.0415062572615632,-0.0283126580683267,4.15489993437711e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,41740,-0.0439158922234298,0.00423941685728979,-0.0522251492637178,-0.0356066351831418,4.75850705687142e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,41802,-0.0249581486713396,0.00241489152135162,-0.0296913360531888,-0.0202249612894904,6.08534258178477e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,41758,0.0311730824970885,0.00301636111138513,0.0252610147187737,0.0370851502754034,6.11731155528119e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41636,-0.0335682946038904,0.00325035488828331,-0.0399389901849257,-0.0271975990228551,6.59595728887332e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39625,-0.0733383912059979,0.00710711642016071,-0.0872683393895129,-0.0594084430224829,7.5003733174411e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39598,0.0408152362576333,0.00396262438710611,0.0330484924589053,0.0485819800563613,9.12424455928855e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41877,-0.0368595781495022,0.00358743276501116,-0.0438909463689241,-0.0298282099300803,1.13415943368831e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,41846,-0.0763973164329252,0.00745296340842315,-0.0910051247134346,-0.0617895081524158,1.45276915075989e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,41802,-0.0268707612226936,0.002621666081204,-0.0320092267418535,-0.0217322957035338,1.47026293250016e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39408,-0.0309928100990786,0.00302516600692524,-0.036922135472652,-0.0250634847255051,1.61315068072331e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41521,-0.0712277758837149,0.00698072419168265,-0.0849099952994129,-0.0575455564680169,2.36573323343945e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,39650,-0.022157000314265,0.00217206643988179,-0.0264142505364333,-0.0178997500920967,2.51802635602396e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,41765,-0.0839439185507053,0.00823429076798028,-0.100083128455947,-0.067804708645464,2.5850071320202e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,39625,-0.0378840526632912,0.00372070001460452,-0.045176624691916,-0.0305914806346663,3.05512759033392e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,39625,-0.0302708858086073,0.00297299125173378,-0.0360979486620055,-0.0244438229552091,3.05532974335309e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,41721,-0.0218082496294997,0.00214584726180217,-0.026014110262632,-0.0176023889963675,3.56385475117636e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39408,-0.0701214575761423,0.00693864921048214,-0.0837212100286873,-0.0565217051235973,6.64033044480692e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39328,-0.0901097917972572,0.00892771674861455,-0.107608116624542,-0.0726114669699727,7.55986818949375e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39160,-0.0349751332310772,0.00347487647583472,-0.0417858911237133,-0.0281643753384412,1.00759348986426e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39589,-0.05705025012087,0.00571366815736587,-0.0682490397093071,-0.0458514605324328,2.23272800701338e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41587,-0.0525833362140206,0.00527349260541055,-0.0629193817206252,-0.0422472907074159,2.47023189089645e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41689,-0.0849407692634987,0.00857686930131329,-0.101751433094073,-0.0681301054329247,4.84528108150679e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,41667,-0.0745066102809824,0.0075628852720139,-0.0893298654141296,-0.0596833551478351,8.09998911224431e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,41740,-0.029192105367069,0.00298171110057281,-0.0350362591241917,-0.0233479516099462,1.47881349590854e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,41740,-0.0423737853320159,0.00435014861129105,-0.0509000766101463,-0.0338474940538854,2.40429316310989e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,41819,0.0303110849622222,0.00312486677048282,0.0241863460920759,0.0364358238323686,3.57563989441754e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,41758,-0.0293538087873249,0.00303497217420625,-0.0353023542487692,-0.0234052633258807,4.70234052978161e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,41715,-0.0545699425751593,0.00566163530578801,-0.0656667477745038,-0.0434731373758148,6.4965958052979e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41689,0.0200679174768096,0.00209922427991235,0.0159534378881814,0.0241823970654378,1.38924261417759e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,41740,-0.0540103906570892,0.00565878893231623,-0.065101616964429,-0.0429191643497494,1.60571046428538e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41547,-0.0294054350207952,0.00308798091254196,-0.0354578776093775,-0.023352992432213,1.98611232789808e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,41865,-0.0382571326356646,0.00402404271416859,-0.046144256355435,-0.0303700089158941,2.29214051615146e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39334,-0.0707897355075551,0.00745032474243022,-0.0853923720027183,-0.0561870990123918,2.50761678005083e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39408,0.0427876069374738,0.00450476023262242,0.0339582768815339,0.0516169369934138,2.58315294451917e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39625,-0.0848886461265948,0.00898936988873886,-0.102507811108523,-0.0672694811446666,4.34223616090125e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,41865,-0.0246341157381588,0.00260961477124983,-0.0297489606898085,-0.0195192707865092,4.35140251095719e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,39598,-0.132499823873707,0.014048305902669,-0.160034503442938,-0.104965144304476,4.84350491906675e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41689,-0.0691855126516034,0.00734869126780047,-0.0835889475364924,-0.0547820777667145,5.52878239749331e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41521,-0.056273648654333,0.0059826199364998,-0.0679995837298726,-0.0445477135787934,6.0020871892126e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,39598,-0.0387930179961774,0.00415826975090937,-0.0469432267079598,-0.030642809284395,1.27189294093458e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,41740,-0.0489254779321465,0.00525610422994277,-0.0592274422228343,-0.0386235136414586,1.50212718623119e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41543,-0.145361213787037,0.0156237121992224,-0.175983689697513,-0.114738737876561,1.56911709240637e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,41925,0.0250925785373509,0.00269916845446277,0.0198022083666038,0.0303829487080979,1.67555649288819e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41636,-0.0580030290036825,0.00624481245099299,-0.0702428614076288,-0.0457631965997362,1.81485516020882e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,41765,0.0381313877117409,0.00410692950568291,0.0300818058806024,0.0461809695428794,1.87327625225678e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41465,-0.0598413838719696,0.0064485442915224,-0.0724805306833535,-0.0472022370605857,1.96590823221198e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39334,-0.0514706803293584,0.00554991625065075,-0.0623485161806339,-0.040592844478083,2.13383438578518e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39408,-0.0528804856537694,0.00570732447969793,-0.0640668416339773,-0.0416941296735615,2.31230414264227e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,41740,-0.0718323005605526,0.00782199115678307,-0.0871634032278474,-0.0565011978932578,4.79559897287396e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,41765,-0.0346219705517347,0.00379094796562232,-0.0420522285643545,-0.027191712539115,7.63744625518523e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,41740,0.0349628043999881,0.00382935030411543,0.0274572778039219,0.0424683309960544,7.82263228624098e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,41877,0.0453007914664466,0.00497734822640556,0.0355451889426917,0.0550563939902015,1.01742326423729e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,41877,-0.0459621246083825,0.00505484003214831,-0.0558696110713932,-0.0360546381453718,1.10164764125975e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,41791,-0.0314219143860584,0.0034629020264078,-0.0382092023578177,-0.0246346264142991,1.30948532784539e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41466,-0.0653311953607824,0.00720426225863036,-0.0794515493876979,-0.0512108413338669,1.38087440441945e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,41721,-0.0281733468839102,0.00310807881227441,-0.034265181355968,-0.0220815124118523,1.42656837141647e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,41865,-0.0444840858376438,0.00493052839840019,-0.0541479214985082,-0.0348202501767795,2.09448323290135e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39408,0.0230972426314626,0.00256027188692965,0.0180791097330805,0.0281153755298448,2.17085633492979e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,41925,-0.0491306810063715,0.00547610106877116,-0.059863839101163,-0.03839752291158,3.30132446162268e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41636,-0.0555073404955977,0.00619098740192957,-0.0676416758033796,-0.0433730051878157,3.49470858372154e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39589,-0.0542810280039169,0.00605885144859934,-0.0661563768431716,-0.0424056791646622,3.80582702059359e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39250,-0.0538547013863189,0.00602164853032382,-0.0656571325057536,-0.0420522702668843,4.39379255242226e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,41765,-0.0256373239333309,0.00286827485252006,-0.0312591426442703,-0.0200155052223916,4.47503698741337e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,41911,-0.0251305580684519,0.00281542172835237,-0.0306487846560226,-0.0196123314808813,4.98694571181196e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,41736,-0.0768777238428894,0.00861555967437957,-0.0937642208046734,-0.0599912268811054,5.12729053526455e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39600,-0.0608903488158297,0.00683257388193965,-0.0742821936244314,-0.047498504007228,5.81316916266053e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41404,-0.0804480402654809,0.00904069002518265,-0.0981677927148388,-0.0627282878161229,6.41769026943119e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39625,-0.0726761092363771,0.00817433929172549,-0.0886978142481591,-0.0566544042245952,7.01303602943992e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,41783,-0.0306688231941415,0.00345708257299131,-0.0374447050372044,-0.0238929413510785,8.15090137334861e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39612,0.0470754194366433,0.00531460524032236,0.0366587931656114,0.0574920457076751,9.41654694462962e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41465,-0.0612127043822775,0.00691957667402396,-0.0747750746633645,-0.0476503341011906,1.02153792907151e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,41758,0.0352522400815805,0.00399304191271656,0.027425877932656,0.0430786022305049,1.19452493665992e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41466,-0.0479418422684142,0.00543130843291529,-0.0585872067969281,-0.0372964777399002,1.21351858929132e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,41636,-0.0407758102921843,0.00462795953178092,-0.0498466109744749,-0.0317050096098937,1.398854363622e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,41911,-0.0429585903771721,0.00488475044368535,-0.0525327012467954,-0.0333844795075488,1.61266673604303e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,39633,0.0356927419245047,0.00406978082322507,0.0277159715109835,0.0436695123380258,2.04535234491931e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,41925,-0.0429979134613794,0.00491617209763011,-0.0526336107727344,-0.0333622161500244,2.46822023534472e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41636,-0.0682055408793338,0.00781974138082991,-0.0835322339857604,-0.0528788477729072,3.05562453293156e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,41765,-0.0591964045816096,0.00678885387456025,-0.0725025581757477,-0.0458902509874715,3.1221423944685e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,41740,-0.0549258416767896,0.00632823815688087,-0.0673291884642762,-0.0425224948893031,4.43976539548291e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,39600,-0.0391496193616815,0.00453330855872907,-0.0480349041367904,-0.0302643345865725,6.6248982578897e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41636,-0.0313136071645748,0.00364053665437647,-0.0384490590071526,-0.0241781553219969,8.76989562582728e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,41855,-0.0597474538403072,0.00694991273170782,-0.0733692827944546,-0.0461256248861599,9.10304545973127e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,41925,0.0261481620962119,0.00304212075086891,0.0201856054245088,0.0321107187679149,9.21628466920647e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,41745,-0.0409399707265137,0.00476302444542618,-0.050275498639549,-0.0316044428134783,9.2294726573879e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,41765,-0.0628082505918339,0.00732641880917814,-0.0771680314578231,-0.0484484697258447,1.12131973729545e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39408,-0.0254337730102954,0.00297113252272214,-0.0312571927548308,-0.01961035326576,1.27824330341406e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41802,-0.034196038533642,0.00399801431434574,-0.0420321465897596,-0.0263599304775243,1.32743051741965e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41847,-0.0279758546667482,0.00327416859673052,-0.03439322511634,-0.0215584842171564,1.43198300190377e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41622,-0.0332780319099984,0.00389677270404516,-0.0409157064099269,-0.0256403574100699,1.49142802745533e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39250,-0.070836095656673,0.00831740315519515,-0.0871382058408555,-0.0545339854724905,1.86407968095515e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39308,0.0519030355018331,0.00609562006328182,0.0399556201778008,0.0638504508258655,1.89183828411651e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41689,-0.0377120415643725,0.00443521504088057,-0.0464050630444984,-0.0290190200842466,2.04870501449093e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41466,-0.0466748403051036,0.00551568282389862,-0.0574855786399449,-0.0358641019702623,2.90550534680153e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,41877,-0.0339132153962819,0.00400799288071881,-0.0417688814424907,-0.026057549350073,2.91643805854359e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39408,-0.0312973147578775,0.00369832616072265,-0.0385460340328939,-0.0240485954828611,2.95326087624164e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41689,-0.0333589607642578,0.00394674894711908,-0.0410945887006112,-0.0256233328279044,3.15705456077497e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39250,-0.0551925202412233,0.00652930664679979,-0.0679899612689509,-0.0423950792134957,3.20833225194407e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,39600,-0.101248463404812,0.0120106755938314,-0.124789387568722,-0.0777075392409028,3.89178770319568e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,39625,-0.0275676458042486,0.00327338618758036,-0.0339834827319061,-0.0211518088765911,4.16835502254723e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41636,-0.0327041970504012,0.00389913195716998,-0.0403464956864543,-0.025061898414348,5.47036643603962e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,41862,-0.0256754401661308,0.00306937659431574,-0.0316914182909897,-0.019659462041272,6.60597134428885e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41466,-0.0568312011816861,0.00680494004417002,-0.0701688836682593,-0.0434935186951128,7.42809885505882e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,41758,0.0530550612061118,0.00635637403261329,0.0405965681021897,0.0655135543100338,7.71229899999438e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,41788,-0.0454368993924752,0.00545094947711016,-0.0561207603676111,-0.0347530384173393,8.46941145747954e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,39633,-0.0673998405970107,0.00808615401712279,-0.0832487024705714,-0.05155097872345,8.6527652500896e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,39598,-0.0345551902873017,0.00414631641035338,-0.0426819704515943,-0.0264284101230091,8.7484215680407e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,41765,-0.0554339981402982,0.00669816353720696,-0.0685623986732238,-0.0423055976073725,1.3956753274373e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,41802,-0.0244329513580017,0.00295487181431587,-0.0302245001140608,-0.0186414026019426,1.48296260997805e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,41865,0.0330493452156011,0.00401866880512647,0.0251727543575532,0.040925936073649,2.15110628658191e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,41925,-0.0384427884069674,0.00467574929902554,-0.0476072570330575,-0.0292783197808774,2.19014237369463e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,41765,-0.0611773345472042,0.00744748134463649,-0.0757743979826918,-0.0465802711117167,2.32813802750154e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39650,0.0216137923689585,0.00263822784937409,0.0164428657841853,0.0267847189537317,2.83944310147891e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,39600,-0.0390565332776505,0.00477000038365192,-0.0484057340296082,-0.0297073325256927,2.95054291425784e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,39598,-0.0604832359846866,0.00739561461068888,-0.0749786406216368,-0.0459878313477364,3.19634304440192e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,41819,-0.0160704679484966,0.00196920919350741,-0.0199301179677711,-0.0122108179292221,3.62516216475295e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41614,-0.0324528177282411,0.00398241101738013,-0.0402583433223062,-0.0246472921341761,4.00156986623612e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39616,0.0640706948863256,0.00786495138410185,0.048655390173486,0.0794859995991652,4.15549441998251e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,41739,0.0421912835226746,0.00519362233954135,0.0320117837371736,0.0523707833081757,4.92452545667183e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39408,-0.0325869614183913,0.00403090327603878,-0.0404875318394273,-0.0246863909973553,6.92043042928403e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,41877,-0.0213022449404722,0.00263979708534109,-0.0264762472277407,-0.0161282426532037,7.65243565440692e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,41706,-0.0281595815461291,0.00351842267967406,-0.0350556899982902,-0.0212634730939679,1.31095273427731e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,41805,-0.066844252889361,0.00835375826656279,-0.0832176190918241,-0.0504708866868979,1.32903995787947e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41465,-0.0704831401059915,0.00886311542019505,-0.0878548463295738,-0.0531114338824092,1.98130247433768e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,41765,-0.036883756374035,0.00466154639494479,-0.0460203873081268,-0.0277471254399432,2.7268287189392e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39408,-0.0349650371406565,0.00441803792600739,-0.043624391475631,-0.026305682805682,2.73271587038045e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41586,-0.034084271149521,0.0043314669706527,-0.0425739464120003,-0.0255945958870417,3.85723097034312e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41836,0.036313016039609,0.00461831186197754,0.027261124790133,0.045364907289085,4.04499363822569e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39633,-0.046570632327601,0.00593191116371065,-0.0581971782084739,-0.0349440864467281,4.51424538175982e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39530,0.0351839359863436,0.00448730683426809,0.0263888145911781,0.0439790573815091,4.89432558974989e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39408,-0.0186128672030643,0.00237475102930949,-0.0232673792205109,-0.0139583551856177,5.01502726616905e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39408,-0.0195135824772676,0.00249400633372357,-0.0244018348913658,-0.0146253300631694,5.58580524005865e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41764,0.0275586472330437,0.00353105802172337,0.0206377735104659,0.0344795209556216,6.41594518277851e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39490,-0.0220481811994855,0.00282601303139333,-0.0275871667410165,-0.0165091956579546,6.65755610830165e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,41740,-0.0412585196631059,0.00530756850869894,-0.0516613539401558,-0.030855685386056,8.19918787070416e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41836,-0.0357448864861147,0.0045994068538745,-0.0447597239197087,-0.0267300490525206,8.3180089884377e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,41689,-0.0592311754542498,0.00762386158637531,-0.0741739441635454,-0.0442884067449542,8.48623424401684e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41636,-0.043940497948951,0.005666530160559,-0.0550468970636467,-0.0328340988342554,9.53384098917746e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,39621,0.0296133751199474,0.00381812312005829,0.0221298538046332,0.0370968964352617,9.53750742484155e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41911,-0.0322695120893816,0.00416896777522763,-0.0404406889288278,-0.0240983352499354,1.06224818766311e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,39608,0.0157579053712047,0.00204426325864414,0.0117511493842622,0.0197646613581473,1.38420350848225e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41466,-0.0410620487393129,0.00534227862659361,-0.0515329148474364,-0.0305911826311894,1.6248709303421e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39385,-0.0325455045305781,0.00424309497092396,-0.040861970673589,-0.0242290383875671,1.86483019408946e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,41791,0.0319401805389801,0.00416576231045508,0.0237752864104881,0.0401050746674721,1.8791183890848e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41333,-0.0331211758603503,0.00432776964004078,-0.0416036043548303,-0.0246387473658704,2.10174561461245e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,41750,-0.0390855371704057,0.00511313673654139,-0.0491072851740269,-0.0290637891667846,2.24903345443971e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,41889,0.0442165712172877,0.00579865188805622,0.0328512135166975,0.0555819289178779,2.59931976611259e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,41765,0.0387495417961705,0.00508726864232672,0.0287784952572101,0.0487205883351308,2.77407909117379e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,41877,-0.032859929361411,0.00431587020564881,-0.0413190349644827,-0.0244008237583394,2.8422300156661e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,41848,-0.0392182764141096,0.00518912443447384,-0.0493889603056783,-0.0290475925225408,4.36888730824405e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41465,-0.0683145326574051,0.00904611213267709,-0.0860449124374522,-0.050584152877358,4.58170177833354e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39308,-0.0420280187895392,0.00556505721767548,-0.0529355309361831,-0.0311205066428953,4.63089184361074e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,39650,0.0221290415678668,0.00293063395999125,0.016384999006284,0.0278730841294497,4.66180047598724e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,41865,-0.0281165218231816,0.00372597797263458,-0.0354194386495454,-0.0208136049968178,4.77758098600632e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39633,-0.0319923990457497,0.00424999385061986,-0.0403223869929647,-0.0236624110985348,5.56948665370251e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39308,-0.0431682588492099,0.00574097621626416,-0.0544205722330877,-0.0319159454653322,5.94666366293611e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39308,-0.0416685219542934,0.00554940967910533,-0.0525453649253398,-0.0307916789832469,6.44981501393293e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41911,0.0223832473105269,0.00299746569687146,0.0165082145446588,0.0282582800763949,8.68858649322054e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",41765,0.0638527183847637,0.00858814433024273,0.047019955497488,0.0806854812720394,1.11041131112423e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,41925,-0.0462658012889698,0.00622652582822367,-0.0584697919122881,-0.0340618106656514,1.14828426734404e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39625,-0.0238162966693787,0.00320524133644099,-0.0300985696888031,-0.0175340236499544,1.16259785275524e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41534,-0.0564845332595724,0.00761941662714656,-0.0714185898487797,-0.0415504766703651,1.30917143426212e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,41805,0.0326503537521948,0.00441221951456145,0.0240024035036543,0.0412983040007352,1.44430454825743e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41689,-0.0262598169762452,0.00354918280592134,-0.033216215275851,-0.0193034186766394,1.45756077820973e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,41740,-0.0780946910606267,0.0105626803238578,-0.098797544495388,-0.0573918376258654,1.51720079984288e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39655,0.0214615935575273,0.00290252569818347,0.0157726431890877,0.0271505439259669,1.52653727561275e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39650,0.0211342009012532,0.00285909708658368,0.0155303706115491,0.0267380311909572,1.55188349919767e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,41836,0.0254166473907475,0.00343971350501241,0.0186748089209231,0.0321584858605718,1.56594807895987e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,41888,-0.0404964907666175,0.00548250861662084,-0.0512422076551943,-0.0297507738780406,1.59740465405689e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,41636,0.0273334081806891,0.00370407932346686,0.0200734127066941,0.0345934036546841,1.68792497808052e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39625,-0.0577065412328214,0.00782266512012435,-0.0730389648682651,-0.0423741175973777,1.73735549835653e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,41689,0.0614799924952769,0.00836462871035219,0.0450853202229866,0.0778746647675672,2.09970814711814e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,41925,0.0213268302685163,0.00291420182658874,0.0156149946884024,0.0270386658486302,2.6562371903697e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41362,-0.0162748692201515,0.00222813585528293,-0.020642015496506,-0.0119077229437969,2.95363107177843e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,39625,-0.0255969874538759,0.00350608861939479,-0.0324689211478897,-0.0187250537598622,3.05935243093112e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,41884,0.0296581446620437,0.00406345162353349,0.021693779479918,0.0376225098441693,3.06937473327275e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,41925,0.0261808564219918,0.00358796704349827,0.0191484410167352,0.0332132718272484,3.11246976997183e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41577,-0.0275689799770082,0.00378046052639347,-0.0349786826087394,-0.020159277345277,3.21915029330921e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41466,-0.0414080973819186,0.0056835496875138,-0.0525478547694457,-0.0302683399943916,3.3889101391043e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,41740,-0.0542935915773975,0.00746399407916853,-0.0689230199725678,-0.0396641631822272,3.68589044558588e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,41774,0.0243003090432222,0.00335479829189811,0.0177249043911019,0.0308757136953425,4.61720495238675e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41740,0.0306426799185969,0.00425573691094851,0.0223014355731378,0.038983924264056,6.33370294002198e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39622,0.0115025132090823,0.00159945981423365,0.00836757197318433,0.0146374544449802,6.82374298303795e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,41765,-0.0214884917008867,0.00299242896075626,-0.027353652463969,-0.0156233309378045,7.29442030947549e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41689,-0.0655633326131812,0.00915158231489663,-0.0835004339503786,-0.0476262312759838,8.24570214125786e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,41836,-0.0438190026158528,0.00613478214288386,-0.0558431756159051,-0.0317948296158004,9.6287411654015e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,41911,-0.0285774190044339,0.00400772233544638,-0.0364325547819088,-0.020722283226959,1.05098493765483e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,41865,0.0162607802284269,0.00228374165272379,0.0117846465890883,0.0207369138677656,1.13289877221215e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,39576,-0.0248957472482047,0.00350215442218228,-0.0317599699156819,-0.0180315245807274,1.24422016507036e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41465,-0.0430213505026493,0.00606765965204299,-0.0549139634206536,-0.0311287375846451,1.40841470522466e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,41925,-0.047206568011504,0.00665924497694699,-0.0602586881663201,-0.0341544478566879,1.42012590382876e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,39633,-0.0307520373098445,0.00435940486361147,-0.039296470842523,-0.022207603777166,1.84017621466029e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,41740,-0.0500380352386076,0.00709523310836696,-0.0639446921310068,-0.0361313783462083,1.84728023628484e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,41877,-0.0243826569633185,0.00346421245739644,-0.0311725133798155,-0.0175928005468214,2.03948905630652e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39308,-0.0451578089548743,0.00642204177158656,-0.0577450108271839,-0.0325706070825646,2.16487629838119e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39600,-0.0307580209565789,0.00437854730837924,-0.0393399736810022,-0.0221760682321555,2.27185183128788e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41466,-0.0222498571204135,0.00316956057528686,-0.0284621958479757,-0.0160375183928512,2.33242411410609e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,41765,-0.0612589853960893,0.00873612995488956,-0.0783818001076728,-0.0441361706845057,2.46149339260251e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41465,-0.055297479162982,0.00790550970342958,-0.070792278181704,-0.03980268014426,2.78773002849611e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,41810,0.0224737805365404,0.00322028971970271,0.0161620126859231,0.0287855483871578,3.11899604816902e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41689,-0.0449228097289706,0.00643725873813416,-0.0575398368557135,-0.0323057826022276,3.12576078617256e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,41740,-0.042093815369493,0.0060354263948689,-0.053923251103436,-0.03026437963555,3.2174879730867e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39259,-0.06375231802524,0.00914402691115057,-0.0816746107710951,-0.0458300252793849,3.30920105082133e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,39650,0.0173499469929819,0.00249878789636037,0.0124523227161156,0.0222475712698482,4.04406436010936e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,39633,0.030121702133062,0.00434507007544613,0.0216053647851876,0.0386380394809365,4.36907718222608e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,41636,-0.0395447213405736,0.00570768424285096,-0.0507317824565615,-0.0283576602245857,4.4583895086338e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,41802,-0.0299839875425602,0.0043327799205734,-0.0384762361868841,-0.0214917388982364,4.71603549521185e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,41636,-0.0495655724643977,0.00716805089746409,-0.0636149522234273,-0.0355161927053681,4.90391164174686e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41534,0.0293377228254611,0.00424659283113066,0.021014400876445,0.0376610447744772,5.12616736122001e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39334,-0.0239571479327391,0.00348276548370952,-0.0307833682808098,-0.0171309275846685,6.37315681868859e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,41848,0.020095248682968,0.00292921588866367,0.0143539855411872,0.0258365118247488,7.17768401787538e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,41786,0.0328236364514942,0.00478561259458842,0.0234438357661009,0.0422034371368875,7.25295724672676e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,41740,-0.0487577390773086,0.00711047561943347,-0.0626942712913982,-0.034821206863219,7.33781307157959e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41765,-0.0462025512891062,0.0067555701225584,-0.0594434687293207,-0.0329616338488918,8.31651578293057e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,41764,-0.0457667352843104,0.00669296417537705,-0.0588849450680494,-0.0326485255005714,8.38285029787134e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,41765,-0.022778974095968,0.00334161055089636,-0.0293285307757249,-0.0162294174162112,9.71709087862614e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41465,-0.0415640143813504,0.00609898195720104,-0.0535180190174645,-0.0296100097452364,9.85260717279929e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,41689,0.0220343090369731,0.00323701005958234,0.0156897693201917,0.0283788487537545,1.04002394313411e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,41758,-0.0462943331813375,0.00682824451493051,-0.0596776924306013,-0.0329109739320737,1.25451040403946e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39498,-0.0380650758457028,0.00561389224092159,-0.0490683046379091,-0.0270618470534965,1.25943810681151e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41465,-0.0348336097760878,0.00513870620795252,-0.0449054739436747,-0.0247617456085009,1.26575500477373e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,41911,-0.0250207064142186,0.0037065607538082,-0.0322855654916827,-0.0177558473367545,1.53565095091876e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,39600,-0.0691056584512893,0.0102556483280224,-0.0892067291742131,-0.0490045877283655,1.68256269954183e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41689,0.0295191597886524,0.00438368256524576,0.0209271419607707,0.0381111776165341,1.72102090186757e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41601,0.0413547572241072,0.00614687976739476,0.0293068728800135,0.053402641568201,1.79505202046045e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39625,-0.0430415933298485,0.00641436452468757,-0.0556137477982362,-0.0304694388614609,2.03903781357145e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39408,-0.0289540633172807,0.00431542746807835,-0.0374123011547143,-0.0204958254798472,2.0515658443005e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,41689,-0.0388288571746787,0.00579177913062979,-0.0501807442707131,-0.0274769700786443,2.10915052303253e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39427,-0.0411975516497794,0.00615165113277558,-0.0532547878700195,-0.0291403154295393,2.23297813348396e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,41764,0.0170726636905112,0.00256211491528791,0.0120509184565469,0.0220944089244755,2.78015080062812e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,39650,-0.0494148537247282,0.00741921945830405,-0.0639565238630041,-0.0348731835864523,2.86079651225761e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41689,-0.020157189087426,0.00302786937745844,-0.0260918130672446,-0.0142225651076075,2.90186089052544e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,41866,-0.0361331331517262,0.00543273714236731,-0.0467812979507661,-0.0254849683526863,3.02517881487722e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,41877,-0.0457820762237168,0.00688551646572917,-0.059277688496546,-0.0322864639508877,3.06548916856189e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41832,-0.0412242672987942,0.00620733391814561,-0.0533906417783596,-0.0290578928192288,3.23251066301112e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39308,-0.0258159953777838,0.00390106283815703,-0.0334620785405716,-0.018169912214996,3.82308255746831e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,41724,-0.046908168024324,0.00710374953397115,-0.0608315171109075,-0.0329848189377406,4.17595119918281e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,41744,0.0317135990892078,0.00480427395369847,0.0222972221399588,0.0411299760384568,4.23723556060738e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41636,-0.0518664745476949,0.0078640760728821,-0.0672800636505438,-0.036452885444846,4.4056917207936e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41465,-0.0462278072326623,0.00701023727612126,-0.05996787229386,-0.0324877421714646,4.43878813039123e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,41644,-0.0508831747924759,0.00775850541215363,-0.066089845400297,-0.0356765041846548,5.64488845763466e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,41805,-0.0253059554161039,0.00385956564004167,-0.0328707040705855,-0.0177412067616222,5.70636629291443e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39427,-0.0380985922599987,0.00581856365122461,-0.049502977016399,-0.0266942075035985,6.1048920353067e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,41744,0.0244124543539003,0.00372947700500687,0.0171026794240869,0.0317222292837138,6.13700385755792e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",41765,-0.0517088716625573,0.00791289749093901,-0.0672181507447978,-0.0361995925803169,6.60582192254175e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,41836,0.0338665844180164,0.00518803049408836,0.0236980446496032,0.0440351241864296,6.91623027666356e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39598,-0.0483564411816447,0.00742235011655513,-0.0629042474100928,-0.0338086349531967,7.58763920335639e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39250,-0.0474276716181733,0.00730256277941026,-0.0617406946658174,-0.0331146485705292,8.69301692215146e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,39598,-0.0426847450420153,0.00657821113194797,-0.0555780388606334,-0.0297914512233973,9.02375108211077e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,41740,-0.0638802181122341,0.00984656566875165,-0.0831794868229873,-0.0445809494014809,9.03623725881924e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,41925,0.0111241419015065,0.00171699410447509,0.00775883345673535,0.0144894503462777,9.56748530774522e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41689,-0.0370193690362583,0.00576419853940516,-0.0483171981734924,-0.0257215398990242,1.38877253408195e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,41925,0.0214078566380704,0.00333361336217567,0.0148739744482061,0.0279417388279347,1.39226399990856e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,41832,-0.0414861925602085,0.00649039446457832,-0.054207365710782,-0.028765019409635,1.69292819328429e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,41877,0.0230962166950565,0.00361584981853316,0.0160091510507315,0.0301832823393814,1.7424940878071e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39413,-0.0316376478497768,0.00495941395545882,-0.0413580992024761,-0.0219171964970775,1.85155116564914e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,41805,-0.0204513376782895,0.00320670515492209,-0.0267364797819368,-0.0141661955746423,1.8578250456326e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,41765,-0.0314278009587837,0.00493150177268765,-0.0410935444332515,-0.0217620574843159,1.91710616067571e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,41911,-0.0289760876002547,0.00454930904702704,-0.0378927333324277,-0.0200594418680817,1.96088317260661e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39308,-0.0215087980013444,0.00337850224074904,-0.0281306623932125,-0.0148869336094763,2.01477634924131e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,39572,-0.0311762808414418,0.00490029310528274,-0.040780855327796,-0.0215717063550876,2.0690663207733e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,41786,-0.0398837077253582,0.00627787693200542,-0.0521883465120888,-0.0275790689386276,2.18014738416017e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39633,-0.0160701652333213,0.00253365638927959,-0.0210361317563093,-0.0111041987103333,2.34641771050064e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,41740,-0.0512390251320233,0.00808527819921816,-0.0670861704024909,-0.0353918798615557,2.41425511868591e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,41925,-0.0438387675620694,0.0069370634874629,-0.0574354119974967,-0.0302421231266421,2.70767494668593e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41534,-0.0419509704077638,0.00665187227476734,-0.0549886400663077,-0.0289133007492198,2.94438762031322e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,41720,0.0438782693330365,0.00696150171814156,0.030233725965479,0.0575228127005939,3.01305397515812e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39600,-0.0395158551290718,0.00628355480760064,-0.051831622551969,-0.0272000877061745,3.32123477039224e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39338,-0.0267250615061496,0.00425148017066169,-0.0350579626406465,-0.0183921603716527,3.38262134066605e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,41740,0.0228734082670098,0.00365026044850906,0.015718897787932,0.0300279187460875,3.81420885494828e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41636,-0.016133049756894,0.00257638776866423,-0.0211827697834758,-0.0110833297303121,3.9228707212095e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,41813,-0.0208161422487707,0.00333385856086809,-0.0273505050280722,-0.0142817794694693,4.39976215719283e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41667,-0.0174642796929255,0.00279889319578588,-0.0229501103566658,-0.0119784490291851,4.51923719986811e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,41871,-0.0163912596515044,0.00262838166806866,-0.021542887720919,-0.0112396315820899,4.6176434490442e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",41758,0.0161460963763712,0.00258952138512026,0.0110706344615355,0.0212215582912069,4.65098490424932e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,41744,-0.0183458156801382,0.00294442555689528,-0.024116889771653,-0.0125747415886235,4.78547096042695e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41689,-0.0358911001158921,0.00576627351081422,-0.0471929961970879,-0.0245892040346962,4.98432387912097e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39598,-0.0227712860663639,0.00366112584269337,-0.0299470927180429,-0.0155954794146849,5.16034355584133e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41836,-0.0286214629418352,0.00460357728921305,-0.0376444744286927,-0.0195984514549776,5.21239756449644e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41466,-0.0225785163685308,0.00365381094136735,-0.0297399858136108,-0.0154170469234508,6.62702046249062e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39600,-0.0265708709215296,0.00430005020447805,-0.0349989693223066,-0.0181427725207526,6.67068030619815e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39250,-0.045677058576931,0.00739976055993789,-0.0601805892744093,-0.0311735278794528,6.95449884273797e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,41911,-0.023322386893793,0.00377943659716278,-0.0307300826242321,-0.015914691163354,6.98882498130005e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39328,-0.0303579208636962,0.0049228763679324,-0.0400067585448437,-0.0207090831825487,7.22386375235093e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41689,-0.0293898819605281,0.00477727360956777,-0.038753338235281,-0.0200264256857753,7.87324607965204e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39308,-0.0410977864598152,0.00670529351430724,-0.0542401617478574,-0.027955411171773,9.14573657928471e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39633,-0.0285482925015382,0.00466142983556121,-0.0376846949792382,-0.0194118900238383,9.41468449269269e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,41802,0.0250818641239212,0.00410200109004785,0.0170419419874275,0.033121786260415,9.95653578214252e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,41621,0.0180265201030844,0.0029495424110309,0.0122454169774638,0.023807623228705,1.01432645941564e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,41877,0.0390988175725131,0.00640923850423324,0.0265367101042159,0.0516609250408102,1.08754596024759e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,39600,-0.0574668681930769,0.00942627924550027,-0.0759423755142574,-0.0389913608718963,1.12085418716484e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39598,-0.0407037049100679,0.00670016305329809,-0.0538360244945322,-0.0275713853256037,1.28064220393864e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,41636,0.0170388017806679,0.00280844907525099,0.011534241593176,0.0225433619681599,1.33949542152329e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41911,0.0166005930565963,0.00273720716143475,0.0112356670201842,0.0219655190930084,1.35703129431583e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41466,-0.0249898315755906,0.00412090075389227,-0.0330667970532195,-0.0169128660979618,1.3635611459389e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41689,-0.0693569940271896,0.0114698078709841,-0.0918378174543185,-0.0468761706000607,1.51663083907732e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39308,-0.0150466947618647,0.00249465893867314,-0.019936226281664,-0.0101571632420653,1.67745643006991e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,39596,0.0311707684641503,0.0051699104461485,0.0210377439896993,0.0413037929386014,1.69994866921564e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,41750,-0.0196594326513517,0.00327396198853012,-0.0260763981488707,-0.0132424671538326,1.96639176632199e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,41802,-0.022143337789179,0.0036947595363466,-0.0293850664804183,-0.0149016090979396,2.11147449504434e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41689,-0.0630194066597164,0.010523289844741,-0.0836450547554088,-0.0423937585640239,2.17249189557306e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39600,-0.0501307106863411,0.00837099673226176,-0.0665378642815741,-0.033723557091108,2.1824484325144e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39589,-0.0238228177891607,0.00399842459810015,-0.031659730001437,-0.0159859055768844,2.63090514414232e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41534,-0.0302570438752505,0.00508200049727871,-0.0402177648499167,-0.0202963229005842,2.68834355144308e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39090,-0.0318415197250869,0.00534915491171328,-0.042325863352045,-0.0213571760981289,2.7232381625151e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39408,0.0300580041101397,0.00505458898296023,0.0201510097035376,0.0399649985167417,2.82110302092487e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41689,-0.0132625055948907,0.00223815829457846,-0.0176492958522645,-0.00887571533751692,3.18917395615736e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41465,-0.0423464847898306,0.00715694500587992,-0.0563740970013552,-0.0283188725783059,3.36536999395448e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41604,0.017413222684667,0.00294394291067463,0.0116430945797447,0.0231833507895893,3.40355269360452e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39250,-0.0312372521034871,0.0052831864357078,-0.0415922975174743,-0.0208822066894998,3.47136032743608e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41689,-0.0388091912957949,0.00656590509369942,-0.0516783652794458,-0.025940017312144,3.49106067032743e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41466,-0.0373757316114253,0.00632794476821873,-0.049778503357134,-0.0249729598657166,3.58372861516129e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41465,-0.0369320690202731,0.00626287431037289,-0.0492073026686039,-0.0246568353719422,3.79498318693576e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41750,-0.0786388136179466,0.0133654455380735,-0.104835086872571,-0.0524425403633225,4.10856968948377e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,41764,-0.018696058316234,0.00317833420996409,-0.0249255933677637,-0.0124665232647044,4.14317524213805e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39600,-0.0393060096457788,0.00668199608618674,-0.0524027219747048,-0.0262092973168528,4.16197551504707e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,41758,-0.0352547872164588,0.00599444337013082,-0.0470038962219152,-0.0235056782110024,4.17079323950993e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39408,-0.0294363735383454,0.005007378349096,-0.0392508351025736,-0.0196219119741173,4.25986575358264e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39308,-0.0156253561914438,0.00265834904939067,-0.0208357203282495,-0.0104149920546381,4.28050263267685e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41823,0.020247300983033,0.00344821465658351,0.0134888002561293,0.0270058017099366,4.41380246066185e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41466,-0.0229103109845207,0.00390287186838895,-0.0305599398465631,-0.0152606821224784,4.46225471613762e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41764,-0.0161918913039384,0.00275895596175351,-0.0215994449889753,-0.0107843376189015,4.4939679633583e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,39600,-0.0326722931622606,0.00557101514032547,-0.0435914828372986,-0.0217531034872227,4.62914186964947e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39598,-0.0402789610965933,0.00686855462574189,-0.0537413281630474,-0.0268165940301392,4.64133917351369e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41465,-0.0430268388472977,0.00734765879812902,-0.0574282500916305,-0.0286254276029648,4.86144466347221e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41522,-0.0353049171658125,0.00603011647313197,-0.0471239454531512,-0.0234858888784739,4.89287646122875e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,41636,0.0213851540625528,0.00365536697657393,0.0142206347884679,0.0285496733366377,5.0233368764963e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,41740,-0.0151093005066726,0.00258605318867592,-0.0201779647564774,-0.0100406362568678,5.26066137694223e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,41758,0.0197489665146277,0.00338018049671772,0.013123812741061,0.0263741202881944,5.2615207464753e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41740,-0.0630003276669791,0.0107850098604112,-0.0841389469933851,-0.0418617083405731,5.29665626291344e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39598,-0.048332042874396,0.00829119085587173,-0.0645827769519046,-0.0320813087968874,5.72163199231877e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,39589,-0.0230379439716,0.00396100751285098,-0.0308015186967879,-0.0152743692464121,6.18851856871547e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39250,-0.0246879357750949,0.00425033954711565,-0.0330186012874416,-0.0163572702627483,6.48543255320609e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41636,-0.0255415132930087,0.00439843214204506,-0.034162440291417,-0.0169205862946003,6.51009890471643e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,39625,-0.0338127831761184,0.00582831782187298,-0.0452362861069894,-0.0223892802452473,6.75465264441302e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,41740,-0.0374500473393565,0.00645640732707921,-0.0501046057004317,-0.0247954889782812,6.76612801474844e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41617,-0.0432397663336335,0.00745688329376937,-0.0578552575894214,-0.0286242750778455,6.84078318433435e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,41805,-0.0243996612255546,0.00421031766717519,-0.032651883853218,-0.0161474385978912,6.97948783774425e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39250,-0.0225412494133966,0.00388967314813401,-0.0301650087837392,-0.0149174900430539,7.01956428093475e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39625,-0.0357638488184857,0.00618502165745559,-0.0478864912670987,-0.0236412063698728,7.56728006214146e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,41877,0.0103325165251694,0.00178947949333218,0.00682513671823832,0.0138398963321005,7.91276437118764e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,41911,-0.0295055926424144,0.00511302757486356,-0.039527126689147,-0.0194840585956818,8.07156413489403e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",41716,-0.0420596102765782,0.00730170778965732,-0.0563709575443066,-0.0277482630088499,8.58782516416064e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39530,-0.0169865385853088,0.00295997224190079,-0.0227880841794343,-0.0111849929911832,9.79145402662808e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41521,-0.0352005031478391,0.0061437533233107,-0.0472422596615281,-0.0231587466341502,1.02987620008729e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,41925,-0.0191450370286479,0.0033510676120802,-0.0257131295483251,-0.0125769445089707,1.1329879353892e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,41765,-0.0227926553182038,0.00399365038845422,-0.0306202100795741,-0.0149651005568335,1.17310209524811e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39633,-0.0174479914289856,0.00305701726154569,-0.0234397452616151,-0.011456237596356,1.17588586613964e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41689,-0.0699502062906385,0.0122840133330928,-0.0940268724235003,-0.0458735401577767,1.2646102812898e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,39633,-0.0695916924641722,0.0122308040908724,-0.0935640684822821,-0.0456193164460623,1.30373711712171e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39489,-0.0368842642459307,0.00648949700303458,-0.0496036783718785,-0.024164850119983,1.35209839918667e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41521,-0.0345029497065888,0.00607641696569034,-0.0464127269593418,-0.0225931724538357,1.39072933357848e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,41718,-0.0508710393594051,0.00896012070361748,-0.0684328759384953,-0.0333092027803148,1.39579641738245e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,41740,-0.0650539889390578,0.0114730275941672,-0.0875411230236255,-0.04256685485449,1.45662288572731e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",41925,-0.0306554239425041,0.00541005778545578,-0.0412591372019974,-0.0200517106830107,1.48869538118456e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39625,-0.0209003890888308,0.00369693142030301,-0.0281463746726247,-0.0136544035050369,1.61174203018161e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39554,0.0165955916137539,0.00293622366859251,0.0108405932233126,0.0223505900041952,1.62537006536622e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,39600,0.0297440085581552,0.00526429729503071,0.019425985859895,0.0400620312564154,1.64302956173707e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,41740,0.0346032537635132,0.00613115821478265,0.0225861836625392,0.0466203238644872,1.697410870801e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39625,-0.0154738911006266,0.00275044879706771,-0.0208647707428793,-0.0100830114583739,1.88986380041408e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,41765,0.0189371514929219,0.00337196806905343,0.0123280940775772,0.0255462089082666,1.99323751056841e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,41911,-0.0241347134557916,0.00430052066432625,-0.032563733957871,-0.0157056929537122,2.03941785320101e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,41758,-0.0254240766652965,0.00454108135596904,-0.0343245961229958,-0.0165235572075972,2.20307830883878e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39598,-0.0184066989918616,0.00329047529910535,-0.024856030578108,-0.0119573674056151,2.27287785477406e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,39598,-0.039649639104833,0.00708883864835747,-0.0535437628556136,-0.0257555153540523,2.28183210969255e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,41911,-0.0452273864786846,0.00810290569072216,-0.0611090816325001,-0.0293456913248692,2.4293761525005e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41689,-0.0196656112981683,0.00352798873551554,-0.0265804692197787,-0.0127507533765578,2.53629842888504e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41865,0.0279086879722612,0.00500935889885799,0.0180903445304996,0.0377270314140229,2.57754665821254e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,39598,-0.0377875063156245,0.00678259420112474,-0.051081390949829,-0.02449362168142,2.58871956500826e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39589,-0.0267878124530124,0.00481465800875885,-0.0362245421501797,-0.017351082755845,2.70138137310284e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41521,-0.0213542819506856,0.00384334599116915,-0.0288872400933772,-0.0138213238079941,2.81213818441938e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41534,-0.0264848606984515,0.00477173141707059,-0.0358374542759098,-0.0171322671209931,2.90680741394626e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39334,0.0194467433167082,0.00350620829149276,0.0125745750653824,0.026318911568034,2.98562593152232e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,39655,0.0319001568731803,0.00575532600150625,0.020619717910228,0.0431805958361325,3.04639654860949e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,41925,0.01444943742812,0.00260798318483694,0.00933779038583963,0.0195610844704004,3.07392172237828e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39598,-0.0184916174344211,0.00333829957801027,-0.0250346846073213,-0.011948550261521,3.1078640720683e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,41855,-0.0212345950072324,0.00384106521892593,-0.0287630828363272,-0.0137061071781376,3.29444311425138e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39334,-0.0222417568461551,0.00403520377857222,-0.0301507562521567,-0.0143327574401536,3.6312612870148e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41465,-0.0378059448751267,0.00686461988512553,-0.0512605998499727,-0.0243512899002806,3.71242487747679e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41465,-0.0289909071681762,0.00527435010905236,-0.0393286333819188,-0.0186531809544336,3.94594490418867e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39334,-0.0290612777244838,0.00529524280305189,-0.0394399536184655,-0.0186826018305021,4.1531140570909e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39308,-0.0223039062318247,0.00406906883414763,-0.0302792811467541,-0.0143285313168954,4.31712610314225e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,41740,0.030988584852266,0.00565767738225937,0.0198995371830376,0.0420776325214944,4.39899591582714e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39336,-0.0161714818910416,0.00295459126144562,-0.021962480763475,-0.0103804830186082,4.51561498267674e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,41865,-0.0338191888638509,0.00618884763104618,-0.0459493302207014,-0.0216890475070004,4.72493283131377e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41465,-0.029043295681415,0.00532046580047329,-0.0394714086503426,-0.0186151827124873,4.88283174304403e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,41865,-0.0400104736152045,0.00733233632821977,-0.0543818528185152,-0.0256390944118937,4.93728469754046e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,41877,-0.0237868620412552,0.00437262988301082,-0.0323572166119564,-0.015216507470554,5.42416730281419e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39308,-0.0497625422010489,0.00914829574806215,-0.0676932018672508,-0.0318318825348471,5.45929231301177e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39598,-0.0244000651755891,0.00448938434732615,-0.0331992584963484,-0.0156008718548299,5.59479675349944e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41521,-0.0220469176454611,0.00405835929878496,-0.0300013018710796,-0.0140925334198426,5.65858285637423e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39600,-0.0165074833304878,0.00304258957832567,-0.0224709589040061,-0.0105440077569695,5.90269563622615e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39600,-0.0293387014863843,0.00541261015475713,-0.0399474173897083,-0.0187299855830604,6.07098799889787e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41689,-0.0735304975220014,0.0135837144895342,-0.100154577921489,-0.0469064171225143,6.30222663595471e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41465,-0.0302593962927601,0.00559540521618593,-0.0412263905164846,-0.0192924020690357,6.49074720768918e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,41758,-0.0139609229686135,0.00258273308485621,-0.0190230798149317,-0.00889876612229532,6.57608757601993e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,39655,-0.0426206916972434,0.00789691502649379,-0.0580986451491712,-0.0271427382453156,6.91138200887236e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41521,-0.0310836765646608,0.00576891529618481,-0.042390750545183,-0.0197766025841385,7.24427207302199e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,41740,-0.0504450426208131,0.00936838094234483,-0.068807069267809,-0.0320830159738173,7.38524836347681e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41679,-0.0274011603977229,0.00508941536838201,-0.0373764145197516,-0.0174259062756942,7.41274825203476e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39589,-0.0359352161804979,0.00668039252105361,-0.049028785521763,-0.0228416468392328,7.63496924455136e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39427,-0.0257698544890752,0.00480115631067286,-0.0351801208579939,-0.0163595881201564,8.15173526951611e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39589,-0.0283494430019995,0.00528468993203326,-0.0387074352687847,-0.0179914507352143,8.28455995217834e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,41865,-0.0136876181320482,0.00255391668125799,-0.0186932948273139,-0.00868194143678252,8.48670372872823e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41447,-0.0420962180502889,0.00788163066712421,-0.0575442141578523,-0.0266482219427254,9.3983093763066e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41408,-0.0189893350423956,0.00355673971628939,-0.0259605448863228,-0.0120181251984684,9.50711154431762e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39334,-0.0215650936851066,0.00403978930678317,-0.0294830807264016,-0.0136471066438116,9.58024538910999e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,41802,0.0158818313311492,0.00297658027149948,0.0100477339990102,0.0217159286632882,9.68044169213188e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,41903,0.0252012434381234,0.00473183242891107,0.0159268518774577,0.0344756349987891,1.02092537238602e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41802,-0.0200943132043263,0.00377297313249787,-0.0274893405440221,-0.0126992858646305,1.02126850855322e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41465,-0.0349478710268432,0.00656461183542439,-0.047814510224275,-0.0220812318294113,1.03400110308173e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,41925,-0.0327230846327057,0.00614684710290941,-0.0447709049544081,-0.0206752643110032,1.03409191053987e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39476,-0.0134211491486013,0.00252462282521731,-0.0183694098860272,-0.00847288841117534,1.08113606031904e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39259,-0.0233016829655465,0.00438320797536217,-0.0318927705972563,-0.0147105953338366,1.08142094440423e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,41655,-0.0387081815796939,0.00729912914568315,-0.0530144747052328,-0.0244018884541549,1.15695466559391e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41465,-0.0325685900214252,0.00615264258345342,-0.0446277694849939,-0.0205094105578565,1.22016139062472e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,39625,-0.0382572725146957,0.00725137540261531,-0.0524699683038217,-0.0240445767255697,1.34637032989282e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39625,-0.0355377492431458,0.00674793036606328,-0.0487636927606298,-0.0223118057256617,1.41693145483927e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39308,-0.0166755691766598,0.00316823309439936,-0.0228853060416825,-0.010465832311637,1.44178168486249e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,41764,-0.0288554796005485,0.00548720266701984,-0.0396103968279074,-0.0181005623731897,1.4735974289357e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,41899,-0.0118010118076224,0.00224564038717519,-0.0162024669664858,-0.00739955664875904,1.50250156841606e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39598,-0.0251662962869481,0.00478939491159728,-0.0345535103136788,-0.0157790822602175,1.51131971051016e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,41750,-0.0432475147897557,0.00823219535259473,-0.0593826176808414,-0.02711241189867,1.51598339189904e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,41636,-0.0497263031868847,0.00946882907304228,-0.0682852081700476,-0.0311673982037218,1.53173051273206e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,39598,-0.0306695019555399,0.00584917352415319,-0.0421338820628801,-0.0192051218481996,1.6057735888813e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,41855,-0.0113773414648776,0.00217511703588527,-0.0156405708552127,-0.00711411207454246,1.71459762353159e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41689,-0.0585418425111102,0.0112254496537059,-0.0805437238323738,-0.0365399611898466,1.86519204727939e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41251,-0.0213101856346803,0.00410091119078036,-0.0293479715686098,-0.0132723997007508,2.0628927776734e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41521,-0.0235643439620574,0.00454131099389907,-0.0324653135100996,-0.0146633744140152,2.14760406185123e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39600,-0.0168559717710662,0.0032486274454455,-0.0232232815641393,-0.010488661977993,2.15602883540111e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41455,-0.0216773979235965,0.00419856328766634,-0.0299065819674226,-0.0134482138797705,2.46584187489303e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39600,-0.0569541515869669,0.0110449869668069,-0.0786023260419084,-0.0353059771320254,2.55898346883845e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,41803,-0.0159120131690723,0.00308625883273779,-0.0219610804812384,-0.00986294585690621,2.56254481973394e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,41877,-0.0302397158145383,0.00589870115890536,-0.0418011700859928,-0.0186782615430837,2.99321885227959e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,41740,-0.023620468989358,0.00461061300089779,-0.0326572704711177,-0.0145836675075984,3.04868985111473e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,41765,-0.0158065259413357,0.00309685101033762,-0.0218763539215975,-0.00973669796107401,3.37070216058842e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,41740,-0.0400524133550798,0.00788130456944343,-0.0554997703111889,-0.0246050563989706,3.7870616767487e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39509,-0.0165370514885121,0.00325703941472119,-0.0229208487413656,-0.0101532542356586,3.89100619018958e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39308,-0.0406027533037682,0.00799851883089197,-0.0562798502123164,-0.0249256563952199,3.91354651232447e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,41758,-0.024473262639778,0.00482866807221125,-0.033937452061312,-0.0150090732182439,4.06777505934319e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,41911,-0.0231986570344143,0.00458457695766516,-0.032184427871438,-0.0142128861973906,4.24507298696567e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41637,-0.0275011650429841,0.00543942284656104,-0.0381624338222437,-0.0168398962637244,4.3418404119252e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39598,-0.0258217216526492,0.00510991624608701,-0.0358371574949798,-0.0158062858103187,4.41317631047172e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,41750,-0.01686028634001,0.00333789569188066,-0.0234025618960961,-0.0103180107839239,4.44992437549858e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41689,-0.0315330505738084,0.00625129231054287,-0.0437855835024725,-0.0192805176451444,4.61414393791073e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39565,-0.0247157770856772,0.00489960427378551,-0.0343190014622968,-0.0151125527090576,4.62124736548212e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41636,-0.0285206768841152,0.00565673062523759,-0.0396078689095808,-0.0174334848586495,4.6711757572785e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39573,-0.0246551617556299,0.00488965570656649,-0.0342388869405002,-0.0150714365707596,4.67290220243686e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39192,-0.0289802609064373,0.00574800665148343,-0.0402463539433448,-0.0177141678695298,4.68818859038898e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41799,0.0263283160220195,0.00522604231152953,0.0160852730914217,0.0365713589526174,4.76870778391543e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,41773,0.0273619380675356,0.00543342781246162,0.0167124195551109,0.0380114565799604,4.82018966208656e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39600,-0.0323503263802663,0.00646750630995015,-0.0450266387477686,-0.019674014012764,5.76212469140441e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,41876,-0.0143809659482931,0.0028874490292086,-0.0200403660455419,-0.00872156585104423,6.42144007021573e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,39625,-0.0249311196800024,0.00500694028184056,-0.0347447226324099,-0.0151175167275949,6.47765392775439e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39633,0.0117502800112666,0.00236223599199944,0.00712029746694772,0.0163802625555855,6.649814194822e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,41765,-0.0188772698642745,0.00379884940414575,-0.0263230146964002,-0.0114315250321489,6.80719346738568e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,41740,-0.0557445450325343,0.0112243065817302,-0.0777441859327255,-0.033744904132343,6.90592992756966e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41614,-0.0172408488062069,0.00348121662646918,-0.0240640333940865,-0.0104176642183273,7.41718357529373e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41636,-0.0228849236097178,0.00462518786977253,-0.031950291834472,-0.0138195553849637,7.59583793459252e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39655,-0.0352952710779967,0.00713471206605837,-0.0492793067274711,-0.0213112354285223,7.64835806216294e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39408,-0.0372282214954271,0.00752766792289534,-0.051982450624302,-0.0224739923665523,7.70836661965484e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41584,-0.0254744357516232,0.00515245099868433,-0.0355732397090444,-0.0153756317942019,7.74365509231827e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,41899,-0.0205896994486518,0.00417393573038482,-0.0287706134802061,-0.0124087854170976,8.19878969384025e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,41765,-0.0199290398119677,0.00404064856467419,-0.0278487109987291,-0.0120093686252063,8.23268354310099e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,39625,-0.0485314595408207,0.00984317130982326,-0.0678240753080743,-0.0292388437735671,8.32272798641207e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,39650,-0.0180861821928148,0.00367161869543967,-0.0252825548358766,-0.0108898095497531,8.51708311216234e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39328,-0.0345058665096904,0.00700776577982078,-0.0482410874381391,-0.0207706455812417,8.60795476959287e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39598,-0.0441944197658157,0.00898833464671758,-0.0618115556733821,-0.0265772838582492,8.92123545377518e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,41711,0.0137326202819235,0.00279983785106067,0.00824493809384457,0.0192203024700024,9.464864537994e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,41740,-0.0384744079317766,0.00784814581358168,-0.0538567737263967,-0.0230920421371566,9.58250428557802e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39600,-0.0294603395124532,0.00601310579115374,-0.0412460268631145,-0.0176746521617918,9.75219170258743e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41466,-0.0350940229856986,0.00716663349444618,-0.0491406246348131,-0.0210474213365841,9.85616720690164e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,41925,-0.018902551135197,0.00386516258886094,-0.0264782698093644,-0.0113268324610295,1.0175741928688e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,41877,-0.0205894269945161,0.00421018825965916,-0.028841395983448,-0.0123374580055841,1.01819288164863e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41716,-0.0358874739554425,0.00734563565400965,-0.0502849198373014,-0.0214900280735836,1.04358347424293e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39600,-0.016031384737296,0.00328139878950202,-0.0224629263647199,-0.00959984310987201,1.0460281381405e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,41721,-0.0128497956338723,0.00263224864114309,-0.0180090029705127,-0.00769058829723183,1.06423794435849e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39328,-0.0176064168919574,0.00361474074604352,-0.0246913087542027,-0.0105215250297121,1.12776433118478e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41466,-0.0269784285806627,0.00554172947563151,-0.0378402183529004,-0.0161166388084249,1.13937974844401e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,41802,0.0149543570370457,0.00307821443660552,0.00892105674129893,0.0209876573327926,1.19861712990295e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39408,0.0191010025578064,0.00393608185863034,0.0113862821148909,0.0268157230007218,1.23434360560322e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39633,-0.0248754140469528,0.0051266718231556,-0.0349236908203378,-0.0148271372735678,1.2379733581849e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41829,-0.0535117776597808,0.0110363243378381,-0.0751429733619434,-0.0318805819576181,1.25689027867606e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41556,-0.0238391138959083,0.00491832815014805,-0.0334790370701985,-0.0141991907216181,1.26798791671739e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41783,-0.0258238262492502,0.0053453063773366,-0.0363006267488299,-0.0153470257496705,1.37293465563959e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39328,-0.0344133652427684,0.00714156785587003,-0.0484108382402737,-0.0204158922452632,1.46446717277519e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39598,-0.0251460273731849,0.00522129470403018,-0.0353797649930841,-0.0149122897532858,1.48379119665888e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39598,0.0367081286313392,0.0076299109870254,0.0217535030967694,0.051662754165909,1.52109327277113e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39308,-0.0242492647990289,0.0050433514865106,-0.0341342337125896,-0.0143642958854681,1.54395792680938e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,41679,-0.0286754374384003,0.00597715924910175,-0.0403906695666397,-0.0169602053101609,1.62429610210338e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39650,-0.0167908367273037,0.00350439013960511,-0.0236594414009298,-0.00992223205367771,1.67800120707282e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41466,-0.0222154564956855,0.00463734647533714,-0.0313046555873463,-0.0131262574040247,1.68178041654083e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",41755,0.0273033757473443,0.00572958642796373,0.0160733863485354,0.0385333651461532,1.90560133763755e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39589,-0.0366295160400881,0.00770113322504304,-0.0517237371611724,-0.0215352949190037,1.99602253963256e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41675,-0.0540707132772491,0.0113711869200477,-0.0763582396405426,-0.0317831869139556,2.00501091297147e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,41805,-0.0127098643529626,0.00267585777687833,-0.0179545455956442,-0.00746518311028112,2.05731431943474e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,41740,-0.0455353715233682,0.00960818290225251,-0.0643674100117831,-0.0267033330349533,2.16782402164428e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41504,-0.0265388798130599,0.00559987766647068,-0.0375146400393425,-0.0155631195867774,2.16865365512507e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39589,-0.0363780607498061,0.00767952854669672,-0.0514299367013317,-0.0213261847982806,2.19602045434262e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41465,-0.0271428184387887,0.00573526945736951,-0.0383839465752329,-0.0159016903023444,2.24006675274103e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39408,-0.0267746234214505,0.00566149534899932,-0.0378711543054891,-0.0156780925374118,2.28202329830485e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,41758,-0.0295874406672129,0.00625718774264339,-0.0418515286427939,-0.0173233526916318,2.28472547160653e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41465,-0.0221654644954095,0.00468827228296608,-0.031354478170023,-0.012976450820796,2.29312742677996e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,41899,-0.0265108650126009,0.00560907278438984,-0.037504647670005,-0.0155170823551968,2.30848264873108e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,39600,0.0590342595981893,0.0124985790229616,0.0345370447131845,0.0835314744831941,2.34944015447194e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,41865,-0.031806372342125,0.00676148584996768,-0.0450588846080617,-0.0185538600761884,2.57622841436572e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41534,-0.0275117131624882,0.00586209284376866,-0.0390014151362747,-0.0160220111887016,2.71781778034725e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41689,-0.026888187215262,0.00574117814838402,-0.0381408963860947,-0.0156354780444293,2.85002733503136e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,41740,-0.0192242242313109,0.00410624229837983,-0.0272724591361354,-0.0111759893264864,2.87340368968731e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39427,-0.0264076271959393,0.00564924416822069,-0.0374801457656518,-0.0153351086262267,2.98167972964483e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,39633,-0.014064884086206,0.0030222704034248,-0.0199885340769186,-0.00814123409549334,3.29751487211837e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,41758,0.0259959914377004,0.00560640091858954,0.0150074456372649,0.0369845372381359,3.57177776183552e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,41802,-0.0279443112429937,0.00603245970180483,-0.0397679322585312,-0.0161206902274562,3.650372071459e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39600,0.0519005696649103,0.0112359304376013,0.0298781460072117,0.0739229933226089,3.89668127329487e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41667,-0.0376354727800867,0.00815611717310072,-0.0536214624393641,-0.0216494831208092,3.98008450538169e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,41802,-0.0411962410830899,0.00895824339838701,-0.0587543981439284,-0.0236380840222513,4.29092359838675e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,41745,-0.0462460330713272,0.0100744528249883,-0.0659919606083042,-0.0265001055343502,4.46440250278214e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,41750,0.0193216621593073,0.00421338381708426,0.0110634298778221,0.0275798944407924,4.56461943828804e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39578,-0.0387648233768873,0.0084536348712194,-0.0553339477244773,-0.0221956990292973,4.5773275002281e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,41805,0.0100500252485396,0.00219319597052825,0.00575136114630419,0.0143486893507749,4.63957569687176e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,39650,0.0148895822450303,0.00325490765523964,0.00850996324076062,0.0212692012493,4.82548752812565e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39600,-0.02542256406897,0.00556577733180685,-0.0363314876393114,-0.0145136404986285,4.98566479255589e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,41911,-0.0240828651246405,0.00528889479677977,-0.0344490989263289,-0.0137166313229522,5.32342614845236e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,41925,0.0156221906522292,0.00343761046841015,0.00888447413414532,0.0223599071703131,5.55523322519671e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39589,-0.0142014065690104,0.00312973261741295,-0.0203356824991397,-0.008067130638881,5.75075619390057e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,39630,-0.0142309646250035,0.00313946726732045,-0.0203843204689516,-0.00807760878105542,5.87852890264315e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39625,-0.0375089207116939,0.00829717682064417,-0.0537713872801565,-0.0212464541432314,6.22823755065001e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39408,-0.0160273320995592,0.0035531767873021,-0.0229915586026713,-0.00906310559644709,6.52937403811349e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41802,-0.0133031936548904,0.00295281602944208,-0.0190907130725969,-0.00751567423718394,6.68619232249578e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39583,-0.0535194618777736,0.0118795082558123,-0.0768032980591657,-0.0302356256963816,6.69977709149082e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39598,-0.0339668999956204,0.00754300687158765,-0.0487511934639322,-0.0191826065273086,6.76592682410752e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,41740,-0.0392046162729219,0.00870969036714868,-0.0562756093925333,-0.0221336231533105,6.8131192374941e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41740,-0.0295558297072828,0.00656954760413322,-0.0424321430113839,-0.0166795164031817,6.88874299727259e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41689,-0.0327343095326577,0.00727611203725137,-0.0469954891256704,-0.018473129939645,6.89027398578552e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,41740,0.0289269502508571,0.00643814230705242,0.0163081913290344,0.0415457091726799,7.08067753663631e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,41765,0.0341498903398077,0.00760966963228566,0.0192349378605278,0.0490648428190876,7.26078829202705e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41521,-0.0260732727094438,0.00581848911044156,-0.0374775113659093,-0.0146690340529784,7.48949292964834e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41617,-0.0110736041003861,0.0024750475968279,-0.0159246973901688,-0.0062225108106034,7.73853274775532e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39035,-0.0597958105609286,0.0133680759014999,-0.0859972393278684,-0.0335943817939889,7.79343116998545e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39250,0.0178170220900588,0.00398853209295047,0.00999949918787582,0.0256345449922417,8.01183717384148e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39334,-0.021777058939717,0.00487552679327753,-0.031333091454541,-0.0122210264248931,8.02825540397901e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39308,-0.0151687691090762,0.00340002241648355,-0.0218328130453839,-0.0085047251727684,8.22668698352818e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,41905,-0.0281373393989546,0.00631008660654605,-0.0405051091477848,-0.0157695696501243,8.29764558980686e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39308,-0.0421549022156379,0.00945799142153725,-0.0606925654018509,-0.0236172390294249,8.39330979224004e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,41765,-0.0262526290152502,0.00589141550264029,-0.0377998034004251,-0.0147054546300752,8.41601820590893e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41614,-0.0430447265911042,0.00966646195889223,-0.061990992030533,-0.0240984611516755,8.53851181162346e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41786,-0.0405990720149553,0.00913128415578635,-0.0584963889602965,-0.022701755069614,8.81366233912314e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,39627,-0.0179138971384347,0.0040370412332757,-0.0258264979556551,-0.0100012963212143,9.19427831351991e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,41740,-0.0461890800477226,0.010410882288386,-0.0665944093329593,-0.025783750762486,9.21275150182362e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39474,-0.0128355951448271,0.00289531360035593,-0.0185104098015248,-0.00716078048812952,9.37412691648524e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,39650,0.0107563096896372,0.00242648909928756,0.00600039105503354,0.0155122283242408,9.38839253862912e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,41702,-0.0201695977516367,0.00455057285624466,-0.0290887205498763,-0.0112504749533972,9.39817512361188e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,41689,-0.0451796584909098,0.0102372592825504,-0.0652446866847086,-0.025114630297111,1.02641529569172e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,39589,-0.0105754248908246,0.00239746518908683,-0.0152744566614348,-0.00587639312021442,1.03832314686508e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41595,0.0116611526188459,0.00264471161428848,0.00647751785484044,0.0168447873828513,1.0456986568693e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41422,-0.0334643199375656,0.00759443672359524,-0.0483494159158122,-0.0185792239593189,1.05943636952277e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41636,-0.0219363786553491,0.00497934404601021,-0.0316958929855291,-0.0121768643251691,1.06394205302006e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39476,-0.0267767212703227,0.00607986397333661,-0.0386932546580624,-0.0148601878825829,1.07207322319881e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39334,-0.016497639227941,0.00374976970485614,-0.023847187849459,-0.00914809060642293,1.09476296045923e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,39625,-0.0182362562514916,0.00414853831673148,-0.0263673913522853,-0.0101051211506979,1.11384775086325e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41447,0.0266615245182678,0.00606822430029032,0.0147678048896988,0.0385552441468368,1.12367417610871e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,41740,-0.0163558794294386,0.00372594398260075,-0.0236587296353361,-0.00905302922354117,1.14378792002425e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,39600,-0.0273167248286525,0.00622486305172354,-0.0395174564100306,-0.0151159932472744,1.15291399014161e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39625,-0.0136106880765513,0.00310423749164339,-0.0196949935601723,-0.00752638259293023,1.17302403873518e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,39643,-0.0263267660793265,0.00600875719836915,-0.03810393018813,-0.014549601970523,1.19007552756601e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,41689,-0.0151415151779616,0.00346153080957851,-0.0219261155647355,-0.00835691479118773,1.22806868251425e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,41877,-0.0220017268838299,0.00503827491143993,-0.0318767457102522,-0.0121267080574076,1.26967186236742e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,41636,-0.0184543460702352,0.0042380522504454,-0.0267609284811082,-0.0101477636593623,1.34425213060478e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,41758,0.0126065503291552,0.00289575346001256,0.00693087354753062,0.0182822271107798,1.35016965997966e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",41744,-0.0444881835050858,0.0102275218341271,-0.064534126299975,-0.0244422407101966,1.37257618681556e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39634,0.0120719380967208,0.00277662908816301,0.00662974508392134,0.0175141311095203,1.38808890710625e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39408,-0.0192508380801897,0.00443187986847942,-0.0279373226224094,-0.01056435353797,1.4136903746231e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41636,-0.0261684701232444,0.00602926201628434,-0.0379858236751617,-0.0143511165713271,1.43396912850034e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,41636,0.0194821342784725,0.00448980523750009,0.0106821160129723,0.0282821525439727,1.44083142831342e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,39625,-0.0126832144977749,0.00292375002103206,-0.0184137645389978,-0.00695266445655209,1.45067393432948e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,41740,-0.0174353371828068,0.00402135106744173,-0.0253171852749926,-0.00955348909062099,1.46384605698033e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,41761,-0.0184025689590486,0.00424746485156755,-0.026727600068121,-0.0100775378499762,1.48450746927763e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39328,-0.021972566138175,0.00507359822700156,-0.0319168186630981,-0.012028313613252,1.4994172241623e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,41689,-0.0621502090582957,0.0143735094358024,-0.0903222875524684,-0.033978130564123,1.54400033700684e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39598,-0.0412634907078594,0.00954436428234683,-0.0599704447012592,-0.0225565367144596,1.55040722459358e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,41740,-0.0186705783993021,0.00432580795184612,-0.0271491619849205,-0.0101919948136837,1.59979150981134e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,41802,-0.024945655443118,0.00578701092327349,-0.036288196852734,-0.0136031140335019,1.63971015429233e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,39534,-0.0115018969356034,0.00266959752532411,-0.0167343080852386,-0.00626948578596812,1.65820015284889e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41383,-0.050185022229369,0.0116562886720041,-0.0730313480264971,-0.0273386964322409,1.67924000599363e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,41689,0.0209802648813419,0.00488874574355934,0.0113983232239656,0.0305622065387182,1.78710894882149e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41443,0.0210611441620887,0.0049179866716178,0.0114218902857178,0.0307003980384596,1.8617091784696e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41617,-0.0164620979559828,0.00384517530625665,-0.0239986415562458,-0.00892555435571975,1.87190317379286e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,41810,-0.0208956369075807,0.00488782414106833,-0.0304757722240746,-0.0113155015910868,1.92445360057208e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,41750,-0.0175378556456925,0.00410805082149799,-0.0255896352558286,-0.00948607603555646,1.97601757545835e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,41865,-0.0297345999826502,0.00696703085592407,-0.0433899804602614,-0.0160792195050391,1.98690880267009e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41636,0.0167227053139333,0.00392044566625783,0.00903863180806797,0.0244067788197987,2.0085132799763e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39308,0.0328127655702319,0.00770012155441768,0.0177205273235733,0.0479050038168906,2.0495211526301e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41465,-0.0449126059112845,0.0105464169308828,-0.0655835830958149,-0.0242416287267542,2.07204097127625e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39600,-0.0179555556019532,0.00422435638672078,-0.026235294119926,-0.00967581708398052,2.15069460317398e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,41765,0.0123716004521972,0.00291257893609317,0.00666294573745461,0.0180802551669398,2.17514060688178e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39406,-0.0304100061722985,0.00715901566252345,-0.0444416768708445,-0.0163783354737526,2.17696653416338e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39308,-0.0236251349020831,0.005564107375199,-0.0345307853574731,-0.012719484446693,2.19468860024143e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39334,-0.0369311352767523,0.00870305312196688,-0.0539891193958074,-0.0198731511576972,2.21939816264873e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41383,-0.0343215267150166,0.00808953362735879,-0.0501770126246399,-0.0184660408053934,2.22394984803488e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,41915,0.0201831877478802,0.00475991509512785,0.0108537541614297,0.0295126213343308,2.24786644223449e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41465,-0.0179242599807347,0.00423149262386978,-0.0262179855235195,-0.00963053443794992,2.29202644910212e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39600,0.0403820622701368,0.0095567401658682,0.0216508515450351,0.0591132729952385,2.40327346105485e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39600,-0.0496107459245732,0.0117610523506455,-0.0726624085318384,-0.0265590833173081,2.48207742916795e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,41865,-0.0138676390916735,0.00329285714671076,-0.0203216390992265,-0.00741363908412038,2.55433464473405e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,39589,-0.0456771065635156,0.0108498807335401,-0.0669428728012543,-0.024411340325777,2.57497126867057e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,41840,-0.0265699427552471,0.00631488501490854,-0.0389471173844679,-0.0141927681260264,2.59901162492035e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41465,-0.0242708527907924,0.00577415343126581,-0.0355881935160734,-0.0129535120655115,2.64757160789105e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41911,-0.0179704372541298,0.00428131518696485,-0.0263618150205809,-0.00957905948767866,2.71737659676454e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,41891,-0.0307021024446875,0.00732168561551562,-0.0450526062510981,-0.0163515986382769,2.76693919876422e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39165,-0.0320076110119691,0.00763803566552416,-0.0469781609163964,-0.0170370611075417,2.80536674737098e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41466,-0.0248244814885877,0.00593726770711558,-0.0364615261945342,-0.0131874367826411,2.91985784756314e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39271,-0.0231708042273089,0.00554264661972981,-0.0340343916019793,-0.0123072168526385,2.93243886596768e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41612,-0.0206182843749986,0.0049359409725926,-0.0302927286812801,-0.0109438400687171,2.97078372980272e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,41758,-0.0104492399394903,0.00250415237867083,-0.0153573786016852,-0.0055411012772955,3.02858167443108e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,41829,-0.0148466466431142,0.00355848723143359,-0.021821281616724,-0.00787201166950433,3.03626811956928e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39308,-0.0199401853162632,0.0047814971746115,-0.0293119197785018,-0.0105684508540247,3.06622073895109e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39600,0.0169970152855351,0.00408748869906017,0.00898553743537719,0.0250084931356931,3.2305349007658e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39408,-0.0304300781481868,0.00732721955391351,-0.0447914284738572,-0.0160687278225163,3.3063972260375e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41865,-0.0232285345026363,0.00560198958094982,-0.0342084340812979,-0.0122486349239747,3.39726753005057e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39250,-0.0161892497777258,0.00390651244804654,-0.0238460141758971,-0.00853248537955463,3.43685707640753e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,41888,-0.0148277851655247,0.00358239656773691,-0.021849282438289,-0.00780628789276031,3.50869443614046e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39589,-0.0509196498089986,0.0123184863752273,-0.0750638831044442,-0.026775416513553,3.59781868820589e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,41636,0.0148563946239645,0.00359465057194102,0.00781087950296015,0.0219019097449689,3.60426426243835e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,41740,-0.0257794727496673,0.00625265999129471,-0.038034686332605,-0.0135242591667297,3.7633176476484e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,41812,-0.0104836018658483,0.00254280551604997,-0.0154675006773062,-0.0054997030543903,3.76502764745195e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41758,-0.0205572306701684,0.00498910678746787,-0.0303358799736054,-0.0107785813667313,3.80492766724093e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39655,0.0235970947322076,0.00573187793317595,0.0123626139831827,0.0348315754812325,3.86931408817861e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,39633,0.0113000544078623,0.0027497584633537,0.00591052781968908,0.0166895809960356,3.9943310727784e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39598,-0.0282668068997767,0.00690477562926177,-0.0418001671331297,-0.0147334466664236,4.2738470987741e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41636,-0.0245604642347172,0.00600389402024737,-0.036328096514402,-0.0127928319550323,4.32554868483021e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41805,-0.0122007323607609,0.00298433954664636,-0.0180500378721877,-0.00635142684933403,4.37209425429298e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41911,-0.0122768558297796,0.00300762035607564,-0.0181717917276879,-0.00638191993187136,4.49266394406304e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41877,-0.0147260048730581,0.00361179423733834,-0.0218051215782413,-0.00764688816787497,4.58471208537943e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39308,0.0336525727754362,0.00826809092518214,0.0174471145620792,0.0498580309887931,4.73154224099365e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,39625,0.0122431506829767,0.00300836114370269,0.00634676284131939,0.0181395385246339,4.74004173972863e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,41865,-0.00995798833016787,0.00244705293404289,-0.0147542120808919,-0.00516176457944381,4.74114277138977e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,41865,-0.0250884470228614,0.00616904632531741,-0.0371797778204836,-0.0129971162252393,4.79328716752562e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41689,-0.0151483530936232,0.00372547879956847,-0.0224502915407774,-0.00784641464646899,4.80760349392609e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39334,0.0188955061051511,0.00464767599669268,0.00978606115163347,0.0280049510586688,4.82547156392787e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41465,-0.0156459219996174,0.00385032812106944,-0.0231925651169135,-0.00809927888232127,4.86233137294689e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41534,-0.0260286898252226,0.00640951871830958,-0.0385913465131094,-0.0134660331373358,4.91629740643169e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,41888,-0.00856433437742026,0.00211064087890398,-0.0127011905000721,-0.00442747825476845,4.98431238417452e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,41750,0.0416697918967138,0.0102715241895825,0.021537604485132,0.0618019793082956,5.00312447175875e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41689,-0.0179190696874334,0.00441927050526036,-0.0265808398777437,-0.00925729949712306,5.04769555581699e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41587,0.0132177168679883,0.0032729959901176,0.00680264472735776,0.0196327890086187,5.41227964970274e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,39650,-0.0084344425059975,0.00208909167843174,-0.0125290621957237,-0.00433982281627129,5.44179384290684e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39598,-0.0297437497719889,0.00736838069719502,-0.0441857759384911,-0.0153017236054866,5.45818006146823e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,39600,-0.0127777829950004,0.00316786985052313,-0.0189868079020257,-0.00656875808797506,5.53100924766412e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,41744,-0.0155657174235887,0.00385989405267898,-0.0231311097668395,-0.0080003250803379,5.54557885378014e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39589,0.018168407948924,0.00450794714202986,0.00933283155054549,0.0270039843473026,5.60798044352636e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,41689,-0.0134921840682133,0.00335152651914949,-0.0200611760457463,-0.00692319209068028,5.7130201322025e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39629,0.00855567491768671,0.00213177994454975,0.00437738622636921,0.0127339636090042,6.02473643669351e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,41689,-0.0321523396895038,0.00801227349576738,-0.0478563957412079,-0.0164482836377997,6.03147793785049e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,41740,0.0192445155794854,0.00479815716348425,0.00984012753905631,0.0286489036199146,6.08446431577308e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41534,-0.0301998304329251,0.0075397877908427,-0.0449778145029768,-0.0154218463628734,6.22601730899285e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,41911,-0.0408258953937965,0.0101972441710296,-0.0608124939690145,-0.0208392968185785,6.27188682276601e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41689,-0.0361199141537867,0.0090269548967896,-0.0538127457514943,-0.0184270825560791,6.33316135088779e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39600,0.0399688033295711,0.0100043963944719,0.0203601863964063,0.059577420262736,6.50817132818613e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41465,-0.0119561171783482,0.00299561292756588,-0.0178275185163773,-0.00608471584031904,6.61020591125848e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,41911,-0.0235678003873979,0.0059054041156945,-0.0351423924541591,-0.0119932083206367,6.61795081071575e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39589,-0.0311275545299779,0.00780298550246675,-0.0464214061148127,-0.015833702945143,6.67306104854005e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41470,-0.0240986327732144,0.00604527374192057,-0.0359473693073787,-0.0122498962390501,6.74653149189256e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41521,0.00949195575254705,0.00238268030196356,0.00482190236069848,0.0141620091443956,6.82139789087274e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41617,0.0196512962811998,0.00493327811588662,0.00998207117406207,0.0293205213883376,6.83015962638904e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,41925,-0.0169427815910528,0.00425972451782763,-0.025291841645995,-0.00859372153611066,7.00306527906869e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39408,0.0224077019188523,0.00563414703565317,0.0113647737289721,0.0334506301087325,7.02084784913566e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,41740,0.0190057294239416,0.00477998240030591,0.00963696391934203,0.0283744949285412,7.0427220819819e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,41689,-0.0329711274307238,0.00829972259896047,-0.0492385837246864,-0.0167036711367613,7.14859125348415e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39308,-0.0318490902330017,0.00802016155660799,-0.0475686068839534,-0.0161295735820501,7.20010402075422e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41689,0.0102943688501631,0.00259384659757569,0.00521042951891472,0.0153783081814114,7.26315776146726e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,39589,-0.0172462148330604,0.00435702567952321,-0.0257859851649259,-0.00870644450119487,7.59750001111018e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,41758,-0.0105656951532236,0.00267489818789984,-0.0158084956015073,-0.00532289470493989,7.85774918874743e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,41736,-0.0392769245771827,0.00995055845879603,-0.0587800191564229,-0.0197738299979425,7.94797917463784e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,41739,0.0141563252842864,0.00358837106081409,0.00712311800509074,0.021189532563482,8.0196000791226e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",41805,-0.0118696929688407,0.00300911298598109,-0.0177675544213637,-0.00597183151631779,8.03525592796746e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,41865,-0.0116170865936209,0.0029463613740456,-0.0173919548867503,-0.00584221830049155,8.09297740880008e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,41736,-0.0101507874076918,0.0025748708057625,-0.0151975341869863,-0.00510404062839728,8.11389473879211e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39598,-0.0369551219480648,0.00938143037292147,-0.0553427254789909,-0.0185675184171387,8.22663984555976e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39308,-0.016593454682458,0.00422107309319485,-0.0248667579451199,-0.00832015141979609,8.50909330933662e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",41877,0.030804251037478,0.00784205328894508,0.0154338265911456,0.0461746754838103,8.60583144037467e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,41740,-0.0390921238897684,0.00995504799021684,-0.0586040179505934,-0.0195802298289434,8.65000158559875e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41758,-0.0130846134191794,0.00334258874638983,-0.0196360873621035,-0.00653313947625534,9.10427138760836e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,41802,0.0116882870048308,0.00298833086915825,0.00583115850128066,0.017545415508381,9.22567327050825e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,39600,-0.0508962227350807,0.0130119761566803,-0.0763996960021741,-0.0253927494679874,9.22798139815179e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41454,-0.0167339304517868,0.004282171468241,-0.0251269865295392,-0.00834087437403446,9.36123128024183e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39308,-0.0221763962297839,0.00568143127752529,-0.0333120015337335,-0.0110407909258344,9.54669898138087e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,41787,0.00884581409933309,0.00227052678669081,0.0043955815974191,0.0132960466012471,9.83056947879262e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41740,-0.0159283340520699,0.00408888370743471,-0.0239425461186419,-0.00791412198549783,9.84732340254562e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,41836,0.0244703435478955,0.00629164956896609,0.012138710392722,0.0368019767030691,0.00010101007157743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,41706,-0.0336542113396743,0.00865331857836511,-0.0506147157532699,-0.0166937069260787,0.000101085030248062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39385,0.0206043348346681,0.00529808734842434,0.0102200836317564,0.0309885860375798,0.000101256426546961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41708,-0.0266089070885557,0.00686704396982001,-0.0400683132694029,-0.0131495009077085,0.000107200711136117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,39630,0.00606079559815471,0.00156476494511175,0.00299385630573568,0.00912773489057373,0.000107994358326124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,39580,-0.0270659741345433,0.00698935991763359,-0.0407651195731052,-0.0133668286959815,0.000108369978432784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39308,-0.0304723187206395,0.00787447379338332,-0.0459062873556708,-0.0150383500856082,0.000109589077804275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,41802,-0.00921254978991175,0.00238398112428109,-0.0138851527935027,-0.00453994678632081,0.000111915930587222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39328,-0.0291685969605243,0.00756098605296304,-0.0439881296243319,-0.0143490642967168,0.000115092634146477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,39633,0.0206151767834495,0.00534598680887551,0.0101370426380535,0.0310933109288455,0.000115819076623712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39408,-0.0311098867208956,0.00807229500665267,-0.0469315849339348,-0.0152881885078563,0.000116919698334175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39625,-0.0225588901692819,0.00586007221173095,-0.0340446317042746,-0.0110731486342892,0.000118982778974652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,41762,-0.014995601239474,0.0038963272718583,-0.0226324026923163,-0.00735879978663177,0.000119331649682136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39600,-0.0203485242080677,0.00529736893616708,-0.0307313673229552,-0.00996568109318021,0.000123096158524563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39600,-0.0321795300951952,0.00839028235498763,-0.0486244835109709,-0.0157345766794194,0.000126094095366569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39650,-0.0128935004127571,0.00336378817102349,-0.0194865252279632,-0.0063004755975511,0.00012727639995805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39427,-0.0224776407140158,0.00586560019218329,-0.0339742170906951,-0.0109810643373366,0.000127765849127215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,39615,-0.0182721665561266,0.00477103812158977,-0.0276234012744426,-0.00892093183781068,0.000128953614679535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,39574,-0.0300265742500105,0.00787189031983583,-0.0454554792768887,-0.0145976692231323,0.000137259949508846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41466,-0.0325414127516126,0.00853240843580985,-0.0492649332858,-0.0158178922174253,0.000137452007756433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,41783,0.0210892298145819,0.00553561074847047,0.0102394327475798,0.031939026881584,0.000139745440505796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41657,-0.0117938363445289,0.00309677413497232,-0.0178635136490747,-0.00572415903998318,0.000140494260416571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,39589,-0.025599983362827,0.00672435739206021,-0.038779723851265,-0.012420242874389,0.000141396965073232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,41805,-0.0265838446632761,0.00698867923422859,-0.0402816559623641,-0.012886033364188,0.000143110013312002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39308,-0.0396631282247396,0.0104419401418505,-0.0601293309027665,-0.0191969255467126,0.000146412270001608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,39589,-0.0288694131439373,0.0076037809123912,-0.043772823732224,-0.0139660025556505,0.000147412965145248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39488,-0.0135549093851514,0.00357517476745254,-0.0205622519293583,-0.00654756684094438,0.000150610781737823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,41765,-0.0251232388171063,0.0066295874121057,-0.0381172301448335,-0.0121292474893791,0.000151585102922578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39250,-0.0306813008530979,0.00809602788662642,-0.0465495155108857,-0.0148130861953101,0.000151676908994476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39408,-0.0157002335274033,0.00414486583073488,-0.0238241705556437,-0.00757629649916294,0.000152764947179455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41465,-0.0184729967775089,0.00487998135423989,-0.0280377602318191,-0.00890823332319872,0.000154118497084749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41534,-0.0176114043656282,0.00466141086854034,-0.0267477696679673,-0.00847503906328917,0.000158720661135424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39373,-0.0220992851731611,0.00586440614497089,-0.033593521217304,-0.0106050491290181,0.000165189738984834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,41740,-0.0346298248763077,0.00920662210308181,-0.0526748041983481,-0.0165848455542674,0.000169695791664457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41465,-0.0389497688469581,0.0103568019930769,-0.0592491007533888,-0.0186504369405274,0.000170127410357232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41751,-0.0234039207437035,0.00622458831992733,-0.035604113850761,-0.0112037276366459,0.000170707505057455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,41914,-0.0137363349650693,0.00365568330978652,-0.0209014742522509,-0.00657119567788772,0.000172332037239829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39625,-0.0311702639580306,0.00833482748821286,-0.0475065258349278,-0.0148340020811334,0.000185127995614883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,41888,-0.0114902175404049,0.0030768848544737,-0.0175209118551734,-0.00545952322563648,0.000188974038487567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39308,-0.0126988020118792,0.0034025676241578,-0.0193678345552284,-0.00602976946852987,0.000190854960738599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,41765,-0.00705093566185151,0.00188954111240075,-0.010754436242157,-0.00334743508154604,0.000191098003791208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39407,0.0124482148460268,0.00334131323514098,0.00589924090515044,0.0189971887869031,0.000195885787847497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39408,-0.0217791376530943,0.00586988532937348,-0.0332841128986664,-0.0102741624075223,0.000208037573653447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39308,-0.0206054394695921,0.00557018558039237,-0.0315230032071612,-0.00968787573202307,0.000217330447921728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41689,0.0169558809570621,0.00458639632589893,0.00796654415830023,0.025945217755824,0.00021905822538127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39250,-0.0150558686849756,0.00407402854845831,-0.0230409646399539,-0.00707077272999729,0.000220491593871614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39470,0.00324854356012495,0.000879725353404357,0.00152428186745241,0.00497280525279749,0.000222990567276529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39334,-0.0178077071820834,0.00482284090287973,-0.0272604753517277,-0.00835493901243911,0.000223276510496855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39600,-0.0189795242405756,0.00514071096360408,-0.0290553177292396,-0.00890373075191161,0.000223570162367526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39462,0.0053384858932309,0.00144641742135732,0.00250350774737056,0.00817346403909123,0.000224613814157647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,39600,-0.04184007604189,0.0113391674366588,-0.0640648442177411,-0.0196153078660388,0.000225449642025694
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,41877,-0.0126021760094498,0.00341694855609112,-0.0192993951793884,-0.00590495683951116,0.000226802904121911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,41925,-0.0159838743573845,0.00433971187769129,-0.0244897096376595,-0.00747803907710958,0.00023126719421218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39600,-0.0430864197073947,0.0116986077594649,-0.066015690915946,-0.0201571484988435,0.000231574998996528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,39655,-0.0115549830740228,0.00313784487629302,-0.0177051590315571,-0.0054048071164885,0.000232096388592757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39408,-0.0306808482646002,0.00833927739311834,-0.0470258319551121,-0.0143358645740882,0.000235216154294109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39334,-0.0333132172653419,0.00906106002594539,-0.0510728949161949,-0.015553539614489,0.000237585750365448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,41865,-0.0183541519334638,0.00499597287258055,-0.0281462587637216,-0.00856204510320588,0.000239920246515527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39334,-0.0127944898647713,0.00349568793519385,-0.0196460382177512,-0.00594294151179132,0.000253348158728454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,41727,-0.0196006139880959,0.00537482139979871,-0.0301352639317013,-0.00906596404449039,0.00026660841533411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,41693,-0.0173669997497294,0.0047636389388728,-0.0267037320699201,-0.00803026742953876,0.000267654012212122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39317,-0.0105353012279252,0.00289595037346798,-0.0162113639599224,-0.00485923849592795,0.000276115329424763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39334,-0.0340714497274613,0.00938774229686641,-0.0524714246293195,-0.0156714748256031,0.000285450740650407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39259,0.0242623217518528,0.00668653296315737,0.0111567171440644,0.0373679263596413,0.000286366540254251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39297,-0.0309966378028366,0.00854447572511164,-0.0477438102240554,-0.0142494653816178,0.000287308948120018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41521,-0.014446465221668,0.00398914135824633,-0.0222651822838308,-0.00662774815950523,0.00029408105718937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41689,-0.0176666775168884,0.00488559458401137,-0.0272424429015507,-0.00809091213222611,0.00030022759976328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39583,-0.0156923429960386,0.00434022205147931,-0.024199178216938,-0.00718550777513911,0.000301038359838275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41452,-0.0229022470090819,0.00635614927173027,-0.0353602995816732,-0.0104441944364905,0.0003155545326949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39578,0.0221555419836939,0.00615236575053514,0.010096905112645,0.0342141788547427,0.00031822074401439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,41758,0.0153897178073145,0.00427973770619515,0.00700143190317196,0.023778003711457,0.000324394648025527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41502,0.021994172652093,0.00611871079330661,0.0100014994972121,0.033986845806974,0.000326131418010861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,41740,-0.011383770176947,0.00316766589968746,-0.0175923953403344,-0.00517514501355961,0.000327156405193501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,41827,0.00928098383089008,0.00258289082906644,0.00421851780591986,0.0143434498558603,0.000327759509836194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41466,0.0288297804745507,0.00802336656497792,0.013103982007194,0.0445555789419075,0.000327826790945743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41465,-0.022229625815059,0.0062004097365566,-0.0343824288987099,-0.0100768227314081,0.000338084539260033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39580,-0.0222218454155489,0.00622462074317043,-0.034422102072163,-0.0100215887589349,0.000358516990101776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41465,0.0145600263662727,0.00409119116300457,0.00654129168678376,0.0225787610457617,0.000373792338094163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39542,-0.0240992136699651,0.00677342855772219,-0.0373751336431006,-0.0108232936968296,0.000375406710841886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,41794,-0.0195398352654517,0.005497504417185,-0.0303149439231343,-0.00876472660776909,0.000380296773509275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41636,0.0153831367201859,0.00434858693383021,0.00685990632987871,0.0239063671104932,0.000405334407257243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,41736,0.0280274140912951,0.00792566113639119,0.0124931182639684,0.0435617099186219,0.000407191088692571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39308,0.0351277051220721,0.00994423220821085,0.0156370099939788,0.0546184002501653,0.000413429579934227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41466,-0.0324030701640065,0.00918812365700788,-0.050411792531742,-0.0143943477962711,0.000422357045140491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39600,-0.0188017819233278,0.00533116455765861,-0.0292508644563386,-0.0083526993903169,0.000422378231356924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39617,-0.0149444317647815,0.00424045746036896,-0.0232557283871047,-0.00663313514245838,0.000426406056673845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,41740,-0.0138969884317371,0.0039453233721499,-0.0216298222411509,-0.00616415462232325,0.000429117169551645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,41765,0.0192979390351678,0.00548085798669483,0.0085554573812459,0.0300404206890896,0.000431424578037816
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,41758,-0.0114691322488125,0.00325761584957357,-0.0178540593139767,-0.00508420518364827,0.000431843129253205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39250,0.0159418881153654,0.00452925671771301,0.00706454494864787,0.0248192312820829,0.000433744316967931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41534,-0.0291450535461461,0.0082916006591988,-0.0453965908381757,-0.0128935162541164,0.000441242689249406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39598,-0.0126661130056331,0.00360639686972714,-0.0197346508702982,-0.00559757514096787,0.000446323610757794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39334,-0.0211576938565693,0.00603155073247407,-0.0329795332922185,-0.00933585442092012,0.000453614828730876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,41726,0.0234988640688647,0.00672659050060485,0.0103147466876792,0.0366829814500503,0.000478431041571383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39250,0.00997069460556949,0.00285766214672243,0.00436967679799352,0.0155717124131455,0.000486592354805647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39241,0.025268372658838,0.00724733255601271,0.0110636008490531,0.0394731444686229,0.000491220891470085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,39613,-0.0179028738623299,0.00513514299257838,-0.0279677541277835,-0.00783799359687623,0.000491579466526078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39598,-0.0213908190807653,0.00613694668503999,-0.0334192345834437,-0.00936240357808689,0.000492985915604065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,41836,-0.0117768949595961,0.00338005882940364,-0.0184018102652272,-0.00515197965396497,0.000495155562839347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41706,-0.0718550756933498,0.0206652872328125,-0.112359038669662,-0.0313511127170374,0.000508529655678725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41614,-0.017635879608549,0.00507222798623409,-0.0275774464615678,-0.0076943127555302,0.00050880905958618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41465,-0.0418033346058793,0.0120307097537974,-0.0653835257233222,-0.0182231434884364,0.000513073437321491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,41774,-0.0122063831965582,0.00352037861868731,-0.0191063252891854,-0.00530644110393112,0.000527295297497821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39600,-0.0283036926814849,0.00816476276724282,-0.0443066277052808,-0.012300757657689,0.000529164890420193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,41805,-0.0101612978903651,0.00293607906239666,-0.0159160128526625,-0.00440658292806765,0.000540196579377754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39314,-0.0214557102601405,0.00620901777347179,-0.0336253850961452,-0.00928603542413574,0.000551253860150546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,41703,0.0106411939857946,0.00308040370451888,0.00460360272493759,0.0166787852466516,0.00055309916291996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,41786,0.029183832041731,0.00845953324872014,0.0126031468742395,0.0457645172092225,0.000562724130333396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39589,-0.0296017513998601,0.00858253477717304,-0.0464235195631193,-0.012779983236601,0.000564634259298229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39534,-0.0108319163924572,0.0031455057238945,-0.0169971076112904,-0.00466672517362396,0.000576140248577395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,41774,-0.0149679453081381,0.00435027522114151,-0.0234944847415754,-0.00644140587470072,0.000582033623244619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,39600,-0.0265745800402833,0.00772613479455865,-0.0417178042376182,-0.0114313558429483,0.000584800967890339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,39589,-0.0178738529093772,0.00520264900683739,-0.0280710449627785,-0.00767666085597589,0.0005935841654821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39308,-0.0159815706042755,0.00465195574506547,-0.0250994038646038,-0.00686373734394713,0.000593810755579935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39589,-0.0214346676928969,0.00624180775962962,-0.033668610901771,-0.00920072448402285,0.000596833833108491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39393,-0.0215152682968054,0.00626667444657652,-0.0337979502120953,-0.0092325863815154,0.000598558210400664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,41805,-0.00996709223902866,0.00290739140533281,-0.015665579393481,-0.00426860508457635,0.000609472784441661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,41789,0.0100908940829272,0.00294433330248586,0.00432000081005492,0.0158617873557995,0.000611643802138087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,41865,-0.0187582646090311,0.00547794410474834,-0.0294950350543378,-0.00802149416372434,0.000618191705040105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,41899,-0.0189974343624543,0.00557282172797458,-0.0299201649492845,-0.00807470377562412,0.000654085062202044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39427,-0.0106719620419934,0.00313182725530337,-0.016810343462388,-0.00453358062159875,0.000657795031050629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39334,-0.0203819038834255,0.00598702590004791,-0.0321164746475194,-0.00864733311933163,0.000665655069979609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41534,0.022368390270265,0.00657649687872696,0.00947845638796011,0.0352583241525698,0.000672784092579697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,39625,-0.0275042403026399,0.00810063713940896,-0.0433814890958814,-0.0116269915093983,0.000687906789314835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39600,-0.0316612814646636,0.0093282977325872,-0.0499447450205345,-0.0133778179087927,0.00069094767944333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39625,-0.0266700885589613,0.00786568210980037,-0.04208682549417,-0.0112533516237526,0.000699616069563352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41744,-0.0107487950371745,0.0031756673700707,-0.0169731030825131,-0.00452448699183591,0.000714551130943793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39334,-0.0163274677456959,0.00482374474131058,-0.0257820074386646,-0.00687292805272714,0.000714821846016446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41245,-0.0117950651334508,0.00348677573659969,-0.0186291455771862,-0.00496098468971538,0.000719684667692178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39600,-0.0239837599624624,0.00709766065793687,-0.0378951748520187,-0.0100723450729062,0.000729740575717869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39485,-0.0402882771576252,0.0119237723226875,-0.0636588709100928,-0.0169176834051577,0.000730531358594698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41696,-0.00979391738334234,0.00290096107318555,-0.015479801086786,-0.00410803367989866,0.000737365065598363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,41758,-0.00959297441908636,0.00284308563259538,-0.0151654222589733,-0.00402052657919942,0.00074259949426735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,41636,-0.0220012408158896,0.0065353031753701,-0.034810435039615,-0.00919204659216425,0.00076342521860741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41447,-0.017316835976811,0.00514660721029203,-0.0274041861089834,-0.00722948584463862,0.000768486333535243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,41866,-0.011272307040509,0.00335218831063055,-0.0178425961293449,-0.00470201795167315,0.000774105051166208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,41805,-0.0239107131088819,0.00711646712938546,-0.0378589886824774,-0.00996243753528645,0.000781877058222638
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,39598,-0.0109714349208788,0.00326668067966463,-0.0173741290530215,-0.00456874078873615,0.000786077682479861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41466,-0.0258467338973592,0.00770180870614415,-0.0409422789614017,-0.0107511888333167,0.000793273679582214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41617,-0.0227433948873029,0.00677862121723897,-0.0360294924730913,-0.00945729730151449,0.000795442354510906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39308,-0.0117166180083369,0.00349830250143304,-0.0185732909111457,-0.00485994510552815,0.000813163624116255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41521,0.0140434087852283,0.00419470001604409,0.00582179675378193,0.0222650208166748,0.000816608578408483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,41707,-0.0114084010567258,0.00340882184042691,-0.0180896918639625,-0.004727110249489,0.00082001185545058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39334,-0.0112542652311228,0.00336478565283842,-0.0178492451106861,-0.00465928535155949,0.000826479436858253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,41865,0.0108391513862496,0.00324205681643071,0.00448472002604535,0.0171935827464538,0.000830190581722874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,41865,0.0104544600725799,0.00312821367880588,0.00432316126212041,0.0165857588830395,0.000834098166403516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,41758,0.0160453716775453,0.00481722942650602,0.00660360200159353,0.0254871413534971,0.000868257711871313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39498,0.0395366604661224,0.0118706403141191,0.0162702054504491,0.0628031154817957,0.000869388851289433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,39633,0.018333067929634,0.00551652597457276,0.00752067701947139,0.0291454588397966,0.00089248900021453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39625,-0.00978328790187164,0.00294625185653225,-0.0155579415406749,-0.00400863426306844,0.000901198106688571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41521,-0.0182692312833206,0.00550282570682796,-0.0290547696687034,-0.00748369289793777,0.000902754833742939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39328,-0.017591183881409,0.00530283478948551,-0.0279847400688006,-0.00719762769401742,0.00091188652921526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41534,-0.0407754177355207,0.0122966142230429,-0.0648767816126848,-0.0166740538583565,0.000915713952858203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41466,-0.021958946645302,0.00662860304093899,-0.0349510086055424,-0.00896688468506158,0.000926362227152237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39241,0.0093845892057258,0.00283396075123422,0.00383002613330672,0.0149391522781449,0.000931147394508644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,41787,0.0132013631346423,0.00398850235936084,0.00538389851029501,0.0210188277589895,0.000935947879588962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41466,0.0114696968242484,0.00346793422975359,0.00467254573393132,0.0182668479145654,0.000944389463286099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,39650,-0.00729498947878969,0.00220633857181036,-0.011619413079538,-0.00297056587804137,0.000948118556455411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39328,-0.0174011304806566,0.00526815041016652,-0.027726705284583,-0.00707555567673019,0.000959415222383201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39276,-0.0148502573760307,0.00449768549034631,-0.0236657209371095,-0.00603479381495195,0.000963973150689106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,41758,-0.0176339365210579,0.00536097902446497,-0.0281414554090093,-0.0071264176331066,0.00100696179970248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41786,0.0317826648120905,0.00967109210185607,0.0128273242924526,0.0507380053317284,0.00101757303718935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,39625,-0.0162120098625157,0.00495318292968914,-0.0259202484047064,-0.00650377132032496,0.00106721601951602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41287,0.0110583051175708,0.00338370928760819,0.00442623491385875,0.0176903753212829,0.00108559553408072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,41911,-0.0205240790080771,0.00630289354754868,-0.0328777503612725,-0.00817040765488166,0.00113158868609529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,41911,-0.0213766960271271,0.00656879045487048,-0.0342515253186733,-0.008501866735581,0.00113963113618729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41744,-0.0138601711196107,0.00427379742324695,-0.0222368140691747,-0.00548352817004667,0.00118549398405843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41534,-0.0153226477105376,0.00472852066017818,-0.0245905482044869,-0.00605474721658841,0.00119632925924113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39334,-0.0154869560151365,0.00478142785430709,-0.0248585546095783,-0.00611535742069456,0.00120322289622257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39250,0.0134796617406319,0.00416789494376413,0.00531058765085417,0.0216487358304096,0.00122370761067087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,41728,-0.0222256027013772,0.0068766919163989,-0.035703918857519,-0.00874728654523534,0.00123221904121326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,41744,-0.00953841682561264,0.00295583502983438,-0.015331853484088,-0.00374498016713726,0.00125411254156408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41689,-0.0269151367164534,0.00836400893500842,-0.0433085942290699,-0.0105216792038369,0.00129415312043079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,41769,-0.0215524414561154,0.00669871122936062,-0.0346819154656622,-0.00842296744656857,0.00129670445216987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41689,-0.0155691002096528,0.0048466656860075,-0.0250685649542275,-0.00606963546507807,0.00131980569575441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41465,-0.034066911309129,0.010612492833344,-0.0548673972624831,-0.0132664253557748,0.00133025550094102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,39600,-0.0106583148840544,0.00332309745601357,-0.017171585897841,-0.0041450438702678,0.00134350451596591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41465,-0.0133602365973592,0.00416817449307446,-0.0215298586037851,-0.00519061459093321,0.00135252680983854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39576,-0.038184012522356,0.0119194285417305,-0.0615460924641478,-0.0148219325805642,0.00136150947468149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41465,0.0130395498373065,0.0040716736918996,0.00505906940118325,0.0210200302734297,0.00136570151613435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,41740,-0.0298996862144748,0.00933975819371431,-0.0482056122741548,-0.0115937601547948,0.00137118343236929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39308,-0.011042221174689,0.0034516147020757,-0.0178073859907574,-0.00427705635862063,0.00138236632390165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,41744,0.0197997319428754,0.00619521107453521,0.0076571182367864,0.0319423456489644,0.00139689269843527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,41911,-0.0297537127075982,0.00931286290740423,-0.0480069240061104,-0.0115005014090859,0.00140202998370419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,39598,0.0309915974727632,0.00970944444136773,0.0119610863676825,0.050022108577844,0.00141736700777983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39241,0.0118030720773416,0.00369898294192282,0.00455306551117284,0.0190530786435103,0.00142243874895611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41676,-0.0216666423875982,0.00679214052441107,-0.0349792378154439,-0.00835404695975252,0.00142629339781996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41534,-0.0127358495116553,0.00399286934455125,-0.0205618734269757,-0.00490982559633483,0.00142785713888217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39650,0.00629073373281853,0.0019723915995669,0.00242484619766741,0.0101566212679696,0.00142969427489087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39244,-0.0350451806333856,0.0110058826064788,-0.056616710542084,-0.0134736507246871,0.00145561426914212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,39589,-0.0153965692497204,0.00483775213571765,-0.024878563435727,-0.00591457506371378,0.00146371913366293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41392,0.0240028428353475,0.00755157676456193,0.00920175237680613,0.0388039332938889,0.00148381087503822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41386,-0.0252040012301254,0.00793759120736399,-0.0407616799965588,-0.00964632246369197,0.00150051973200443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39328,-0.0228513157111014,0.00721733055932369,-0.0369972836073758,-0.00870534781482697,0.00154891303970966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39334,-0.0115550271076659,0.00365150643287915,-0.018711979716109,-0.00439807449922276,0.00155807532491632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,39650,0.00691400457256508,0.00218494656102661,0.00263150931295292,0.0111964998321772,0.00155834313627851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41466,-0.0219896521010347,0.00695203963315901,-0.0356156497820263,-0.00836365442004301,0.00156488251787774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41911,-0.0120070945456631,0.00379819992170326,-0.0194515663922014,-0.00456262269912467,0.00157440895240879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39598,-0.0133871929882938,0.00424112238801859,-0.0216997928688102,-0.00507459310777737,0.00160094258032631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,41802,0.00934981698684277,0.00296611050148732,0.00353624040392763,0.0151633935697579,0.00162399629514089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39308,-0.0113959739029557,0.0036225997832501,-0.0184962694781259,-0.00429567832778552,0.00166086836450832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,41862,-0.0188870484994864,0.00600568100566991,-0.0306581832705994,-0.00711591372837338,0.00166531103825947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,41836,0.0121574260228253,0.00386684838509359,0.00457840318804185,0.0197364488576087,0.00167015714645129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39589,0.0160542209588771,0.00510751676709095,0.00604348809537881,0.0260649538223753,0.00167525423099062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41384,0.0132418428929307,0.00421326920124126,0.0049838352584978,0.0214998505273636,0.00167670849952788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,41758,-0.0141154373565518,0.00449323793575505,-0.0229221837106317,-0.00530869100247195,0.00168466329035731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41317,-0.0304542560304402,0.00971296810878369,-0.0494916735236563,-0.0114168385372242,0.00171997756956623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41465,-0.0284871651735903,0.00909491982822915,-0.0463132080369195,-0.0106611223102612,0.00173887034241877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41465,0.0182695285944637,0.005840428330318,0.00682228906704039,0.029716768121887,0.00176324307841535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,39600,-0.00860565433687702,0.00275123285019947,-0.013998070723268,-0.00321323795048607,0.00176503657364016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,41740,0.022610155543071,0.00724074938059663,0.00841828675710163,0.0368020243290404,0.00179634268427849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41465,-0.0212839734816478,0.00681854222514458,-0.0346483162429312,-0.0079196307203644,0.00180340268661408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41636,-0.0096265246573352,0.00308593432006413,-0.0156749559246609,-0.0035780933900095,0.00181562748346847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,41786,0.0163688557455302,0.00524875307687263,0.00608129971485988,0.0266564117762006,0.00182092662685665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,40938,0.0167815954566182,0.00538179495387499,0.00623327734702324,0.0273299135662132,0.00182368393987493
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,41836,0.0109975585470178,0.00352892827880733,0.0040808591205554,0.0179142579734801,0.00183464347740917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,41877,-0.0136039066669117,0.00436789351910274,-0.0221649779643531,-0.00504283536947036,0.00184634467983547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,41877,0.017862226631294,0.00573563633947044,0.00662037940593195,0.0291040738566561,0.00184803229380003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,41765,-0.0226440830073177,0.00729400022302948,-0.0369403234444555,-0.0083478425701799,0.00191017684028583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39250,0.00697170655188107,0.00225093646180223,0.0025598710867487,0.0113835420170134,0.00195834819728616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,41636,0.0121565093622764,0.00393468599257858,0.00444452481682242,0.0198684939077304,0.00200864638978095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,41703,-0.03626818144489,0.0117468471807323,-0.0592920019191252,-0.0132443609706547,0.00202281498255919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39250,-0.0147726542785288,0.00478607610738493,-0.0241533634490033,-0.00539194510805439,0.00202986518740904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,41819,-0.010673925063488,0.00346227179269582,-0.0174599777771718,-0.00388787234980425,0.00205398737022775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,41848,0.00636666023094688,0.00206726837753906,0.00231481421097033,0.0104185062509234,0.00207601708624164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41758,-0.00967546795893581,0.00314254594367442,-0.0158348580085377,-0.00351607790933396,0.00208220115030948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39598,-0.0137529641161546,0.00447246284705266,-0.0225189912963778,-0.00498693693593133,0.00210996458650092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,41748,-0.00963115117257877,0.00313287433843176,-0.015771584875905,-0.00349071746925252,0.00211484768602004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,41869,-0.018713891884771,0.00609014356482778,-0.0306505732718335,-0.00677721049770855,0.00212478838336904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,41706,-0.0116229383314099,0.00378531709268819,-0.0190421598330788,-0.00420371682974107,0.00214114880754687
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,41802,-0.0302405848691733,0.00986300035674548,-0.0495720655683944,-0.0109091041699521,0.00217335593304271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39598,-0.00758480491424457,0.00247405282656112,-0.0124339484543044,-0.00273566137418477,0.00217657961091242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41534,0.0153363516826897,0.00500744471507918,0.0055217600411345,0.0251509433242449,0.00219793042377604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39328,-0.0150467335366237,0.00491619912270946,-0.0246824838171342,-0.00541098325611314,0.00221407565920523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39600,0.0152220474634938,0.0049812874850601,0.00545872399277604,0.0249853709342116,0.00224964244042486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39408,-0.0389291433765288,0.0127524427819002,-0.0639239312290531,-0.0139343555240044,0.00227357713673536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,39598,-0.0160925755817922,0.00527510982541664,-0.0264317908396088,-0.00575336032397561,0.00228881513135087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39259,0.019136854279241,0.00628102790999505,0.00682603957565067,0.0314476689828312,0.00231879593153221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39600,-0.01324637139909,0.00434808603236638,-0.0217686200225281,-0.00472412277565189,0.00232083944274585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41466,-0.013591207256792,0.00446335870493774,-0.02233939031847,-0.00484302419511405,0.00233102179154838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39600,-0.0217711772913831,0.00715063926583092,-0.0357864302524118,-0.00775592433035453,0.00233503755657093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,41706,-0.00633606708050889,0.00208362055666035,-0.0104199633715632,-0.0022521707894546,0.00236343551042851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,39650,0.00966608218349162,0.00317946014344228,0.00343434030234475,0.0158978240646385,0.00237002355035117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41640,0.0191508736857548,0.00630394092073463,0.00679514948111491,0.0315065978903947,0.00238687691757682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39308,-0.0257068674069629,0.00847409477357239,-0.0423160931631648,-0.00909764165076103,0.0024224760943187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",39650,-0.00546672584230344,0.00180222360723208,-0.00899908411247832,-0.00193436757212855,0.00242438296230869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39600,-0.0274012088025564,0.00903647400954642,-0.0451126978612674,-0.00968971974384538,0.00243271305214333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41070,-0.0137145607178041,0.00452750038849746,-0.0225884614792591,-0.00484065995634906,0.00245729938140124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39427,-0.0374750408085086,0.0123711934947821,-0.0617225800582815,-0.0132275015587357,0.00245765841807594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39600,-0.0249836477277513,0.0082496827356826,-0.0411530258896892,-0.00881426956581337,0.00246391913890872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39308,-0.0226121223706136,0.00749637276527882,-0.0373050129905601,-0.00791923175066712,0.00256388819690916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39600,-0.011796605988283,0.00391222933642757,-0.019464575487681,-0.00412863648888495,0.00257297802806297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39334,0.00851410161386655,0.00282577013366759,0.00297559215187807,0.014052611075855,0.00259265152986089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39589,-0.0169886512320643,0.00563946473110481,-0.0280420021050297,-0.00593530035909887,0.0025973107595418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,41877,-0.00719239548841024,0.002388159955213,-0.0118731890006277,-0.00251160197619276,0.00260287416830812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39600,-0.0215300928866103,0.00715232301166127,-0.0355486459894664,-0.00751153978375424,0.00261647292354613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,41765,-0.00795035466276777,0.00264304304582473,-0.0131307190325842,-0.0027699902929513,0.00263443437470126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,41740,0.0165309567445433,0.00550373366698067,0.00574363875726117,0.0273182747318254,0.00267317471167062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,41805,-0.0092499035639494,0.00309064759654568,-0.0153075728531789,-0.00319223427471987,0.00276879431189755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41467,-0.0144380089500815,0.00482875345755098,-0.0239023657268815,-0.00497365217328161,0.00279498280709057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,41802,-0.0080357096037461,0.00269136099483275,-0.0133107771536183,-0.00276064205387391,0.00283409974419315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39373,-0.0210059985772346,0.00704076610795537,-0.0348059001488271,-0.00720609700564207,0.00285627620317245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,41740,-0.0258031501611948,0.0086788984874366,-0.0428137911965706,-0.0087925091258191,0.00295352423527898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,41925,-0.0212347663157857,0.0071467221078149,-0.0352423416471029,-0.0072271909844685,0.00297110408917806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39600,-0.0186892265819789,0.00629917635508204,-0.0310356122379397,-0.00634284092601808,0.00301434682256733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,41740,0.00869281144191436,0.00293336265297582,0.00294342064208176,0.014442202241747,0.00304777839157799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39250,-0.023205924516096,0.00783926859006343,-0.0385708909526203,-0.00784095807957163,0.00308101303303795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41925,0.0094811436876189,0.00320300966468635,0.00320324474483366,0.0157590426304041,0.0030810726725984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,41689,-0.0188271385810287,0.00636354269072173,-0.0312996822548433,-0.00635459490721408,0.00309598991506506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39334,-0.0310407876212545,0.0104978329748819,-0.0516165402520231,-0.0104650349904859,0.00311449964806806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,41705,-0.0107479514268156,0.00364158553644508,-0.017885459078248,-0.00361044377538324,0.0031684772145898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39259,-0.0133458281634398,0.0045267605210879,-0.022218278784772,-0.00447337754210748,0.00320316055336465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39600,0.0110335301024265,0.00374602690833985,0.00369131736208041,0.0183757428427726,0.00323217897438629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,41810,0.0114078959848153,0.00387398394521101,0.00381488745220174,0.0190009045174289,0.00323783898136051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39408,-0.0211575265320905,0.00718890866674347,-0.0352477875189077,-0.00706726554527331,0.00325656237881536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39250,0.00983721646328943,0.00335551763285418,0.00326040190289523,0.0164140310236836,0.00337879386050904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,41740,-0.0246334216674311,0.00841553692138211,-0.0411278740333401,-0.0081389693015222,0.00342685582531601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,41765,-0.0342212564918556,0.0117480707511504,-0.0572474751641104,-0.0111950378196008,0.0035866171435415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,41877,-0.0144562436448622,0.00496326276880291,-0.0241842386717159,-0.00472824861800847,0.00358973980442105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,41925,-0.00859848279657315,0.00295942088493671,-0.0143989477310491,-0.0027980178620972,0.00367315562623865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,39630,0.00704773711032659,0.00242600684056428,0.0022927637028206,0.0118027105178326,0.00367892043141875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39408,-0.0169065046640591,0.00582849373410132,-0.0283303523828977,-0.0054826569452205,0.00373123260375924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39308,0.01769341870439,0.0061066114307596,0.00572446030010122,0.0296623771086789,0.00377008244873266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,41758,0.00883983119191686,0.00305314971138956,0.00285565775759332,0.0148240046262404,0.00379400958546071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41454,0.0267497364451346,0.00924260039251493,0.00863423967580538,0.0448652332144639,0.00380791131016734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,41709,0.0226008634726798,0.00781761598315328,0.00727833614569935,0.0379233907996602,0.00384627597538215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39308,-0.0273877482505817,0.00947468063817862,-0.0459581223014118,-0.00881737419975159,0.00385249408140865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,39600,-0.0207346225144118,0.00717670420842015,-0.0348009627629153,-0.00666828226590829,0.00387030979175015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,41838,-0.0127949951846051,0.00443115813338292,-0.0214800651260356,-0.0041099252431746,0.00388938110477706
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39308,-0.0196074505592648,0.00679480064904285,-0.0329252598313888,-0.00628964128714081,0.0039138022598111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,41740,0.00988967390329545,0.00343509851465083,0.00315688081457982,0.0166224669920111,0.00399572886156219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39600,-0.0166706429530832,0.00579993386479666,-0.0280385133280847,-0.00530277257808179,0.00405723930226418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,39598,-0.0118145055269514,0.00411248137381645,-0.0198749690196316,-0.00375404203427112,0.0040757708463078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,41765,0.0256549928860939,0.00896065890987081,0.00809210142274709,0.0432178843494407,0.00420220386007015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41636,0.0345885021722845,0.0120876343786567,0.0108967387901174,0.0582802655544516,0.0042234148789589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,41877,-0.013541424583017,0.00473459534597415,-0.0228212314611263,-0.00426161770490767,0.00424165567495171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39600,0.013755976502249,0.00481820410160503,0.00431229646310314,0.0231996565413949,0.00431172212872587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,41765,-0.0267195442237275,0.00935945016707271,-0.04506406655119,-0.00837502189626498,0.00431285242698722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39655,0.0081489377558068,0.0028545411941914,0.00255403701519166,0.0137438384964219,0.00431538847315564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39600,0.0128445949370493,0.00450498115124708,0.00401483188060506,0.0216743579934936,0.00436358628388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39250,0.01340569051228,0.0047045179699096,0.00418483529125722,0.0226265457333028,0.00438671354689941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41466,-0.011787435935314,0.00413739552191403,-0.0198967311582655,-0.00367814071236254,0.00439266092832459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,41689,-0.0170918637332304,0.00600230741512362,-0.0288563862668727,-0.00532734119958808,0.00441259267298653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39600,0.0352389418925881,0.012392865377141,0.0109489257533918,0.0595289580317844,0.00447051927998806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,39589,-0.0122199331819985,0.00429988975823584,-0.0206477171081408,-0.00379214925585629,0.00449256308392377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39328,-0.0243668158062444,0.00858354928933041,-0.041190572413332,-0.00754305919915679,0.00453713218537417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41911,-0.0298602980579911,0.0105210611844604,-0.0504815779795335,-0.00923901813644873,0.00454451991107897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41534,-0.00935295544746183,0.00330487537183678,-0.0158305111762619,-0.00287539971866175,0.00466127592093141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41509,-0.0144129855056347,0.0050934784179844,-0.0243962032048841,-0.00442976780638523,0.0046664440106046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39598,-0.00835418898734235,0.00295606016333253,-0.0141480669074741,-0.00256031106721059,0.00472001594010026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41865,0.0213622824881658,0.00756502637693493,0.0065348307893733,0.0361897341869582,0.00475255714366659
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,39630,0.0116363473204027,0.00412636817643769,0.00354866569458488,0.0197240289462206,0.00481097185737294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,41765,-0.0175654168576101,0.00623159252543497,-0.0297793382074626,-0.00535149550775753,0.00482802051772154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39308,-0.0122743617465921,0.00435664115709574,-0.0208133784144997,-0.00373534507868443,0.00485042120659273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41689,-0.0105194913345142,0.00373601998653147,-0.0178420905081158,-0.00319689216091248,0.00487446705741388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,41911,0.0240048500232474,0.00853084676074776,0.00728439037218184,0.040725309674313,0.00490180148736574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41466,-0.0161834160531549,0.0057559364189958,-0.0274650514343867,-0.00490178067192313,0.00493696718252734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,41758,-0.0168513563265567,0.00600447172915255,-0.0286201209156957,-0.00508259173741775,0.00501615323787283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,41758,0.0059979900158663,0.0021443455067914,0.00179507282255516,0.0102009072091774,0.0051635369743741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39250,0.0174979965401256,0.00626437451244806,0.00521982249572739,0.0297761705845238,0.00522736601620384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39427,0.0100939118853507,0.00361500798083925,0.00300849624290578,0.0171793275277956,0.00524389069315518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39250,-0.0189526190140486,0.00679656735168738,-0.0322738910233559,-0.00563134700474137,0.00530372830674642
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39250,-0.00850963589613449,0.00305253822018779,-0.0144926108077026,-0.00252666098456641,0.00531737245273271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41521,-0.015535826137801,0.00557912805206093,-0.0264709171198404,-0.00460073515576154,0.0053666246237799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39328,0.0146054041478273,0.00524903507034,0.00431729540996088,0.0248935128856937,0.00540372762781073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39520,0.0203604712675925,0.00732093613307127,0.00601143644677283,0.0347095060884122,0.00542629682381996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39368,0.0103483357890079,0.0037228654454633,0.00305151951589981,0.0176451520621159,0.00545086327833477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,41740,-0.0116027559841283,0.00417525792539973,-0.0197862615179118,-0.00341925045034481,0.00546154685886952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,41865,-0.00876109777871216,0.0031569529913536,-0.0149487256417652,-0.0025734699156591,0.00552492074624998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41689,0.0169388893702993,0.00610811883597715,0.00496697645178407,0.0289108022888145,0.00555906200066874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39600,-0.0146386798150864,0.00527874172378489,-0.0249850135937048,-0.00429234603646803,0.00556120381928085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39328,-0.0176165835266793,0.00635542859893402,-0.0300732235805899,-0.00515994347276858,0.00558270025579044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39250,0.0093647376624903,0.00338338142529941,0.00273331006890345,0.0159961652560771,0.00565225613420659
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39598,0.00913699083297377,0.00330263956753734,0.00266381728060059,0.015610164385347,0.00567436321748986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39334,-0.0137910921796049,0.00501102650035643,-0.0236127041203035,-0.00396948023890626,0.00593049611308185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,41805,0.0101528037211308,0.00369039490521149,0.00291962970691625,0.0173859777353453,0.00594686727229859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41836,-0.0127688747563185,0.00464238242230193,-0.0218679443040302,-0.00366980520860667,0.00595851593256933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41764,-0.00937099024157193,0.00340780094969308,-0.0160502801029704,-0.0026917003801735,0.00597013203221121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39250,0.017341241671768,0.00631863798359871,0.00495671122391451,0.0297257721196215,0.00607123021153739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,41758,-0.00775869344519352,0.00283660382555068,-0.0133184369432729,-0.00219894994711418,0.00624249129821472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41689,-0.0403670940995157,0.0147609496633665,-0.0692985554397141,-0.0114356327593174,0.00625169931813092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39655,0.0216512929929942,0.00793657119402241,0.00609561345271031,0.0372069725332782,0.00638122856974623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,41740,-0.0181330007463264,0.00666382313379952,-0.0311940940885735,-0.00507190740407936,0.00651486275478895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,41736,0.00999041275867618,0.0036717886887261,0.00279370692877302,0.0171871185885793,0.00651986092861242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,39589,-0.0246211275031799,0.00907033027083642,-0.0423989748340193,-0.00684328017234057,0.00664857815183353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39408,0.00624079691152972,0.00229912313880573,0.00173451555947048,0.010747078263589,0.00664963171937292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39334,-0.0166239810987177,0.00612994196392583,-0.0286386673480124,-0.00460929484942311,0.00669989928442892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,41758,-0.0124645528274453,0.00459785409835209,-0.0214763468602154,-0.00345275879467519,0.0067177770525154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41614,0.00961365830741988,0.00354630798470143,0.00266289465740507,0.0165644219574347,0.00671904696339173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41877,-0.0098171031102962,0.00362178355900353,-0.0169157988859431,-0.00271840733464929,0.00672536901987672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,41877,0.0097072112460369,0.00358608389163232,0.00267848681843755,0.0167359356736363,0.00679992360718171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,41802,0.0122920650368117,0.00454146654585382,0.00339079060693817,0.0211933394666852,0.00680575551240695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41465,-0.00870557601188005,0.00321641642266984,-0.0150097522003129,-0.00240139982344716,0.0068064299826555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,41689,-0.0297905242762195,0.0110323726548591,-0.0514139746797434,-0.00816707387269565,0.0069369678261917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39655,-0.00720712630840408,0.00266990706577069,-0.0124401441573146,-0.00197410845949353,0.00695718966045559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41465,-0.0176253113054148,0.00653685809220803,-0.0304375531661425,-0.00481306944468707,0.00702063499815324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39328,-0.0126749392133038,0.00470325578175327,-0.0218933205455402,-0.00345655788106735,0.00705133616451755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41465,-0.0113074713043674,0.0041969879719551,-0.0195335677293994,-0.0030813748793354,0.00706520874320374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41581,-0.0125990658675569,0.00467745036887213,-0.0217668685905463,-0.00343126314456753,0.00707809673729508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39167,-0.00888473170530701,0.00329936429264931,-0.0153514857188997,-0.00241797769171436,0.00709533838561897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39655,0.042016081117453,0.0156155546231892,0.0114095940560021,0.0726225681789039,0.00714189419405852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,41764,-0.00942945653444579,0.00350861745523721,-0.0163063467467107,-0.00255256632218085,0.00720766939191019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39600,0.0173017013412351,0.00644155220360707,0.00467625902216525,0.029927143660305,0.00724320085455226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41521,-0.0275417012941442,0.0102650924833182,-0.0476612825614479,-0.00742212002684051,0.00730481276281726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41466,-0.0143747300571621,0.00536281215600167,-0.0248858418829254,-0.00386361823139886,0.00736177312193265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39408,-0.0194741531007487,0.00728310915390836,-0.0337490470424091,-0.00519925915908829,0.00750922136965672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39600,-0.0117673438817638,0.00440192687816109,-0.0203951205629595,-0.00313956720056802,0.00752365755377391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,41888,-0.0136867727425191,0.00512513012477053,-0.0237320277870693,-0.00364151769796883,0.00758255995905762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41466,0.0131050215469662,0.00491161575594796,0.00347825466530824,0.0227317884286243,0.00763614379750171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41521,0.0093602726943956,0.00351088561098754,0.00247893689686003,0.0162416084919312,0.00768388311185809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41662,-0.00815750597173288,0.00306699752391818,-0.0141688211186125,-0.00214619082485326,0.0078289628369823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39308,-0.0124856887512951,0.00469588651894148,-0.0216896263284204,-0.00328175117416981,0.00785229407493064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39328,0.00898630842911439,0.0033866224577064,0.00234852841200984,0.0156240884462189,0.00797857507657226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39308,-0.0121384350264098,0.00457466950960567,-0.0211047872652369,-0.00317208278758266,0.00798026621712517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41534,0.0129187207610996,0.00486939452660439,0.00337470748895498,0.0224627340332442,0.00798667811807149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,41740,0.0224409156884882,0.00847896358029582,0.00582214707110839,0.039059684305868,0.00813884619597844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39600,-0.0285440813199827,0.0107902090834749,-0.0496928911235936,-0.00739527151637186,0.00817179603369784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41534,-0.0201071558617448,0.00760988301923541,-0.0350225265794462,-0.00519178514404338,0.00824582339365103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41593,0.0299740534254018,0.0113557264199613,0.00771682964227755,0.052231277208526,0.00831143189796449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41598,-0.0084046569955772,0.0031878733405634,-0.0146528887430815,-0.00215642524807293,0.00838790340294666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,41769,-0.013188476124608,0.00501119314099751,-0.0230104146809631,-0.00336653756825292,0.00850319649599728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39259,0.0142636099770919,0.00542881438599787,0.00362313378053605,0.0249040861736477,0.00861659810468167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39221,0.0116633203516212,0.00444187510309426,0.00295724514955651,0.020369395553686,0.00865784331617392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41465,-0.0147694907212993,0.00563076087411003,-0.025805782034555,-0.00373319940804364,0.00872618277855006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39250,0.00743699995393983,0.00283697882135188,0.00187652146409014,0.0129974784437895,0.00876809058999135
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39600,-0.0150293890298743,0.00573507848123214,-0.0262701428530894,-0.00378863520665935,0.0087893946166398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39241,0.0138374624888638,0.00528354999756564,0.00348170449363515,0.0241932204840925,0.00883205875984968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39250,0.0131339467846033,0.00501951990140532,0.00329568777784888,0.0229722057913577,0.0088942454335795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,39633,0.0134968424668531,0.00516286660107471,0.00337762392874669,0.0236160610049595,0.00895542972887422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39308,0.0112588187991045,0.00430736775171934,0.00281637800573457,0.0197012595924744,0.00896532679488455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39650,0.0043409838951171,0.0016630004747462,0.00108150296461455,0.00760046482561965,0.00905763692765455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41465,-0.0211416699986513,0.00810211065954035,-0.0370218068913504,-0.00526153310595224,0.00908054099472626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38213,-0.0301021776024379,0.0115677155994515,-0.0527749001773629,-0.00742945502751301,0.00927543077631556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39334,0.0083070537020262,0.00319469542504697,0.00204545066893413,0.0145686567351183,0.00932795195887471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39600,-0.0265239967008124,0.0102028547162591,-0.0465215919446802,-0.00652640145694458,0.00934396761422891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39334,-0.0123902238642332,0.00477177568273455,-0.0217429042023929,-0.00303754352607346,0.00942895648368913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,41911,-0.00650398097497993,0.00250633344453872,-0.0114163945262758,-0.00159156742368405,0.00946896610363118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41375,0.0256439187743499,0.00989271343675743,0.00625420043830532,0.0450336371103944,0.00954721388390938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39427,-0.0200623588926204,0.00774243956794276,-0.0352375404457882,-0.00488717733945263,0.00957648404115986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39241,-0.0140170839116607,0.00541806720090974,-0.0246364956254438,-0.00339767219787765,0.00969187668382226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39633,0.00917193133903712,0.00354530021032996,0.0022231429267904,0.0161207197512838,0.00969233198275841
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39600,-0.0133217572106695,0.00515988305872179,-0.0234351280057642,-0.00320838641557477,0.00984162470025949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,41783,-0.0195454786250426,0.00757152254500756,-0.0343856628132574,-0.00470529443682776,0.00984942686157127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,41764,0.0106266619675611,0.00411840220132552,0.00255459365296314,0.0186987302821592,0.00988253802576593
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39542,0.00901889051189296,0.00349927414653783,0.0021603131846788,0.0158774678391071,0.00996877723745385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,41758,0.00955727645533199,0.00371732056968856,0.00227132813874242,0.0168432247719216,0.0101510632487121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39241,0.0189870810856035,0.0073984710909709,0.00448607774730051,0.0334880844239065,0.0102910050008367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41534,-0.0150866320858439,0.00591693736755867,-0.0266838293262589,-0.00348943484542888,0.0107918645339212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41466,-0.0224383088455421,0.00880490167399188,-0.0396959161265661,-0.00518070156451798,0.0108337084329305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,39625,0.0271457918679044,0.0106746078056236,0.00622356056888224,0.0480680231669266,0.011003290565955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,41740,-0.0161395051727779,0.0063508331568577,-0.0285871381602189,-0.00369187218533677,0.0110548440351209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,41865,0.00820880913605119,0.00323182179557877,0.0018744384167168,0.0145431798553856,0.0110967339954924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39589,-0.0122728682025285,0.00484248518589729,-0.0217641391668871,-0.00278159723816977,0.0112772803384609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,39650,0.00575701646189377,0.00227283606115421,0.00130225778203152,0.010211775141756,0.0113239080073167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39427,0.00955107022059424,0.00377248166620346,0.00215700615483547,0.016945134286353,0.0113627403148658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,41925,0.00825596045752269,0.00326271510489248,0.00186103885193342,0.014650882063112,0.0114048095372077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,41740,0.0184841904877612,0.00731448914751634,0.00414779175862921,0.0328205892168933,0.0115136497521594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39427,-0.0128909506124012,0.00511171002860587,-0.0229099022684687,-0.00287199895633371,0.0116882723931426
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39259,0.0203984997495282,0.00810414848738639,0.00451436871425087,0.0362826307848055,0.0118489485494384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41465,-0.0153803999191909,0.00611500996003157,-0.0273658194408527,-0.00339498039752901,0.0119089774357344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,41805,0.0180619118137497,0.00718418794319133,0.00398090344509468,0.0321429201824047,0.0119447695590039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,41722,-0.0129615935083427,0.00515586611328144,-0.0230670910903744,-0.00285609592631112,0.0119505808101931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,39604,-0.00875796791573815,0.00348511102456412,-0.0155887855238838,-0.00192715030759247,0.0119862395455302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39408,-0.0116305474850004,0.00463452692527568,-0.0207142202585408,-0.0025468747114601,0.0121032317917087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,39650,0.00641157320515041,0.00256248734993084,0.00138909799928596,0.0114340484110149,0.0123606003635893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39250,-0.0152200561139135,0.00608602200352614,-0.0271486592408248,-0.00329145298700231,0.0124054545952176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41521,-0.0256530028255154,0.010268947802436,-0.0457801405182899,-0.00552586513274079,0.0124979305625765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39589,-0.0149181640100729,0.00597417569019665,-0.0266275483628584,-0.00320877965728752,0.0125355867466057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39600,-0.00969685873557216,0.00389177652390707,-0.01732474072243,-0.00206897674871431,0.0127305346343908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41466,-0.0183499224516748,0.00736608828214058,-0.0327874554846704,-0.00391238941867929,0.0127460658427912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41534,0.0195402592454303,0.00787126858804572,0.00411257281286073,0.0349679456779999,0.0130597630485279
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,41802,0.00659978278157591,0.00265943778177707,0.00138728472929285,0.011812280833859,0.0130900644029577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39427,-0.0190538731894614,0.00770006579288209,-0.0341460021435103,-0.00396174423541252,0.0133571944167917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,41786,-0.0219409708804949,0.00887219145429641,-0.0393304661309158,-0.00455147563007393,0.0134107496460634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39250,-0.0114393417276367,0.00462819516920629,-0.020510604259281,-0.00236807919599236,0.013464116994684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39625,0.00747839845693899,0.00302750917604286,0.00154448047189498,0.013412316441983,0.0135207040546557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41666,0.00883421454667078,0.00358264794685715,0.00181222457083076,0.0158562045225108,0.013682222560344
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41466,-0.0155968827610303,0.00632632841589767,-0.0279964864561898,-0.00319727906587088,0.0136992786417439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39600,-0.0216172610654722,0.0087704336419563,-0.0388073110037066,-0.00442721112723786,0.0137245939557835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39408,-0.0221297820897928,0.00897905732215068,-0.0397287344412081,-0.00453082973837748,0.0137320791614756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,41865,-0.0075480070971749,0.00306268768438948,-0.0135508749585783,-0.00154513923577152,0.0137328713202356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,39598,-0.0202288835402519,0.00820827613610121,-0.0363171047670103,-0.00414066231349355,0.0137375590379229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41287,-0.0165588988970513,0.00672138548520259,-0.0297328144480484,-0.00338498334605427,0.0137675879962226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,41740,0.0117986718056286,0.004790044202997,0.00241018516775452,0.0211871584435028,0.0137843557122163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39308,-0.020129005960247,0.00818710718775893,-0.0361757360482545,-0.00408227587223947,0.0139628295610268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39250,0.00899404481912206,0.00366220647463141,0.0018161201288445,0.0161719695093996,0.0140687394176519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,41836,-0.00779379648257208,0.00318007632899803,-0.0140267460874082,-0.00156084687773594,0.0142659425379409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39328,-0.0143070432118882,0.00585213635503491,-0.0257772304677567,-0.00283685595601982,0.0145110092037404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,39655,-0.00708452462358364,0.00290480009282328,-0.0127779328055173,-0.00139111644165001,0.0147475619155263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,41911,0.00241799966773939,0.000992364622343856,0.000472965007945436,0.00436303432753335,0.0148389192285873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39655,-0.0107418269119956,0.00440908060982737,-0.0193836249072573,-0.00210002891673397,0.0148542023536037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41466,-0.0124980771919334,0.00513649445037003,-0.0225656063146586,-0.00243054806920812,0.0149798898087313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,39650,0.00868725980910552,0.00357157699228299,0.00168696890423086,0.0156875507139802,0.0150177318738287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39334,-0.0238893215327877,0.00982659833605551,-0.0431494542714565,-0.00462918879411886,0.0150698334453409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39600,0.0132132779209667,0.00543532518624248,0.00256004055593147,0.023866515286002,0.015073064483744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41636,-0.00956165323240617,0.00394085943606521,-0.017285737727094,-0.00183756873771836,0.0152677040047348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41274,-0.0160150914852935,0.00660917959975402,-0.0289690835008114,-0.00306109946977564,0.0154001148586982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,41875,-0.0212284906832997,0.00876403901105797,-0.0384060071449733,-0.00405097422162606,0.015439017635759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39250,-0.0180604328749077,0.00746137847650012,-0.0326847346888479,-0.00343613106096747,0.0155148453818795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,41758,0.0129180777421631,0.00534187877986743,0.00244799533362296,0.0233881601507033,0.0156082089537851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41521,-0.029787482504914,0.0123455883301707,-0.0539848356320485,-0.00559012937777955,0.0158441711155648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39250,0.0104578245349986,0.00435103207447653,0.00192980166902461,0.0189858474009726,0.0162547370818287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,41819,0.00583749211923042,0.00243038145535693,0.00107394446673083,0.01060103977173,0.016324632096844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,41736,0.0227437240581892,0.00948038040010402,0.0041621784739853,0.0413252696423931,0.0164523829579172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39328,-0.0177662482734112,0.00740736812878643,-0.0322846898058326,-0.00324780674098983,0.0164813138183035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39241,0.0113689439567888,0.0047454773204815,0.00206780840864503,0.0206700795049325,0.0166038844630073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41534,0.0110687898659846,0.0046256509701954,0.00200251396440163,0.0201350657675676,0.0167292845826295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39250,-0.0172351201907708,0.00720830951946786,-0.0313634068489278,-0.00310683353261376,0.0168194780913567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39308,-0.0265638443518982,0.0111099420395011,-0.0483393307493205,-0.00478835795447598,0.016819827269232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39250,0.0118379538941006,0.00495144159838676,0.00213312836126259,0.0215427794269387,0.0168285310007871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41877,0.0160397820585949,0.00672005717296897,0.00286846999957575,0.0292110941176141,0.0170072435956329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39250,0.00918615343383405,0.00384868897486331,0.00164272304310196,0.0167295838245661,0.017011849385782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39630,0.00476606059348146,0.00199784442576553,0.000850285518981017,0.0086818356679819,0.017067993034314
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,41802,0.00950303672802114,0.00398500652916472,0.0016924239308583,0.017313649525184,0.0171071820565446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,41740,0.012466301299514,0.005231559319189,0.00221244503390361,0.0227201575651245,0.0171908224269218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41740,-0.0157620919381833,0.00662508283781189,-0.0287472543002946,-0.002776929576072,0.0173666225027539
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39600,-0.0137356139972616,0.00577476710925615,-0.0250541575314037,-0.00241707046311959,0.0173975086644196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39023,0.0133376202154648,0.00561059799698777,0.0023408481413688,0.0243343922895608,0.0174616664219744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,41911,0.0187562547627406,0.00791524101452313,0.00324238237427527,0.0342701271512059,0.0178196942689862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39600,-0.0263051681485783,0.0111065889945813,-0.0480740825779576,-0.00453625371919888,0.0178809889863284
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,41925,0.00749364556218687,0.00316444269193432,0.00129133788599561,0.0136959532383781,0.0178949803301616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39334,0.0147106890417785,0.00621430399029927,0.00253065322079189,0.026890724862765,0.0179394092396514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39334,-0.00932307953027618,0.00394397583198885,-0.0170532721609743,-0.00159288689957803,0.0181024519557615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39408,-0.0147067699507591,0.00622616372518969,-0.0269100508521308,-0.00250348904938727,0.0181897690852014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,41728,-0.00871322230231038,0.00369195825745604,-0.0159494604869242,-0.00147698411769654,0.0182868015051148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39308,-0.0046391580714313,0.00196631690274535,-0.00849313920081219,-0.000785176942050406,0.0183266294894921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,41685,-0.008215091682797,0.00348266670228783,-0.0150411184192811,-0.00138906494631285,0.0183462316268729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,41911,-0.0119720168828399,0.00507997305222659,-0.021928764065204,-0.00201526970047576,0.0184521062143656
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39397,-0.00847647738687558,0.00359767016211648,-0.0155279109046239,-0.00142504386912728,0.018485624246039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39241,0.0123007069697289,0.00522179958247999,0.00206597978806808,0.0225354341513897,0.0185086128069785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,41764,-0.00608201553069661,0.00258316616854069,-0.0111450212210364,-0.00101900984035685,0.0185631989496349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41465,-0.0113256981367252,0.00481632651289368,-0.0207656981019969,-0.00188569817145364,0.0187117773872896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41570,0.00972296385786705,0.00413824301635045,0.00161200754582018,0.0178339201699139,0.0188115803329708
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,41911,-0.00857090555457262,0.00365074610401837,-0.0157263679184486,-0.0014154431906966,0.018903610679997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41533,-0.0185122632228217,0.00789352096872338,-0.0339835643215195,-0.00304096212412388,0.0190294655192795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41521,-0.0153496449673725,0.00654724789515776,-0.0281822508418817,-0.00251703909286329,0.0190706181981422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41591,-0.0141740197435093,0.00604700437601044,-0.0260261483204898,-0.00232189116652884,0.0190944994378442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39600,0.0177532526047554,0.00757725828413773,0.00290182636784549,0.0326046788416654,0.0191488880573252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39589,0.0136416167000978,0.00582311313555635,0.00222831495440738,0.0250549184457883,0.019164193671745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,41805,-0.010632770579358,0.00453989678033059,-0.019530968268806,-0.00173457288991006,0.0191917310694181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,41744,-0.0756284580510518,0.0323094373441764,-0.138954955245637,-0.0123019608564661,0.0192596911728641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41293,0.0123031141878817,0.00525830064616554,0.00199684492139723,0.0226093834543662,0.0193120168128104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39476,0.00900856037950446,0.00385089400673638,0.00146080812630115,0.0165563126327078,0.0193357110147315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,41775,0.0240823574927762,0.0103013660744338,0.0038916799868859,0.0442730349986666,0.0194134000743226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,39600,-0.0176380203527906,0.00755581734857809,-0.0324474223560037,-0.00282861834957757,0.0195946266866177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39655,0.00665720824599253,0.0028519745430375,0.00106733814163902,0.012247078350346,0.0196006967027496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39625,-0.0122065725702309,0.00522946816761618,-0.0224563301787586,-0.00195681496170315,0.0196036391797407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39328,-0.0125544453678395,0.00537885854241906,-0.0230970081109809,-0.0020118826246982,0.0196122415804677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,41862,-0.0129310762938833,0.00554155821955914,-0.0237925304042192,-0.0020696221835474,0.0196382006938719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,41858,-0.0229640140606027,0.00985218100065985,-0.042274288821896,-0.00365373929930942,0.0197758756826694
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41488,-0.0187231852910345,0.00803863295654379,-0.0344789058858603,-0.00296746469620863,0.0198664732271971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39408,0.0161187089826156,0.00692742487234394,0.00254095623282145,0.0296964617324097,0.0199944753532567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,41689,0.00698301977210426,0.00300331842738913,0.00109651565442157,0.0128695238897869,0.0200817511761677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39600,0.024230422937853,0.0104340856100131,0.00377961514222735,0.0446812307334787,0.0202383208627687
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39334,0.0086437925753555,0.00372441520247013,0.00134393877851405,0.015943646372197,0.0203138195869195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39250,0.0165208795162515,0.00712434515501056,0.00255716301243081,0.0304845960200722,0.0204174952783133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41840,-0.0170529887527377,0.00735807953537067,-0.0314748246420642,-0.00263115286341118,0.0204869517373454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39408,0.00741456088999912,0.00320202656361894,0.00113858882530599,0.0136905329546922,0.0205996292092855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39241,0.0120609453901724,0.00520966911985634,0.00184999391525398,0.0222718968650908,0.0206259642758161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,41740,0.0161199580140867,0.00697286270799459,0.00245314710641725,0.0297867689217561,0.020803350790486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39600,0.00640894419826265,0.0027737554984845,0.000972383421233032,0.0118455049752923,0.0208752648055273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39328,0.00944054570138073,0.00408597827313563,0.0014320282860349,0.0174490631167266,0.020880813615373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41367,-0.0207008275277337,0.00897174262869286,-0.0382854430799717,-0.00311621197549569,0.0210519965911413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41534,0.0141381837242751,0.00613864230796459,0.00210644480066452,0.0261699226478857,0.0212864701296797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,39589,0.0131686575363042,0.00571945735495775,0.00195852112058696,0.0243787939520213,0.0213294597967254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,41805,-0.00979138822386608,0.00425303053323567,-0.018127328069008,-0.00145544837872417,0.0213385630161236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41534,-0.0147639091527697,0.00641908485658167,-0.0273453154716698,-0.00218250283386965,0.021463940617556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,41877,-0.0151872372249557,0.00660869423459972,-0.0281402779247712,-0.00223419652514028,0.0215733145934398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39308,-0.0121410967563113,0.00528661048219157,-0.0225028533014068,-0.00177934021121586,0.0216622462875881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41689,0.0210887600378301,0.0091886071218885,0.00307909007892866,0.0390984299967316,0.0217432133010866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39241,0.00750255012405327,0.00327313429752825,0.00108720690089791,0.0139178933472086,0.0219157958605393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41173,-0.00698653832732698,0.00305769653459011,-0.0129796235351236,-0.000993453119530376,0.022335125569532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39250,0.0148212114234322,0.00649509339806525,0.0020908283632243,0.0275515944836401,0.0225143558976942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,41877,-0.0147687898488018,0.00647289418872394,-0.0274556624587008,-0.00208191723890291,0.0225265818709637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,39598,-0.0266099292922039,0.0117212047492569,-0.0495834906007475,-0.00363636798366031,0.0232123821424444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39427,0.0170323774688824,0.00750698943734966,0.00231867817167702,0.0317460767660877,0.0232958726301143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,41865,0.0313591046404293,0.013842090175599,0.00422860789625525,0.0584896013846033,0.023498732657058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39600,-0.0157072203894001,0.00694685001229923,-0.0293230464135065,-0.00209139436529358,0.0237752085452079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39250,0.00961539158237301,0.00425890037303675,0.00126794685122098,0.017962836313525,0.0239834731752181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39600,0.00739902017016908,0.00327952979200966,0.000971141777830155,0.013826898562508,0.0240825288705939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41466,-0.0101296154501361,0.00449724642036943,-0.0189442184340602,-0.00131501246621198,0.0243135423869793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39250,0.00845418942515705,0.00376461776894072,0.00107553859803325,0.0158328402522809,0.0247438679319849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41617,-0.026957347456676,0.0120218088573264,-0.0505200928170357,-0.00339460209631621,0.0249542144012585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39408,-0.0167123575153003,0.00745758071823975,-0.0313292157230503,-0.00209549930755043,0.0250470004878929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39250,0.00855691851352069,0.00382629520364641,0.00105737991437372,0.0160564571126677,0.0253497634814228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39295,-0.00905649510452236,0.00405439652565437,-0.0170031122948049,-0.00110987791423979,0.0255203323387728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,39650,0.00357902782619889,0.00160287089799751,0.000437400866123762,0.00672065478627401,0.0255764178788447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39600,-0.0176257860079385,0.00789767899201989,-0.0331052368322974,-0.00214633518357948,0.0256503728281273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,41765,0.0084437568723928,0.00379211352016509,0.00101121437286922,0.0158762993719164,0.0259866914712819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,39583,0.00590518046981328,0.00265224908473157,0.000706772263739404,0.0111035886758871,0.0260022270252755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41925,-0.00657553812621158,0.00295426808739894,-0.0123659035775135,-0.00078517267490966,0.0260458732364955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39328,-0.0197606450903133,0.00888386633763467,-0.0371730231120772,-0.00234826706854929,0.0261470192888691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39259,0.01478989926723,0.00665085959025718,0.00175421447032599,0.0278255840641341,0.0261856362600034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39250,0.00786219329835918,0.00353814220434804,0.00092743457783703,0.0147969520188813,0.026295805675217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39600,-0.0159850371584431,0.00719743438058593,-0.0300920085443915,-0.00187806577249465,0.026375620873963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41636,0.0145726850257626,0.00658404897438091,0.00166794903597605,0.0274774210155492,0.026892029257778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39328,0.0097781991400085,0.00442247024510267,0.00111015745960726,0.0184462408204097,0.0270550100439485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,39598,0.00949071411645057,0.00429595922587804,0.0010706340337296,0.0179107941991715,0.0271799552198145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41622,-0.0111366659480379,0.00504177027397711,-0.021018535685033,-0.00125479621104276,0.0272003300707094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,39625,0.0157869950839516,0.00715028843869672,0.00177242974410603,0.0298015604237972,0.0272729912505551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,39600,-0.0111903136049172,0.00507092945176261,-0.0211293353303719,-0.00125129187946244,0.0273515581654872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,41765,-0.00793673407392722,0.00359760309825659,-0.0149880361465101,-0.000885432001344298,0.027393001138714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39259,0.00888383662862373,0.00403992380933589,0.000965585962325379,0.0168020872949221,0.0278985478957318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39625,-0.0255821086432072,0.0116353743536084,-0.0483874423762796,-0.00277677491013486,0.0279235625395051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39250,-0.0179121992347809,0.00815132716454954,-0.033888800477298,-0.00193559799226383,0.0280092056830714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,41736,-0.0102531760266749,0.00466628674880064,-0.0193990980543242,-0.00110725399902565,0.0280172783107072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41636,0.013542276343606,0.00620877315078571,0.00137308096806598,0.025711471719146,0.0291900034630851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39241,0.0078794616020033,0.00361303826521394,0.000797906602183978,0.0149610166018226,0.0292170100075928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,39600,-0.0130212589322117,0.00598020582258706,-0.0247424623444823,-0.00130005551994104,0.0294724307618391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41534,-0.00881443257428561,0.00404949704065037,-0.0167514467739603,-0.000877418374610877,0.0295229689873539
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,41758,0.0178262472752494,0.00819019414663743,0.00177346674784004,0.0338790278026588,0.0295329732476249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,41925,0.00623889350351127,0.00287068546382002,0.00061234999442404,0.0118654370125985,0.0297744400171725
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39259,0.0129839127150262,0.00598490646484949,0.00125349604392115,0.0247143293861312,0.0300711017155116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,41740,0.0145284828942718,0.00669712923957474,0.00140210958470528,0.0276548562038382,0.030073246720328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39416,0.005120860586595,0.00236200830039624,0.000491324317818376,0.00975039685537162,0.0301795648827921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,41911,-0.00642074052502187,0.00296512960395081,-0.0122323945487655,-0.000609086501278286,0.0303735086694108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,41802,-0.01656998732499,0.00765456661110064,-0.0315729378827473,-0.00156703676723273,0.0304270575153634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,39650,0.00601116544539251,0.00278325066212184,0.000555994147633702,0.0114663367431513,0.030812359987216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41443,-0.0273475657406161,0.0127032514178405,-0.0522459385195834,-0.00244919296164882,0.0313529288616396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39625,-0.0173631520086248,0.00806749386630243,-0.0331754399865776,-0.00155086403067206,0.0314003985827085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39589,-0.00814454065000647,0.00378577897891112,-0.0155646674486723,-0.000724413851340676,0.0314702075404313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,41810,-0.00793204760870822,0.00368881390310558,-0.0151621228587952,-0.000701972358621275,0.0315497759605316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,39598,-0.00666622137426315,0.00310444857857943,-0.0127509405882788,-0.00058150216024747,0.0317901988910421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41465,-0.0178728614151172,0.00833273042147105,-0.0342050130412005,-0.00154070978903397,0.0319796286471732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,39600,-0.015734049216393,0.00734921052104067,-0.0301385018376327,-0.00132959659515329,0.032302652143775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39372,-0.0102919423094474,0.00480920665175671,-0.0197179873468905,-0.000865897272004219,0.0323731285670743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,39600,-0.0139371126565552,0.00652025008019462,-0.0267168028137367,-0.00115742249937377,0.032578354398516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41636,-0.00693664442891915,0.00324681677761937,-0.0133004053130531,-0.000572883544785193,0.0326617519828414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39600,0.00835901617147956,0.00391376834740605,0.000688030210563701,0.0160300021323954,0.0327179489721713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39600,-0.01439505976548,0.00674885952110473,-0.0276228244268453,-0.00116729510411478,0.0329499294271283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41609,-0.00637043292265155,0.0029925984220649,-0.0122359258298987,-0.000504940015404359,0.0332953699692275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39598,0.0136465009409205,0.00641225608038939,0.00107847902335727,0.0262145228584837,0.033343482164336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,41689,-0.0103554927984495,0.00486801015761225,-0.0198967927073695,-0.000814192889529466,0.0334176501270207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41925,-0.00533478752269859,0.00250851084430554,-0.0102514687775375,-0.000418106267859733,0.0334654116024771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39546,0.016758699304543,0.00788358788986354,0.00130686704041046,0.0322105315686756,0.0335446890545519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,39589,-0.00761224450194339,0.00358128592512026,-0.0146315649151791,-0.000592924088707683,0.0335620045518152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39399,0.00481151156545297,0.00227010423040671,0.000362107273855813,0.00926091585705013,0.0340700321585648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41521,-0.0102501783558516,0.00484099194261015,-0.0197385225633675,-0.000761834148335663,0.0342473823266839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41534,-0.0113027077479562,0.00534104159837846,-0.0217711492807779,-0.000834266215134372,0.0343469239242292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41557,0.00937211874312567,0.00443169766210221,0.00068599132540533,0.018058246160846,0.0344667202043605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39600,-0.0071379219318863,0.0033760094516938,-0.0137549004572061,-0.000520943406566448,0.0345114545876727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39250,0.00971972642217831,0.00460323481968609,0.000697386175593569,0.018742066668763,0.0347526625741703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41636,-0.0139801275574719,0.00662280056271281,-0.026960816660389,-0.000999438454554779,0.034799146318222
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39328,-0.02803974493671,0.0133143290269625,-0.0541358298295565,-0.00194366004386341,0.0352290385965457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,41765,-0.00973923520131845,0.00463359819607282,-0.0188210876656212,-0.000657382737015716,0.0355833465426171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39427,-0.00782872954624615,0.00372878066346735,-0.0151371396466422,-0.00052031944585014,0.0357922852536242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39408,0.01189319902364,0.00566666930811987,0.000786527179725058,0.022999870867555,0.0358577784441733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,41786,-0.0117823038266169,0.00562541698983252,-0.0228081211266886,-0.000756486526545128,0.0362365896979596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39334,-0.0125791383872533,0.00600855828339063,-0.0243559126226989,-0.00080236415180762,0.0363246601643545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39308,-0.00698715864292243,0.00335474221399266,-0.0135624533823481,-0.000411863903496813,0.0372958059912376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39250,0.00794286050756689,0.00381514355470881,0.000465179140337627,0.0154205418747962,0.0373727133894921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39598,0.00850242028105758,0.00408727264457298,0.000491365897694537,0.0165134746644206,0.0375285901788522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,41740,-0.00775114119659322,0.00372934748344069,-0.015060662264137,-0.000441620129049468,0.0376902789790494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41431,-0.00652412325935963,0.0031406218727376,-0.0126797421299253,-0.00036850438879394,0.0377905084246603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39334,-0.0104450718203116,0.00503287159684909,-0.0203095001501358,-0.000580643490487434,0.0379759945310628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39600,-0.0238276085303706,0.011496725373802,-0.0463611902630226,-0.0012940267977187,0.0382368449304447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,41698,-0.00789193808416495,0.00381504709857249,-0.015369430397367,-0.000414445770962866,0.0385999730845466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41465,-0.0114285395419092,0.00552475974492542,-0.022257068641963,-0.000600010441855344,0.0386032030115478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,41737,-0.0089937383340523,0.00435182783261349,-0.0175233208859747,-0.000464155782129867,0.0387859721000888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,41865,-0.00503930743570287,0.00243848811892083,-0.0098187441487877,-0.00025987072261804,0.0387940112628175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39427,0.0153238101349496,0.00741526438654596,0.00078989193731949,0.0298577283325797,0.0388028997942908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41534,0.00815339156344919,0.0039658082022552,0.000380407487029,0.0159263756398694,0.0398100787353555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39408,-0.00647929654230725,0.00315426885752866,-0.0126616635030634,-0.00029692958155108,0.0399865488230383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39598,-0.0184927534309478,0.00901164931210992,-0.0361555860826832,-0.000829920779212318,0.0401841274711791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39320,-0.00614855887692376,0.00300484458379715,-0.0120380542611662,-0.000259063492681343,0.0407595388698947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39600,-0.0167617022218554,0.00819370611615208,-0.0328213662095134,-0.000702038234197285,0.0408115802742242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39250,0.00942507459913852,0.00461536503487905,0.000378959130775586,0.0184711900675014,0.0411653842172098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39589,0.0134916866310179,0.00660913717367633,0.000537777770612306,0.0264455954914235,0.041238015734883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",41802,-0.0133759387739646,0.00656049310963575,-0.0262345052688507,-0.000517372279078538,0.0414837004067658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,41744,0.00515653925956045,0.00253081624005487,0.000196139429052908,0.010116939090068,0.0416199017478905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,41836,-0.0102179800804796,0.00501528377983088,-0.0200479362889482,-0.000388023872011112,0.0416329994014918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39107,0.0238594030728225,0.0117192025358397,0.000889766102576704,0.0468290400430683,0.0417830421276716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41521,0.0113994274495563,0.00560905680556669,0.000405676110645596,0.022393178788467,0.0421411560556934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39241,0.0102753144129611,0.00505722756924953,0.000363148377231998,0.0201874804486901,0.0421979107597013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41764,0.00762124588385697,0.00375155066660982,0.000268206577301723,0.0149742851904122,0.0422251368749154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41521,-0.0159932786054187,0.00787357942826904,-0.031425494284826,-0.00056106292601134,0.0422491607477139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,41829,-0.0182725540967151,0.00899828847951338,-0.0359091995165613,-0.000635908676868854,0.042308445457005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,39655,-0.00476600578149488,0.0023479158296251,-0.00936792080756008,-0.000164090755429692,0.0423918408334541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39250,0.0151529403937642,0.00746978452843825,0.000512162718025212,0.0297937180695031,0.0425274905022977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39250,-0.0138140998170205,0.00681399585975156,-0.0271695317021335,-0.000458667931907407,0.0426553067567669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39600,-0.0110466991607516,0.00545770262243817,-0.0217437963007304,-0.000349602020772751,0.0429884479729315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39241,0.00658401454168605,0.00325296242569719,0.000208208187319564,0.0129598208960525,0.0429945008075874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,41751,-0.0123957122604544,0.00612457918460225,-0.0243998874622748,-0.000391537058634006,0.042997655708293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,41865,-0.0208129587724792,0.0102898636712525,-0.0409810915681341,-0.000644825976824175,0.0431276044312832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,41911,-0.0145495119346658,0.00720517862676353,-0.0286716620431223,-0.000427361826209283,0.0434746856629455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39334,-0.00610356838024153,0.00302843785195622,-0.0120393065700757,-0.000167830190407345,0.0438857386461361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41521,0.00641892062164117,0.0031869517053031,0.000172495279247097,0.0126653459640352,0.0440170462754943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39328,-0.0122349374402073,0.00607618276169383,-0.0241442556531272,-0.000325619227287372,0.044077579210038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39589,0.015560722216813,0.00774264900698084,0.000385130163130501,0.0307363142704954,0.0444829646723033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41465,-0.00661399370721706,0.0032912639695778,-0.0130648710875895,-0.000163116326844574,0.0444985801259072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39308,0.00929320449872152,0.00462615714207011,0.000225936500264099,0.0183604724971789,0.0445792744470364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,39598,-0.015631096621415,0.00778845368488632,-0.0308964658437922,-0.000365727399037862,0.0447786004255392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,41865,-0.00796664790609266,0.003974601920053,-0.0157568676693965,-0.000176428142788784,0.0450487080947141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41590,0.00926893626810379,0.00462548724670251,0.00020298126456687,0.0183348912716407,0.0451032975351498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,41877,0.0134400129317568,0.00671999900870761,0.000268814874689889,0.0266112109888237,0.0455203574551448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41465,-0.00960041873272548,0.00480244342039443,-0.0190132078366986,-0.000187629628752401,0.0456218199747947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,39598,-0.00483924397758147,0.00242912862098903,-0.00960033607471997,-7.81518804429567e-05,0.0463767815877201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39385,-0.0185514218903192,0.00932845776385774,-0.0368351991074804,-0.000267644673158061,0.046760525761927
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41925,-0.00523076171721372,0.00263744455905426,-0.0104001530529601,-6.13703814673723e-05,0.0473578978777126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41465,-0.00675529794092706,0.00341417047795923,-0.0134470720777271,-6.35238041269632e-05,0.0478816856182773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39328,-0.0155698571159321,0.0078727906454117,-0.031000526780939,-0.000139187450925142,0.0479904192379316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39600,0.00932732060718787,0.00471637357804633,8.3228394217056e-05,0.0185714128201587,0.0479934979229282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39414,0.0114826058341291,0.00581609638496328,8.30569196010496e-05,0.0228821547486571,0.048375259288177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,41765,-0.00605017250764493,0.00306980279749149,-0.0120669859907282,-3.33590245616177e-05,0.0487600254347314
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,41633,0.0104544729275578,0.00530551332466542,5.56668112135349e-05,0.020853279043902,0.0488031138692913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39334,0.00919380525019406,0.00467242067239486,3.58607323001255e-05,0.018351749768088,0.0491311524401788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41447,-0.00865711358642889,0.00440092122701751,-0.0172829191913832,-3.1307981474573e-05,0.0491915598188498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41899,-0.00813114340846871,0.00413393189294168,-0.0162336499186344,-2.86368983030173e-05,0.0492123531165661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39250,-0.0255794099716233,0.0130135852136283,-0.0510860369903348,-7.27829529118817e-05,0.0493716051794693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39408,0.00733244202532944,0.0037409472926302,1.85331774250203e-07,0.0146646987188846,0.0500156560589762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39308,-0.0129021503800385,0.00659949140473487,-0.0258371535333188,3.2852773241842e-05,0.050606461211064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39241,0.0135955799764619,0.00695867248782077,-4.34180996668407e-05,0.0272345780525906,0.0507557014812132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39308,-0.0134602306967026,0.00689680632698925,-0.0269779710976015,5.75097041963183e-05,0.0510044517772996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41466,-0.0105608685271737,0.00542660491893737,-0.021197014168291,7.52771139435181e-05,0.0516610910934882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41783,-0.0137899632138323,0.00709012187004859,-0.0276866020791276,0.000106675651462921,0.0518017098203576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39308,-0.00660162267778304,0.00339441292335607,-0.0132546720075609,5.14266519948611e-05,0.0518192244527882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,38782,-0.0119296712363922,0.00613397713064683,-0.02395226641246,9.29239396755752e-05,0.0518204149991259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39241,0.0119179103781481,0.00613688353445274,-0.000110381349379228,0.0239462021056755,0.0521618265391582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39334,-0.0106559171111057,0.00549016051022458,-0.0214166317111459,0.000104797488934499,0.0522951250672263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39625,-0.0172784204377114,0.00890594284836019,-0.0347340684204974,0.000177227545074567,0.0523929947810761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39334,-0.0120793348142542,0.00623583832953889,-0.0243015779401505,0.000142908311641978,0.0527614347577814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39250,0.0104924185669969,0.00542362362619058,-0.000137883740336599,0.0211227208743305,0.0530686527103031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39600,-0.0100996307560753,0.00522142209204889,-0.0203336180564912,0.0001343565443405,0.0531057746196896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,41740,0.010361419820304,0.00536107133397669,-0.000146279994290319,0.0208691196348983,0.0532928520200467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,41805,-0.0261077656385442,0.0135218962744403,-0.0526106823364472,0.0003951510593589,0.0535320241664073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39259,0.0147434198073704,0.00764367279122036,-0.000238178863421545,0.0297250184781623,0.0537772811963193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41617,0.0166573134686886,0.00863784472001743,-0.000272862182545568,0.0335874891199228,0.0538257648649204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,39600,-0.0123831463528225,0.00642301934680467,-0.0249722642725596,0.000205971566914672,0.0538892613309232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,41802,0.00486470219015564,0.00252553958809385,-8.53554025083171e-05,0.00981475978281959,0.0541004635410843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39625,0.0100503880400215,0.00522748790228715,-0.000195488248461306,0.0202962643285043,0.0545555618336804
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39554,-0.0100986352570542,0.00526071543081681,-0.0204096375014552,0.000212366987346731,0.054930402804887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41521,-0.00900356962666561,0.00469074134498422,-0.0181974226628347,0.000190283409503458,0.0549513971455874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41466,-0.0141125036688554,0.00735786610671875,-0.0285339212380241,0.000308913900313391,0.0551311141911558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39334,-0.0121299964199527,0.00632552337471901,-0.0245280222344019,0.000268029394496605,0.0551847916478786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41465,-0.0187404070343668,0.00978092212281898,-0.037911014395092,0.000430200326358422,0.0553851477338345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,41863,-0.0058501325515922,0.00305565973397244,-0.0118392256301782,0.000138960526993777,0.0555747831887391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39598,-0.00570441385594144,0.0029823412565866,-0.0115498027188512,0.000140975006968289,0.0558085593533856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,39625,0.0110396845327518,0.00577256094004633,-0.000274534909739044,0.0223539039752426,0.055845486856182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41744,0.0120806034343047,0.0063241561979332,-0.000314742713644319,0.0244759495822538,0.0561251305680721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39598,-0.0113503355136861,0.00594477561415483,-0.0230020957174296,0.000301424690057351,0.0562499297488568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,41765,0.00531945002827562,0.00278717947536694,-0.000143421743443596,0.0107823217999948,0.0563428816628566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39334,0.00609941923835009,0.00320037308571861,-0.00017331200965839,0.0123721504863586,0.0566968340470633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41805,0.0246606048521632,0.0129553543429954,-0.000731889660107753,0.0500530993644341,0.0569961697596666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39643,-0.0234157885236965,0.0123199515495117,-0.0475628935607395,0.000731316513346503,0.057375240793823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,41814,-0.007195192818053,0.00378685086145832,-0.0146174205065113,0.00022703487040531,0.0574487612613773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,41911,-0.00726659835434394,0.00382915940109182,-0.0147717507804839,0.000238554071796034,0.0577571406110907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39427,0.0340658026647099,0.0179523836442693,-0.00112086927805789,0.0692524746074778,0.0577800758199843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,41865,-0.0103868642466735,0.00547754831280679,-0.0211228589397748,0.000349130446427811,0.0579471761467277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,41925,-0.00517443189060917,0.00273140859028199,-0.0105279927275619,0.000179128946343522,0.0581910697322616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39250,0.0138655007958728,0.00732915130451261,-0.000499635760971898,0.0282306373527175,0.0585408747044842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,39600,0.0141749732922633,0.00749519319818625,-0.000515605376181765,0.0288655519607083,0.0586227630189987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39655,0.012373914775523,0.00654416555261551,-0.000452649707603368,0.0252004792586494,0.0586729567307075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41521,0.00990631627557098,0.00524486819237333,-0.000373625381480744,0.0201862579326227,0.0589458845576579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,41734,-0.00484406612206219,0.00256736266378449,-0.00987609694307979,0.000187964698955413,0.0592110363642674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,39589,-0.00914822045215092,0.00484929476436399,-0.0186528381903043,0.000356397286002499,0.0592532316317695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39259,0.00597855652483338,0.00317038145101289,-0.000235391119151894,0.0121925041688186,0.0593554070016431
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,41925,0.00628515332586471,0.00333371430141406,-0.000248926704906849,0.0128192333566363,0.0594069648884304
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39600,-0.00606217539741227,0.00321551423703142,-0.0123645833019939,0.000240232507169303,0.0594170881229742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,41758,0.0108995593973979,0.00579303647000879,-0.000454792083819282,0.0222539108786152,0.0599269009929211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39308,-0.0160162044183828,0.00851722792418571,-0.0327099711497868,0.000677562313021237,0.0600741626631195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39334,-0.00922109579076007,0.00490663895196342,-0.0188381081366084,0.000395916555088235,0.0602292422980456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41447,-0.00736905427552355,0.00392631655938849,-0.015064634731925,0.000326526180877887,0.0605631503636392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39408,0.00654859601292808,0.00349299758253614,-0.000297679248842745,0.0133948712746989,0.0608501785070566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,41865,-0.00710974737035066,0.0037949106941115,-0.0145477723308092,0.000328277590107885,0.0610219900857047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39408,0.0220158005290858,0.0117672197920943,-0.00104795026341895,0.0450795513215906,0.0613799454459191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,41764,-0.0212366860061624,0.0113557084508212,-0.0434938745697719,0.00102050255744718,0.0614875159310881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39328,-0.00806292073545914,0.00431939959731643,-0.0165289439461993,0.000403102475281053,0.0619740680075151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39633,0.00689063195462045,0.00369664107695417,-0.000354784556209717,0.0141360484654506,0.0623447119872124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39600,-0.00869718580068893,0.00466914378746252,-0.0178487076241155,0.000454336022737612,0.0625319772380981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,41865,0.015691763119167,0.00842498270274952,-0.000821202978222055,0.0322047292165561,0.0625508442823934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39241,0.00521532131043034,0.00280229798357822,-0.000277182737382974,0.0107078253582437,0.0627594007704466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39259,0.00835235902817475,0.00448915768765119,-0.00044639003962158,0.0171511080959711,0.0628334845274382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41740,0.0243177562345739,0.0130757756974234,-0.00131076413237587,0.0499462766015237,0.0629423436352967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39408,0.0179571808733045,0.0096625254845473,-0.000981369076408226,0.0368957308230172,0.0631343545415158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,41765,-0.0229317989816128,0.0123546042268537,-0.047146823266246,0.00128322530302051,0.0634568112375717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41689,0.0137558140162086,0.00741270829702591,-0.000773094245962214,0.0282847222783793,0.063517807285022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39589,-0.0172584189008731,0.00930694721858983,-0.0355000354493091,0.000983197647562977,0.0637146258161634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39241,0.0161859648446338,0.00873306381571408,-0.000930840234165765,0.0333027699234334,0.0638509957589764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,41865,-0.0124048698178314,0.00671108556720604,-0.0255585975295552,0.00074885789389246,0.0645646018878174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41689,-0.00395039051398915,0.00214025903935027,-0.00814529823111567,0.000244517203137369,0.0649505801249297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39250,0.010985134598294,0.00595359363729908,-0.000683908930812218,0.0226541781274002,0.0650468545282513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,39600,-0.00724236320276427,0.00392582695814232,-0.0149369840407232,0.000452257635194681,0.0650935914526085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41855,-0.00604689227496533,0.00327788492279427,-0.0124715467236421,0.000377762173711431,0.0650955854122559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39241,-0.0188137172031964,0.010223041825137,-0.0388508791804648,0.00122344477407207,0.0657483993137775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41689,0.00529293477945122,0.00287673944626507,-0.000345474535228319,0.0109313440941308,0.0658044328414358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,41740,-0.022426270697259,0.012198946878601,-0.0463362065793169,0.001483665184799,0.0660293405248519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,41765,-0.00777336335186404,0.00422916920175056,-0.0160625349872951,0.000515808283567052,0.066079684420863
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39259,0.00815084958060349,0.00443948132542375,-0.000550533817227057,0.016852232978434,0.0663867647441707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39600,-0.0277939679637314,0.0151554260274479,-0.0574986029775292,0.00191066705006643,0.06669160575128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39633,-0.0126406608731696,0.00690393731857793,-0.0261723780175823,0.000891056271243165,0.0671371918071115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41521,0.00682245938558867,0.00372688597864682,-0.000482237132559103,0.0141271559037364,0.0671824099557604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,41740,-0.0170297900485666,0.00931836879373586,-0.0352937928842889,0.00123421278715565,0.0676396989377227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39224,0.00956341775599035,0.00523764659489716,-0.000702369570008091,0.0198292050819888,0.0678934142722781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39600,0.0154125795863277,0.00844265129389107,-0.00113501694969878,0.0319601761223542,0.0679434315646349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39259,0.00922671845432144,0.00505784662654982,-0.000686660933716214,0.0191400978423591,0.0681440088415272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39250,-0.0130313256940306,0.00715250150080377,-0.027050228635606,0.000987577247544771,0.0684943073944224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,41911,-0.00835253838121948,0.00459502323634569,-0.017358783924457,0.000653707162018074,0.0691269884595892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41740,-0.0292868068360513,0.0161436273019868,-0.0609283163479455,0.0023547026758429,0.0696789066353691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,41758,-0.00985973635430528,0.00544842848622419,-0.0205386561873047,0.000819183478694129,0.0703732379216949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,39598,-0.00918548349097822,0.00507675794064432,-0.0191359290546411,0.000764962072684641,0.0704284781312283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39600,-0.0115666372820265,0.00639729577933847,-0.0241053370095299,0.000972062445476879,0.0706258576736386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,39650,0.00292541237038375,0.0016198135982243,-0.000249422282135883,0.00610024702290338,0.0709427412196668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39259,0.00592716255454394,0.00328855919520491,-0.000518413468057692,0.0123727385771456,0.0715172616121357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,41790,0.00522970414674812,0.00290573744107778,-0.000465541237764323,0.0109249495312606,0.0719173557340719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41840,-0.00588951008191809,0.00327326651967676,-0.0123051124604845,0.000526092296648362,0.0719977848003162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,41740,0.0118661183697213,0.00659654042625893,-0.00106310086574621,0.0247953376051888,0.072066990378779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,39600,-0.0207419104708506,0.0115374493468338,-0.0433553111906449,0.00187149024894367,0.0722377133423669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39589,0.00852081823912951,0.00474434563925267,-0.000778099213805715,0.0178197356920647,0.0725228656090342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,41740,-0.0140929211829596,0.00785867088461899,-0.0294959161168128,0.0013100737508936,0.0729486330790265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41465,0.0238742707673224,0.0133310757892529,-0.00225463777961321,0.0500031793142581,0.0733370935240369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41447,-0.0128851937068777,0.00719737259826764,-0.0269920439994822,0.0012216565857269,0.0734350952877098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39427,0.00652117689307915,0.00364446288034221,-0.000621970352391591,0.0136643241385499,0.0735882962478761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39427,0.0159157800816632,0.00889564373457077,-0.00151968163809552,0.0333512418014219,0.0736160873572825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41521,-0.0171722744603283,0.00959871452073811,-0.035985754920975,0.00164120600031837,0.0736353091477449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,41765,-0.0237243906908184,0.0132640198480242,-0.0497218695929458,0.00227308821130906,0.0736978110172995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39241,0.00809789391406611,0.00452991148703115,-0.00078073260051495,0.0169765204286472,0.0738610251649605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39427,0.010254199609785,0.00575105905882975,-0.00101787614552129,0.0215262753650914,0.0746125756004738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39250,0.00613150785996054,0.00344301204292227,-0.000616795744167101,0.0128798114640882,0.0749645115359213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39328,-0.00757892714326478,0.00425747451985132,-0.0159235772021734,0.000765722915643797,0.0750803309723493
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39250,-0.0167484388933782,0.00941457266542216,-0.0352010013176057,0.0017041235308492,0.0752697724043806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,39633,-0.00498085120995513,0.00280493840861603,-0.0104785304908426,0.000516828070932293,0.0758027575773555
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39600,-0.0148079868825851,0.00834153745528399,-0.0311574002949417,0.00154142652977157,0.075890742135366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,39600,0.0147392137524978,0.00831688946563318,-0.0015618896001432,0.0310403171051388,0.0763885945124264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,41805,-0.00906387792131281,0.00511963609892344,-0.0190983646752028,0.00097060883257713,0.0766811859478865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39250,0.00659196944909072,0.00372484654563637,-0.000708729780356574,0.013892668678538,0.0768008831242205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39241,-0.0106508912045304,0.00602425732859518,-0.022458435568577,0.00115665315951614,0.0770894360302119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39334,0.0104626019056894,0.00591856027556052,-0.00113777623440924,0.022062980045788,0.0771292187505837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39334,-0.0150587533871967,0.00852073240272022,-0.0317593888965283,0.00164188212213493,0.0772051708403915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39259,-0.00606855264735695,0.00343408427528922,-0.0127993578269238,0.00066225253220993,0.0772312031759235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39259,0.0160428857331807,0.0090903885460242,-0.00177427581702676,0.0338600472833881,0.0776229101699531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39522,-0.00820830815942201,0.00465290570266523,-0.0173280033366459,0.000911387017801843,0.0777388543674541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39408,-0.00591208457091103,0.00335971055685831,-0.0124971172623533,0.00067294812053126,0.0784868766462251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41466,-0.00700538374781592,0.00398467211115725,-0.0148153410856841,0.00080457359005229,0.0787571864128309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,41704,-0.00503873975360459,0.00286828196869688,-0.0106605724122505,0.000583092905041299,0.0789905977730039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39655,-0.00506429439064282,0.00288329474368922,-0.0107155520882737,0.000586963306988044,0.0790433496231715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39385,0.00549283825093225,0.00313750443935948,-0.00065667045021233,0.0116423469520768,0.0800255228288762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,41744,-0.0101766225502502,0.00582049238938008,-0.0215847876334352,0.00123154253293474,0.0804159429198673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39328,-0.00927542822497445,0.00531055423581075,-0.0196841145271635,0.00113325807721463,0.0807349014789034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,41750,-0.00951495867138468,0.0054532388274496,-0.0202033067731859,0.00117338943041653,0.0810383371347038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41689,-0.0064195949779417,0.00368057633914454,-0.013633524602665,0.000794334646781608,0.081150833774639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,41911,0.00462018552615588,0.00265034853214556,-0.000574497596849415,0.00981486864916117,0.0813153202431592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39308,-0.0117632208550179,0.00676785890313238,-0.0250282243051573,0.00150178259512157,0.0822218032293694
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39250,0.0155327998000854,0.00893776126735879,-0.00198521228393788,0.0330508118841086,0.0822600122178912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41614,-0.00942435904718704,0.00542307360166755,-0.0200535833064554,0.00120486521208135,0.0822651082187059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41465,-0.0107151524363194,0.00617153130381836,-0.0228113537918033,0.00138104891916464,0.0825484135896785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39334,-0.00925405145133488,0.00533006435783637,-0.0197009775926942,0.00119287469002442,0.0825573784745688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41636,-0.0147632533966541,0.00850400103369793,-0.031431095422702,0.00190458862939382,0.0825810660895031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41466,-0.00719036972580858,0.00414247327472327,-0.0153096173442662,0.000928877892649027,0.082628926181418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,41636,0.00227515214237547,0.00131078975021025,-0.000293995768036615,0.00484430005278756,0.0826385830258918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41465,-0.0138253300454887,0.00797996046969547,-0.0294660525660918,0.00181539247511447,0.0832074610073757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39334,-0.0120438427445368,0.0069569709215812,-0.025679505750836,0.00159182026176231,0.0834465078745809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,41836,-0.00859816026920537,0.00496887674343397,-0.018337158686336,0.00114083814792521,0.0835815688010564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39328,-0.0144255697055632,0.00833701317032618,-0.0307661155194025,0.00191497610827613,0.083604680347995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39334,-0.00679834879893091,0.00393053593491419,-0.0145021992313627,0.000905501633500901,0.083726244822571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39334,0.00714859014674147,0.00413402005600094,-0.000954089163020373,0.0152512694565033,0.0838002107224895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41689,-0.00398476147044728,0.00230809419234043,-0.00850862608743453,0.000539103146539969,0.0842938024796726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41636,0.0094849672135833,0.00550957815607074,-0.00131380597231534,0.0202837403994819,0.0851763401461677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41465,-0.0107230712648776,0.00623514296357556,-0.0229439514734857,0.00149780894373049,0.0854965751457777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,39600,-0.00649765695716743,0.00378352570056479,-0.0139133673302744,0.000918053415939552,0.0859424669818935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,39633,-0.0155109166100855,0.00904870590967796,-0.0332463801930543,0.00222454697288332,0.086527697435138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39241,0.00738502600302756,0.00430899833803918,-0.00106061073952924,0.0158306627455844,0.0865833036938541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39259,0.0140182612743808,0.00818647982610169,-0.00202723918477849,0.0300637617335401,0.0868580660863522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39650,0.00339382534264442,0.00198237553441635,-0.000491630704811633,0.00727928139010046,0.0869248735564807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39259,0.00895541528768524,0.00524364223550194,-0.00132212349389856,0.019232954069269,0.0876911420901269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39250,0.00664570399933814,0.00389247283661377,-0.000983542760424842,0.0142749507591011,0.0877913907392631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,41734,0.005407982616378,0.00317055417715621,-0.000806303570848168,0.0116222688036042,0.0880894531561717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,41740,0.00832844234819895,0.00488315624109436,-0.001242543884346,0.0178994285807439,0.0881164752807068
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,41758,0.0223654178900881,0.0131252215822931,-0.00336001641120645,0.0480908521913826,0.0884041243605387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39241,-0.0167827268878298,0.0098523512964742,-0.0360933354289193,0.00252788165325959,0.0885180399002885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39334,-0.0156770919938994,0.00922290655285407,-0.0337539888374934,0.00239980484969457,0.0891976168137674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41865,0.00824368615749985,0.00485236281051971,-0.00126694495111878,0.0177543172661185,0.089361205168719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39224,0.00487758810001832,0.00287342687147761,-0.000754328568077795,0.0105095047681144,0.0896350101519306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41689,0.0171075836386997,0.0100877772983316,-0.00266445986603018,0.0368796271434296,0.0899338187050951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,41765,-0.0122979542344652,0.00725175797197931,-0.0265113998595446,0.00191549139061426,0.0899363550000558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41689,-0.00445540124077928,0.0026297105500207,-0.00960963391881986,0.000698831437261296,0.0902405560224179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39328,-0.00684253564567602,0.00404853416765629,-0.0147776626142824,0.00109259132293031,0.0910327728172237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39334,0.00833073999451294,0.00493046208505962,-0.00133296569220391,0.0179944456812298,0.0911245666131705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,41925,0.0041537907847064,0.00245950841021442,-0.000666845699313862,0.00897442726872665,0.0912676789302601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,41689,-0.0101146665086515,0.00599062854652834,-0.021856298459847,0.00162696544254408,0.0913554331467536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39625,-0.0132557475007562,0.0078528039328093,-0.0286472432090624,0.00213574820755005,0.0914342697780056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,41802,0.00699676695376382,0.00415609020944567,-0.00114916985674971,0.0151427037642773,0.0923024896629547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41521,0.010907871672635,0.00648022984280415,-0.00179337881926115,0.0236091221645311,0.0923501227478115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41636,-0.0171871466067634,0.0102169118506588,-0.0372122938340547,0.00283800062052798,0.0925491286536078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39250,-0.00838085039637041,0.00498411139502628,-0.0181497087306219,0.00138800793788111,0.0926925440603052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41521,-0.00883121478151387,0.00525215738719214,-0.0191254432604105,0.00146301369738271,0.0927006408712291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39250,0.00712182042119296,0.00423549760878005,-0.00117975489201594,0.0154233957344019,0.0927028917860072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39259,-0.0117149638770944,0.00696777460809678,-0.0253718021089641,0.00194187435477528,0.0927327163304874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39308,-0.00700887094797622,0.00417043196434836,-0.015182917598099,0.00116517570214656,0.0928677987600387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39334,-0.00750477871228299,0.00447377236617326,-0.0162733725499826,0.00126381512541659,0.0934727470927334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39328,-0.0140648765924173,0.0083855604193921,-0.0305005750144258,0.0023708218295912,0.093518183179411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39259,0.0117677780323887,0.00703899662502546,-0.00202865535266118,0.0255642114174386,0.0945935820395987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39408,-0.00918153887567054,0.00549278384154024,-0.0199473952050894,0.00158431745374833,0.0946393080465828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39406,0.00695651227526638,0.0041648268145088,-0.00120654828117088,0.0151195728317036,0.0948888871071943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41560,-0.0043260882774528,0.0025911829058847,-0.00940480677298682,0.000752630218081214,0.0950341967659664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41534,-0.00565068221517302,0.00338553239801832,-0.0122863257152889,0.000984961284942893,0.0951281981969619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39308,-0.00738924525577578,0.00443177331671223,-0.0160755209565318,0.0012970304449802,0.0954773002079518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,41750,-0.00563523038251964,0.00338806393881395,-0.012275835702595,0.00100537493755571,0.096284281475968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41465,-0.0117521009875583,0.00707289980572509,-0.0256149846067795,0.00211078263166286,0.0966238739228461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39094,-0.00420175014322977,0.00253034743373464,-0.00916123111334965,0.000757730826890118,0.0968351858937483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39589,0.00728733482912738,0.00438988942458326,-0.00131684844305581,0.0158915181013106,0.0969375595952349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39600,-0.00522086500890059,0.00314562005097393,-0.0113862803088095,0.00094455029100832,0.0969982434346291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39250,0.0090872405173347,0.00548641543939498,-0.00166613374387947,0.0198406147785489,0.0976871960111921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,41637,0.00854459514139786,0.00516585099134396,-0.0015804728016363,0.018669663084432,0.0981406687890895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,39589,-0.00697142774537039,0.00421509929300086,-0.0152330223596521,0.0012901668689113,0.0981727771318131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39308,-0.012279143892141,0.00743075314894697,-0.0268434200640771,0.00228513227979505,0.0984667988811035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39334,-0.0186626221989973,0.0112979746474701,-0.0408066525080387,0.00348140811004411,0.0985932497208956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39625,0.0061049483367274,0.00369638049834179,-0.0011399574400225,0.0133498541134773,0.0986442509271133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39589,-0.00925184461486782,0.00560889789167989,-0.0202452844825604,0.00174159525282476,0.0990750094402992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39600,-0.00484537165717717,0.00293861532121423,-0.0106050576867571,0.000914314372402728,0.0992044292250755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39250,0.0112189936572021,0.00681112358516807,-0.00213080856972728,0.0245687958841316,0.0995551681399147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,41805,-0.0184573054724205,0.0112087608401574,-0.040426476719129,0.003511865774288,0.0996464737612283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,41747,0.00394951227181248,0.0023995149966076,-0.000753537121538413,0.00865256166516338,0.0997953342017404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,41840,0.0128969864662421,0.00785562385745875,-0.00250003629437708,0.0282940092268612,0.100665152754512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39259,0.00823696691683519,0.00504151082801798,-0.00164439430608005,0.0181183281397504,0.102324280883402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39241,0.00942599072253789,0.00577141832177522,-0.00188598918814153,0.0207379706332173,0.102452506561991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39334,-0.0168474929999615,0.0103203056882455,-0.0370752921489227,0.00338030614899974,0.102611812049139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,39655,0.00401532092642687,0.00245979108735836,-0.000805869604795529,0.00883651145764926,0.102627328148983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39250,0.00750245675988594,0.00459991838877802,-0.00151338328211899,0.0165182968018909,0.102920353095432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,41758,-0.00530652987352191,0.00325454295682354,-0.011685434068896,0.00107237432185222,0.103019956424133
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39427,-0.013032755091861,0.00799466977721916,-0.0287023078552105,0.00263679767148859,0.103092434008292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39600,0.020116081469595,0.0123433103705098,-0.00407680685660432,0.0443089697957942,0.10319031982346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39334,0.0154068246807779,0.00946199464480955,-0.00313868482304886,0.0339523341846046,0.103493799519244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41764,-0.00608541382062594,0.00374078047447078,-0.0134173435505887,0.00124651590933678,0.103808505771138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41636,-0.00592501231549882,0.00364353940706283,-0.013066349553342,0.00121632492234434,0.103937793515051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39633,-0.00407398466269015,0.00250671767172727,-0.00898715129927559,0.000839181973895301,0.10414281100261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39221,0.0135068890096136,0.0083118891897566,-0.0027844138023093,0.0297981918215366,0.104190459223234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41521,-0.00482930951728093,0.00297231295693242,-0.0106550429128685,0.000996423878306604,0.104237070694989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,41925,-0.00301343493548716,0.00185878753937173,-0.00665665851265575,0.000629788641681422,0.105002037670471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41689,-0.00551873072591137,0.00341176489711282,-0.0122057899242525,0.00116832847242975,0.105781785698167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39241,0.0138482412574221,0.00857385782850991,-0.00295652008645731,0.0306530026013015,0.106303448900398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41299,-0.0063757067024133,0.00395073554006649,-0.0141191483609436,0.00136773495611702,0.10659512845194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,41732,-0.00512228957120143,0.00318304833069532,-0.0113610642993643,0.0011164851569614,0.107587850064291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,41791,0.00452003019939102,0.00281110434671736,-0.000989734320175017,0.0100297947189571,0.107876688092655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41465,-0.0055861565008431,0.00347800424926287,-0.0124030448293983,0.00123073182771213,0.108268026794922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,41877,-0.0103701934583999,0.006467027274211,-0.0230455669158534,0.0023051799990537,0.108837343020701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39600,0.0125304942371682,0.00781413248349042,-0.00278520543047303,0.0278461939048094,0.108837978406144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39241,-0.0115860752219361,0.00723702192569331,-0.025770638196295,0.00259848775242274,0.109418750878174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41740,-0.00710484855226484,0.00444172105515285,-0.0158106218203644,0.00160092471583475,0.109717809858807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39250,-0.021468765714353,0.0134249707416993,-0.0477817083680835,0.00484417693937762,0.109813238385035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39241,0.00438331346552208,0.00274184234207195,-0.000990697524938946,0.00975732445598311,0.109922633904155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,41879,-0.00353552715300752,0.00221230492079715,-0.00787164479776994,0.0008005904917549,0.110040225731459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39241,-0.0252703591448526,0.0158395590534331,-0.0563158948895816,0.00577517659987633,0.110653547991212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39600,-0.00467999427029732,0.00293598098253644,-0.0104345169960687,0.0010745284554741,0.110961669192198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41521,-0.0143434910195492,0.00902549154037301,-0.0320334544386803,0.00334647239958191,0.112035215056357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39585,0.0150553500900325,0.00948778806606466,-0.0035407145194542,0.0336514146995193,0.112583674740031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39308,-0.00510697947986429,0.00322142385068617,-0.0114209702272092,0.00120701126748061,0.112923752693573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39600,-0.0133924970190608,0.00845433405975742,-0.0299629917761854,0.00317799773806371,0.113200076330331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41865,-0.00955516131762558,0.00603544404411993,-0.0213846316441006,0.00227430900884948,0.113405528368708
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,41758,0.00487820970524662,0.00308218010253929,-0.00116286329573039,0.0109192827062236,0.113510691864636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,41805,-0.00708099857025339,0.00447926882858775,-0.0158603654742854,0.0016983683337786,0.11393902394144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39241,-0.0074619470447787,0.00472380367500518,-0.0167206022477889,0.00179670815823146,0.114217222258343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,41865,-0.008044614560699,0.00509433458022766,-0.0180295103379452,0.00194028121654721,0.114330175879079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,41765,0.0129989083758448,0.00823975154386283,-0.00315100465012636,0.0291488214018159,0.114685008827585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39250,0.0127144144869852,0.00805933678523339,-0.00308188561207227,0.0285107145860426,0.1146870963947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39408,-0.00741016718320224,0.0046980191242236,-0.0166182846666805,0.00179795030027602,0.114756678624728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",41728,0.018628479337904,0.0118122211168597,-0.00452347405114106,0.0417804327269491,0.114807803206624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39625,-0.00506253612104398,0.00321382259426559,-0.0113616284058045,0.00123655616371658,0.115230165156213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39625,-0.00483944559623861,0.00307351649069448,-0.0108635379179998,0.00118464672552258,0.115386023349723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39589,-0.00595652676332868,0.00379004366629408,-0.0133850123492651,0.00147195882260771,0.116066372533596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,41743,0.0110301881929232,0.0070237712968625,-0.00273640354892736,0.0247967799347737,0.116344243333524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39308,-0.00897477519682648,0.00571829817022376,-0.020182639610465,0.00223308921681208,0.116564845082121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,41740,0.00842029416269942,0.0053652419712261,-0.00209558010090373,0.0189361684263026,0.116575222339131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39308,0.0163047707412119,0.0103924849918279,-0.0040644998427708,0.0366740413251946,0.116700766202823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41534,-0.00955897303475202,0.00609420306521091,-0.0215036110425654,0.00238566497306136,0.116780705685856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39334,0.00574982455088904,0.00367035723321386,-0.00144407562621011,0.0129437247279882,0.117247706195872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39250,0.00825819381289292,0.00527949682500247,-0.00208961996411192,0.0186060075898978,0.117800101687365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39241,0.00671993940625404,0.00431127017331039,-0.00173015013343433,0.0151700289459424,0.119099195317716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39600,-0.0106555978354772,0.00683792755336612,-0.0240579358400748,0.00274674016912042,0.119188999939364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39600,0.0166669400711531,0.0107054018638995,-0.00431564758209002,0.0376495277243962,0.11952965442486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39259,0.00811906887694241,0.00522020255292232,-0.00211252812678534,0.0183506658806702,0.119900320403526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,41758,-0.00750427477303441,0.00483188606411714,-0.016974771458704,0.00196622191263518,0.120429598389628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39250,0.00956514067400388,0.00616457663202766,-0.00251742952477032,0.0216477108727781,0.120780547641618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39600,0.013056027799574,0.00842014928484887,-0.00344746479872983,0.0295595203978777,0.121033622204704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41466,0.00750663266266252,0.00486054420159566,-0.00202003397246497,0.01703329929779,0.122515646207461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41521,-0.00584464639537838,0.0037891781398804,-0.013271435549544,0.0015821427587872,0.1229869370938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,41911,-0.0125555951628921,0.00814425385522375,-0.0285183327191307,0.00340714239334641,0.123182254099722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39328,-0.00800295795877194,0.00519808601814424,-0.0181912065543346,0.00218529063679076,0.123688095318203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39328,-0.00666639053839225,0.00433027474203935,-0.0151537290327894,0.00182094795600488,0.123715569410712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39598,-0.00782637469594125,0.00509672928492117,-0.0178159640943867,0.00216321470250425,0.124673118940076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39633,-0.0229772817620928,0.014966471514747,-0.0523115659309969,0.00635700240681125,0.124751000696992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41521,0.010060719311486,0.00655923444220281,-0.00279538019523147,0.0229168188182036,0.12509713649046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39259,-0.0124313562756415,0.00815076428133757,-0.0284068542670631,0.00354414171578011,0.127244683791346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,41925,0.00491603232755686,0.00322668479437013,-0.0014082698694086,0.0112403345245223,0.127643597999421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41689,0.00537096727086411,0.00353405084429243,-0.00155577238394906,0.0122977069256773,0.128591322087509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39250,-0.0110621358961916,0.00728198517381167,-0.0253348268368625,0.00321055504447923,0.12876451517734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,39589,-0.00856141367731349,0.00564350505809628,-0.0196226835911822,0.00249985623655521,0.1292857635456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41465,-0.0100360284357877,0.0066343753913629,-0.023039404202859,0.00296734733128357,0.130372446235543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39241,0.00848848882735139,0.0056248930924839,-0.00253630163391705,0.0195132792886198,0.131304615500668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39334,0.00601637519854094,0.00399980335559111,-0.00182323937841763,0.0138559897754995,0.132567601470824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39633,0.00440985208143039,0.00293402830541624,-0.00134084339718545,0.0101605475600462,0.132867002509573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41373,0.0109247524853565,0.00726986745914139,-0.00332418773456061,0.0251736927052736,0.132929694688605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39250,0.00839090958511342,0.00558809532503879,-0.00256175725196261,0.0193435764221895,0.133238153029428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39650,-0.00409800562604525,0.00273225678117763,-0.0094532289171534,0.0012572176650629,0.133678958803879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41465,-0.00602441899768345,0.00401753922364103,-0.0138987958760199,0.00184995788065297,0.13376083282924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,41846,-0.00606282778444187,0.00404955376968789,-0.0139999531730301,0.0018742976041464,0.134375594924114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39598,-0.0145203498056049,0.00969943289730413,-0.033531238284321,0.00449053867311118,0.134413940342095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39334,-0.00656401976523983,0.00438720069772844,-0.0151629331327876,0.00203489360230792,0.134637471850796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,41758,0.00609937403229242,0.00407705631238499,-0.00189165633998217,0.014090404404567,0.134671388637865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39250,0.00634349617772328,0.00424398802830296,-0.00197472035775051,0.0146617127131971,0.135021934682744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41863,-0.00453835219445808,0.00304097505342941,-0.0104986632991797,0.00142195891026357,0.135618012007858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39633,0.00986671727679687,0.00662176316409445,-0.00311193852482824,0.022845373078422,0.13624130016124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41521,0.012639846452857,0.00848682727615046,-0.00399433500839791,0.0292740279141119,0.13641993702895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,41765,-0.00567753249246687,0.00381281789918638,-0.0131506555748722,0.00179559058993845,0.136494289428712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,41836,-0.0106997132221631,0.00718727828819259,-0.0247867786670206,0.00338735222269434,0.136589768351359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,41866,0.00669511465455103,0.0044987926376034,-0.00212251891515163,0.0155127482242537,0.136721255472367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41521,-0.0116824428822974,0.00786992225051623,-0.0271074904933092,0.00374260472871442,0.137716101178703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41521,-0.00823732484677574,0.00555407107778103,-0.0191233041592266,0.00264865446567509,0.138068310347393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41799,0.00777966132306719,0.00524803283163323,-0.00250648302693394,0.0180658056730683,0.138258910495515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41740,0.0132242103887243,0.00892548865986499,-0.0042697473846111,0.0307181681620597,0.1384645817308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41521,-0.00501746269883281,0.00338733485652764,-0.011656639017627,0.00162171361996137,0.138566478967572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39063,-0.00385203755307727,0.00260769869889145,-0.00896312700290452,0.00125905189674998,0.139657779678995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,41840,0.0113394821354811,0.00769969274076982,-0.00375191563642772,0.02643087990739,0.140850650018397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,39589,-0.00645058962219923,0.00438488522775188,-0.0150449646685929,0.00214378542419445,0.141293635784154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39250,-0.00890241956192801,0.00605296725297229,-0.0207662353777537,0.00296139625389767,0.141387478976981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41465,-0.00744111069838669,0.0050661049180577,-0.0173706763377798,0.0024884549410064,0.141910648490861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39250,0.013332298887014,0.00908052933001528,-0.00446553859981596,0.031130136373844,0.14207149092864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39241,0.00739360342366355,0.00504811340091451,-0.00250069884212889,0.017287905689456,0.143052240921378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39427,0.0116196222742886,0.0079540843112171,-0.0039703829756969,0.0272096275242741,0.144089141610951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,41758,-0.00505304113903048,0.00345973507201091,-0.0118341218801719,0.0017280396021109,0.144168799535643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41534,0.0095886039428092,0.00657340021407048,-0.00329526047676895,0.0224724683623873,0.144672605107434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41466,-0.0099689091884034,0.00683781343322266,-0.0233710235175198,0.00343320514071301,0.144890058026938
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39241,0.0121956202776187,0.0083723628940317,-0.0042142109946834,0.0286054515499209,0.145241934385651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,41802,-0.00533325726903238,0.00366157436060308,-0.0125099430158144,0.00184342847774967,0.145265088564529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,41720,-0.00686307787966727,0.00471466337921472,-0.0161038181029281,0.00237766234359358,0.145502875667994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39241,0.00815153568082246,0.00560907329984321,-0.00284224798687023,0.0191453193485152,0.146176425666886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39308,-0.00983211669094598,0.00676783609988219,-0.0230970754467151,0.00343284206482312,0.146316620736957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39334,0.00712160449982851,0.00490606534525164,-0.0024942835768647,0.0167374925765217,0.146644349731269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39259,0.00632185956345483,0.00435955672715994,-0.00222287162177866,0.0148665907486883,0.147055814735822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41465,0.0114677810056432,0.00792453535788622,-0.00406430829581383,0.0269998703071001,0.147886714422662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,41740,-0.0131235267638995,0.00909339642734308,-0.0309465837614919,0.004699530233693,0.148989927528483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,41636,0.00874173415546579,0.00606702298086527,-0.00314963088703014,0.0206330991979617,0.149648096892908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41534,0.0098700778701702,0.00685407239336626,-0.00356390402082767,0.0233040597611681,0.149882784735394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39334,0.00342113066687204,0.00237640160218723,-0.00123661647341494,0.00807887780715901,0.150002266158983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39600,0.0115494342824096,0.00803613786860163,-0.00420139594004959,0.0273002645048688,0.150693259064546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,41758,-0.00558197661828443,0.00388409119824534,-0.0131947953668453,0.00203084213027644,0.15070244937983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41802,-0.0146959002448588,0.0102427266802696,-0.0347716445381873,0.0053798440484697,0.151377915322411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39297,-0.00881946876916376,0.0061473856131178,-0.0208683445708746,0.00322940703254713,0.151410434902488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39655,0.00999616666298576,0.00696913369174701,-0.00366333537283838,0.0236556686988099,0.151501113392028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39241,0.00517777681052649,0.00361820640043091,-0.00191390773431809,0.0122694613553711,0.152449802849063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,41911,-0.00975262720747926,0.00683046103711098,-0.0231403308402168,0.00363507642525826,0.153368891032711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41521,-0.00747179570130129,0.00523675262086356,-0.0177358308381939,0.00279223943559128,0.153661875758094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39493,0.00484625110302814,0.00339889750151373,-0.00181558799993877,0.0115080902059951,0.15394598266151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39250,0.00763474076657333,0.00535863960665571,-0.00286819286247185,0.0181376743956185,0.154257757821227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41740,-0.0156381299259511,0.0109810941131465,-0.0371610743877183,0.00588481453581602,0.154442490357271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39598,-0.00432569377273812,0.00303859122651507,-0.0102813325767077,0.00162994503123142,0.154594924289208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,41640,0.019613932422176,0.0137798257885562,-0.00739452612339416,0.0466223909677461,0.154649867674836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,41740,-0.00657276162728026,0.00461800448470306,-0.0156240504172983,0.00247852716273773,0.154675719646268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39408,-0.0119701292371283,0.00841766572996718,-0.0284687540678639,0.00452849559360741,0.15504791461347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,41765,0.00433287070809715,0.00305091394382345,-0.0016469206217968,0.0103126620379911,0.155576700117667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41534,-0.0064845371105565,0.00457396368428359,-0.0154495059317523,0.00248043171063934,0.15630062116983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41534,-0.00488517460096892,0.00344688779999804,-0.0116410746889651,0.00187072548702723,0.156427757057303
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41534,0.00925425608217021,0.00654262288512295,-0.00356928477267077,0.0220777969370112,0.157251955012675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41458,-0.0121187147887095,0.00857275400109717,-0.0289213126308599,0.00468388305344098,0.157494347230824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39328,0.0102904662134108,0.00728286152905324,-0.00398394238353353,0.0245648748103552,0.157693501506458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39427,0.00568416718360507,0.00402324323257387,-0.00220138955223972,0.0135697239194499,0.157733842570121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41689,-0.00318357519323418,0.00225339000517745,-0.00760021960338199,0.00123306921691362,0.157740169695162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,41708,0.0131612229719762,0.00932166959699364,-0.00510924943813136,0.0314316953820837,0.158004482772277
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39600,0.0152729914558767,0.0108259810840443,-0.00594593146885011,0.0364919143806036,0.158340119231894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39334,-0.00916380308267039,0.0064985066518094,-0.0219008761202168,0.00357326995487604,0.158527372866614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,41865,-0.00926057376070038,0.0065679951786557,-0.0221338443108656,0.0036126967894648,0.158576591046698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39308,0.0405586871654955,0.0287701020950078,-0.0158307129407198,0.0969480872717108,0.158642191135302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39250,0.00767158549240975,0.00544318301954778,-0.00299705322590389,0.0183402242107234,0.158748112693988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,41740,0.00507895393124018,0.00360630645448936,-0.00198940671955895,0.0121473145820393,0.159050112256296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41758,-0.00560731553293695,0.00399018127627181,-0.0134280708344297,0.00221343976855581,0.159962119878374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39250,0.0103812124676053,0.00739634740568986,-0.00411562844754685,0.0248780533827574,0.160479266745264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,39655,-0.0105911474631074,0.00755128838997518,-0.0253916727074588,0.00420937778124394,0.16077567691442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39633,0.0126923073994066,0.00905280061781607,-0.0050511818115129,0.0304357966103261,0.160934112997935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,39596,-0.00469200504719128,0.00334870326771369,-0.0112554634519101,0.00187145335752756,0.161200169953486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39600,-0.00742907458389354,0.0053068181059466,-0.0178304380715489,0.0029722889037618,0.161568086513396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41598,0.00977753078634037,0.00699684344352099,-0.00393628236296076,0.0234913439356415,0.162311081405384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,41765,-0.00822234627281356,0.00588915774479259,-0.019765095452607,0.00332040290697992,0.16268271354255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39250,-0.0106008816247696,0.00760694126551222,-0.0255104865051735,0.00430872325563438,0.163473534718537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39241,-0.0114076894251801,0.00819419791763437,-0.0274683173437435,0.00465293849338322,0.163901018995543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,41786,-0.00460765183186177,0.00331599841694645,-0.0111070087290768,0.00189170506535328,0.164697621069582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,41836,-0.00834191355771072,0.00601251446078163,-0.0201264419008427,0.00344261478542126,0.165335530121743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41521,0.00408771370480223,0.00294860544300646,-0.00169155296349043,0.00986698037309488,0.165672821696949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39259,0.0107960594236484,0.00780048535713906,-0.00449289187634416,0.026085010723641,0.16638006498122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,38964,-0.0166129303632025,0.0120058624124277,-0.0401444206915608,0.00691855996515571,0.166469454784374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39308,0.00502088482255905,0.00363033428978788,-0.00209457038542519,0.0121363400305433,0.166682511885178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39408,0.00679655948994711,0.00491556653886386,-0.00283795092622604,0.0164310699061203,0.166797568182155
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39427,-0.00875467122164984,0.00633355120546229,-0.0211684315843559,0.00365908914105625,0.166917647322004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41686,-0.00441594731158773,0.00319896626236927,-0.0106859211858315,0.00185402656265604,0.167478029478016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39334,-0.00956115066168143,0.00693570008857336,-0.0231551228352852,0.00403282151192236,0.168064881619005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39250,0.00718272139548058,0.00521313660860439,-0.00303502635738402,0.0174004691483452,0.1682903357159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39308,0.0109177140983205,0.00793697519929227,-0.00463875729229231,0.0264741854889334,0.168989461745435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41534,-0.00710692176847202,0.00516783441573636,-0.0172358772233153,0.00302203368637124,0.169086317297213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,41925,0.00374368674584098,0.00272261350333007,-0.00159263572068596,0.00908000921236791,0.169143953172856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,41689,0.0121860465915751,0.00888070057538789,-0.00522012653618516,0.0295922197193354,0.170026478406189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41534,0.00535199518304512,0.00390600130636058,-0.00230376737742162,0.0130077577435119,0.170648884006634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39241,0.00635104087080313,0.00463777833312034,-0.00273900466211274,0.015441086403719,0.170898645504622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,41636,0.0154148915812446,0.0112647457237076,-0.00666401003722244,0.0374937931997115,0.171204556817254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41534,-0.00554056991855405,0.00405321413941234,-0.0134848696318022,0.00240372979469415,0.171662504690428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,41740,-0.0050759430724073,0.00371371568694465,-0.0123548258188188,0.00220293967400422,0.17170830787179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41124,0.00436711374667949,0.00319851900066136,-0.00190198349461678,0.0106362109879758,0.172166039112591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,39566,-0.0136307709247368,0.00999035189066607,-0.0332118606304423,0.00595031878096868,0.17247175892719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,41740,0.0121844103074402,0.0089423264479289,-0.00534254953050047,0.0297113701453808,0.173046197419357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39259,0.00420859542696848,0.00309428326353032,-0.00185619976955094,0.0102733906234879,0.173820832682017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,41824,0.0163345460762344,0.01204149546431,-0.00726678503381322,0.0399358771862821,0.174956494288145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39308,0.00783219076442469,0.00577552925632822,-0.00348784657797861,0.019152228106828,0.175096193171998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39408,-0.0141902200805724,0.0104744078373629,-0.0347200594418038,0.00633961928065894,0.175525050113894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39328,0.00871738657722862,0.00644317774946125,-0.00391124181171542,0.0213460149661727,0.176095690252234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39259,0.0101286534300073,0.00750398543650333,-0.00457915802553919,0.0248364648855539,0.177118477011292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41465,0.00439604494039338,0.00325783797882536,-0.00198931749810433,0.0107814073788911,0.177240310238796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,41765,-0.00365418012897523,0.00270846599364818,-0.00896277347652566,0.00165441321857519,0.177305682214615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39427,-0.0187897005709901,0.0139585845178699,-0.0461485262260151,0.00856912508403485,0.178297297593132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,41732,0.00415232897787644,0.00308754298544167,-0.00189925527358923,0.0102039132293421,0.178692010398253
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39334,-0.0178799713772235,0.0133166479245884,-0.0439806013094168,0.00822065855496981,0.179404625067877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,41758,0.0105262307520013,0.00784832537172921,-0.00485648697658792,0.0259089484805906,0.179876328363472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41689,0.00373603997319512,0.00278682326788606,-0.00172613363186155,0.0091982135782518,0.180070744611125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39655,-0.00693117223544792,0.00517366507642024,-0.0170715557852316,0.00320921131433575,0.180369610116698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39334,-0.0132261991527224,0.00989439101697127,-0.0326192055459861,0.0061668072405413,0.181336811210112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,41744,-0.00573307821476491,0.00428908285649583,-0.0141396806134967,0.00267352418396692,0.181354288371578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39250,-0.00505851388464699,0.00378647646809754,-0.0124800077621182,0.00236297999282418,0.181596696271749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39600,-0.00355345312324855,0.00266436978846953,-0.00877561790864882,0.00166871166215173,0.18233188415408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39598,-0.0156840496633111,0.0117722295641182,-0.0387576196089827,0.00738952028236049,0.182791792823313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39334,0.00843543169347959,0.00633576753963898,-0.0039826726842128,0.020853536071172,0.183086181391292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39241,0.00437761522629107,0.00328841729230839,-0.00206768266663337,0.0108229131192155,0.183144315493838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39250,-0.00846322357642664,0.00636857049051472,-0.0209456217378355,0.00401917458498222,0.183907866304788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39250,-0.00626164685445073,0.00471598043214813,-0.0155049685014611,0.00298167479255961,0.184288898088211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39308,-0.00364661209647782,0.00275558992967181,-0.00904756835863457,0.00175434416567894,0.185747004723678
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39259,0.010148922375237,0.0076711189925272,-0.00488647085011635,0.0251843156005903,0.185862373283084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39241,0.00716385418618303,0.00542867495964532,-0.0034763487347218,0.0178040571070879,0.186986242792278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39259,0.00796514133750865,0.00604449475124272,-0.00388206837492709,0.0198123510499444,0.187615207435415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41465,-0.00657365355773227,0.00498895152724915,-0.0163519985511406,0.00320469143567606,0.187646882570718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39427,0.00863550150492749,0.00655558524135468,-0.00421344556812767,0.0214844485779827,0.187774698131077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,41925,-0.00278155552632847,0.00211222024702676,-0.00692150721050093,0.00135839615784398,0.187899128965875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39250,0.00724191574312822,0.00550669197157598,-0.0035512005211607,0.0180350320074171,0.188500636579993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39589,-0.00561730605074881,0.00427177745199478,-0.0139899898566586,0.00275537775516095,0.188543738242778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39589,0.0068272225998354,0.0051939246809493,-0.00335286977482522,0.017007314974496,0.188717824652511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39259,0.00694105325509679,0.00529362316787192,-0.00343444815393218,0.0173165546641258,0.189814966417005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39334,-0.00560067581486563,0.00427996881181878,-0.0139894146860304,0.00278806305629917,0.190705133332308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,39589,-0.0120382499330802,0.00920942712134969,-0.0300887270909256,0.0060122272247652,0.1911836933903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39408,-0.00556284593304756,0.00426192524194152,-0.0139162194072529,0.00279052754115782,0.191838074343326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41466,-0.00874458273853807,0.00671148102178225,-0.0218990855412313,0.00440992006415515,0.192622346758106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39250,-0.0157366267836466,0.012079938938789,-0.0394133071036731,0.00794005353637989,0.192702815590301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,41877,0.00395777282424825,0.00303828159163815,-0.00199725909536252,0.00991280474385901,0.192721897038849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39427,0.00383591554738362,0.0029453600560597,-0.00193699016249339,0.00960882125726064,0.192821467168144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,41908,-0.00842655475947933,0.00647070217155739,-0.0211091310157318,0.00425602149677315,0.192849099328147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41466,0.0119530529131014,0.0091999641487164,-0.0060788768183827,0.0299849826445856,0.193881447334547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39427,-0.00939212134917445,0.00723156738536283,-0.0235659934244856,0.0047817507261367,0.194051549522532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,39600,-0.00474325964570758,0.00365291516931132,-0.0119029733775578,0.00241645408614261,0.194147563917568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39241,0.00561813273323851,0.00433343014274432,-0.00287539034654036,0.0141116558130174,0.194844063102082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39589,-0.00396747496496605,0.00307272906753516,-0.00999002393733497,0.00205507400740287,0.196665196519739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41521,0.00785496382363634,0.00608524992333183,-0.00407212602609406,0.0197820536733667,0.196789109687336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39328,-0.00828993421911313,0.00642381445209053,-0.0208806105452106,0.0043007421069843,0.196904833852075
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,41723,0.0156287868349185,0.0121381739691609,-0.00816203414463686,0.0394196078144739,0.197917298630529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39600,-0.0120526010020538,0.00936949917078917,-0.0304168193768006,0.00631161737269294,0.198342586999009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,41689,-0.0123293946788981,0.00959235742855816,-0.0311304152388721,0.00647162588107585,0.198697915464905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39334,0.00638250160909747,0.00497577403396104,-0.00337001549746616,0.0161350187156611,0.199619526022867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39158,-0.00550063009208269,0.00428913623066576,-0.0139073371041876,0.0029060769200222,0.19971075543185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39241,-0.00844599372834009,0.00659299186927328,-0.0213682577921157,0.00447627033543553,0.200201811620157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,41802,0.00407041380434903,0.0031965159016649,-0.00219475736291417,0.0103355849716122,0.202901835673734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,41636,-0.0131990819962829,0.0103862444331197,-0.0335561210851975,0.00715795709263166,0.203814175397478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41559,0.023031870025897,0.0181559036240591,-0.0125537010772589,0.0586174411290529,0.20462049245295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39241,-0.00499346234408927,0.00393685075649726,-0.0127096898268239,0.00272276513864536,0.20468643975616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39589,0.0129892931711662,0.0102429204636963,-0.00708683093767859,0.033065417280011,0.204780541366707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,41707,-0.00273519710056877,0.00216499433772135,-0.00697858600250262,0.00150819180136508,0.206477350582365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39427,-0.00718436003658735,0.00568698054874388,-0.0183308419121253,0.00396212183895065,0.206508746079565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39250,-0.00759168545842396,0.00601186137734573,-0.0193749337580216,0.00419156284117366,0.206694278344735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39408,0.00487203698348445,0.00385889795113544,-0.00269140300074101,0.0124354769677099,0.206779549331268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39328,-0.0111903675878315,0.00888699984537835,-0.0286088872847731,0.00622815210911007,0.207991293116891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39250,0.00688735311031681,0.00549171216529219,-0.00387640273365589,0.0176511089542895,0.20982015708614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41805,0.00592271006673236,0.00472713227634404,-0.00334246919490196,0.0151878893283667,0.210257663229955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41689,0.00974330269316198,0.00780826964589366,-0.0055609058127896,0.0250475111991136,0.212119884112169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39427,0.00524341511112576,0.0042023649464419,-0.00299322018390037,0.0134800504061519,0.21215708453459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,39633,-0.00578999921739678,0.0046520940010941,-0.0149081034595412,0.00332810502474766,0.213305018419445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39625,-0.0045080607318088,0.00362625846616978,-0.0116155273255016,0.00259940586188398,0.213831123703246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41534,-0.0108595111524379,0.0087361143970694,-0.0279822953706939,0.00626327306581815,0.213868392569275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",41911,0.00881836412481614,0.00710765289186371,-0.00511263554323672,0.022749363792869,0.214743702891138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39600,0.0119042668236921,0.00959835020743967,-0.00690849958288962,0.0307170332302739,0.214912746292986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39589,0.00476188249301204,0.00385778163191365,-0.00279936950553871,0.0123231344915628,0.217096036181571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41534,0.00364828500905139,0.00295630658236706,-0.00214607589238806,0.00944264591049083,0.217199779995375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39408,0.0159486381051295,0.0129626420899204,-0.00945814039111443,0.0413554166013734,0.218591361169849
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,41925,0.00539893691615819,0.00438975569266663,-0.00320498424146841,0.0140028580737848,0.218758282419676
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,41732,0.00565693413569351,0.00460724703946961,-0.00337327006166692,0.0146871383330539,0.21953133153477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39408,-0.00384063785755412,0.00312837941945212,-0.00997226151968027,0.00229098580457203,0.219595173223695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,39625,-0.00709801220168298,0.00578168662931997,-0.0184301179951501,0.00423409359178416,0.219596500160974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39308,0.00627979911556206,0.00512277590469889,-0.00376084165764777,0.0163204398887719,0.220278833475631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39408,0.0126928994710174,0.0103641940437617,-0.00762092085475546,0.0330067197967902,0.220719656181755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,39567,-0.0116117094858739,0.00949182865058592,-0.0302156936410223,0.00699227466927455,0.221228550981724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39598,-0.00578159654728096,0.00472649944830501,-0.0150455354659588,0.00348234237139686,0.221268996069935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39334,-0.0116792845323356,0.00956017895665967,-0.0304172352873886,0.0070586662227173,0.221863203671825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39328,-0.00450401413069483,0.00369135279489204,-0.0117390656086832,0.00273103734729356,0.222433809039861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41663,0.00285107820109893,0.0023400896539705,-0.00173549752068325,0.00743765392288111,0.223108135593408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,41728,0.00913086778405838,0.00749640553916495,-0.00556208707270492,0.0238238226408217,0.223233401266289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39598,-0.0048010248698041,0.00394186238925941,-0.0125270751527525,0.00292502541314433,0.223265865865473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39600,-0.0154963285040019,0.0127269167988859,-0.0404410854298183,0.00944842842181456,0.223401099043597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,41818,0.00491687418245302,0.00403857579349343,-0.00299873437279411,0.0128324827377002,0.223444418404285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,41925,0.00211158395815888,0.00173567158138286,-0.00129033234135153,0.00551350025766928,0.223785467247692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39328,0.00536149509201438,0.0044078824950367,-0.00327795459825754,0.0140009447822863,0.223881214915712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39250,0.00798331995193488,0.00657544793993996,-0.00490455801034744,0.0208711979142172,0.224732477690545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41447,0.0063407620160767,0.00522663406629142,-0.00390344075385449,0.0165849647860079,0.225089596452859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39241,0.0152872798092498,0.0126092059827522,-0.00942676391694457,0.0400013235354441,0.22538990525122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39241,0.00406389631857026,0.00335624984383212,-0.0025143533753407,0.0106421460124812,0.225981938163375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39600,-0.0034234524043234,0.0028378048789585,-0.00898554996708207,0.00213864515843527,0.227699480884972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,39589,0.00521535162696087,0.00432477610197699,-0.00326120953291403,0.0136919127868358,0.227872729780286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41466,0.0111699935854489,0.00927270844951754,-0.00700451497560542,0.0293445021465033,0.228376208348503
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,39589,-0.00445132882359561,0.00369589373820039,-0.0116952805504684,0.00279262290327716,0.228461536321917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39589,-0.00571459806537382,0.00474569273848364,-0.0150161558328018,0.00358695970205412,0.228551667730185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39633,0.00819260507269026,0.0068158777012207,-0.00516651522170232,0.0215517253670828,0.229393869314491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,41740,-0.00619420744878719,0.00515869648415211,-0.0163052525577253,0.00391683766015094,0.229877159891682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39334,0.00552401571806532,0.00460135996541402,-0.00349464981414616,0.0145426812502768,0.229964697339561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41521,0.0120049741719221,0.0100095297070495,-0.00761370405389481,0.0316236523977391,0.230412137180947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,41785,0.00692193251247012,0.00577242115829415,-0.00439201295778641,0.0182358779827267,0.230495641303173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39250,-0.00895560706320086,0.00747825914415571,-0.0236129949857461,0.00570178085934434,0.23111797545715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,39579,-0.00788161626521208,0.00659095662425221,-0.0207998912487464,0.00503665871832225,0.231791539089963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,39655,-0.00967327467875213,0.00809688336280755,-0.0255431660698549,0.00619661671235068,0.232233362393162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41840,0.00454098870458596,0.00380242508979819,-0.00291176447141849,0.0119937418805904,0.232407493724572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39241,0.0051321203328827,0.0043192452479057,-0.00333360035301247,0.0135978410187779,0.234781768693822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,41746,0.00764052136441937,0.00643312990315464,-0.00496841324576374,0.0202494559746025,0.234979638710161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39328,-0.00799122606189198,0.00674018158881024,-0.02120198197596,0.00521952985217608,0.235802648075293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39250,0.00591627728166981,0.00499129679586357,-0.00386666443822279,0.0156992190015624,0.235917921404969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39625,0.00342363367283817,0.00288888900890539,-0.00223858878461639,0.00908585613029273,0.236001907632247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,41896,-0.00665565053043949,0.00561822353113395,-0.017667368651462,0.00435606759058305,0.236175483568485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39600,0.0163750187602809,0.0138241640361694,-0.0107203427506111,0.0434703802711728,0.236232304896502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,41758,0.00466777835014201,0.00394157434992802,-0.00305770737571692,0.0123932640760009,0.236338626098174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41534,-0.0109038408967284,0.00923469724472793,-0.0290038474963951,0.00719616570293838,0.237724964206827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41465,-0.006036802513068,0.00512191168694073,-0.0160757494194718,0.00400214439333583,0.238570159099248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39328,-0.00513929162739821,0.0043867029397404,-0.0137372293892894,0.00345864613449298,0.241399230954922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39328,-0.00464663485731613,0.0039732399138146,-0.0124341850883927,0.00314091537376049,0.242235238891865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41534,0.00427874965324224,0.00365876296379196,-0.00289242575579,0.0114499250622745,0.242242901346329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41689,-0.00294491724783503,0.00252012331388139,-0.00788435894304255,0.00199452444737249,0.242601922996998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,41802,0.0053768840444525,0.00460881944977347,-0.00365640207710349,0.0144101701660085,0.243372391922879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,41765,0.0110054506439864,0.00943543728452264,-0.00748800643367795,0.0294989077216508,0.243475746247469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,41765,-0.0057880190838236,0.00496436742876398,-0.015518179244201,0.0039421410765538,0.243670861245306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41534,0.00675827000940973,0.00580249472755713,-0.00461461965660224,0.0181311596754217,0.244154645016788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39250,0.0115580580714229,0.009954366265534,-0.0079524998090237,0.0310686159518696,0.245625485603707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39308,0.0061310827770808,0.00528906137756752,-0.00423547752295153,0.0164976430771131,0.246400302285585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39600,0.00700800780569084,0.00606751438628392,-0.00488432039142565,0.0189003360028073,0.24811357931763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41466,-0.00366949469133843,0.00317812642465916,-0.00989862248367038,0.00255963310099353,0.248271854023583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39328,0.00805562024808306,0.00697827356796738,-0.00562179594513301,0.0217330364412991,0.248367728787569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41581,0.00346447198536858,0.00300441696647889,-0.00242418526893004,0.0093531292396672,0.248879812646846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41617,-0.00894986892844614,0.00776183193052604,-0.0241630595122772,0.0062633216553849,0.248906349151434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39633,0.00507010969682722,0.00440487747873973,-0.00356345016150264,0.0137036695551571,0.249748239919958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41465,-0.0122409732319469,0.010635186012504,-0.0330859378164547,0.00860399135256085,0.249758496049666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39600,-0.00721584845973093,0.00628251067582524,-0.0195295693843484,0.00509787246488654,0.250761908866384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41465,-0.00536894219569694,0.00468768436710399,-0.0145568035552208,0.00381891916382689,0.252094083627166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39408,-0.0104083800277524,0.00909037848711087,-0.0282255218624897,0.0074087618069849,0.252239220460077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39250,0.0086087795616142,0.00752162541737899,-0.00613360625644862,0.023351165379677,0.252426670642824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39427,0.00438685312550063,0.00383614231207017,-0.00313198580615691,0.0119056920571582,0.252832066526741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39334,-0.00528197779714932,0.00461950598849948,-0.0143362095346083,0.00377225394030965,0.252894939300977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41508,-0.00491825804714717,0.00430805483392642,-0.0133620455216429,0.00352552942734861,0.253623871334451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41625,-0.0125494360751432,0.0109960845176568,-0.0341017617297504,0.00900288957946408,0.253781034818363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41521,-0.00587018555876792,0.00514527850231811,-0.0159549314233114,0.00421456030577558,0.25393775488793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39562,0.00334687734058318,0.00293399319485905,-0.00240374932134055,0.0090975040025069,0.254009590775227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39241,0.0057431840036989,0.00504751588660311,-0.0041499471340432,0.015636315141441,0.255219658419378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39259,-0.00903249074375535,0.00798324894272511,-0.0246796586714966,0.00661467718398586,0.257899426242077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39259,0.0129408906489862,0.0114474508320367,-0.00949611298180568,0.0353778942797782,0.258307682190599
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41534,-0.00803416732622083,0.00710789895952386,-0.0219656492868876,0.00589731463444594,0.258364327062558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,41802,0.00672876822427304,0.00596301892268618,-0.00495874886419187,0.018416285312738,0.259164618662433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39410,0.00645216076330451,0.00571920250997273,-0.00475747615624204,0.0176617976828511,0.259278479247663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41466,0.00658603407500394,0.00583866799080424,-0.00485775518697238,0.0180298233369803,0.259339753908223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41466,-0.00429417737073984,0.00380944309237698,-0.0117606858317987,0.00317233109031904,0.259659743676352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39589,0.00438115488954205,0.00390327131399545,-0.00326925688588903,0.0120315666649731,0.26170351741132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,41805,-0.0129284359531992,0.0115200313857005,-0.0355076974691722,0.00965082556277391,0.261773585280595
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39334,-0.00528097782880076,0.00470836864616259,-0.0145093803752794,0.00394742471767791,0.26205117727229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,41758,0.00296492193850646,0.00264498762365943,-0.00221925380386603,0.00814909768087895,0.262325892348703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41666,0.00480358932690881,0.00429169069511525,-0.00360812443551708,0.0132153030893347,0.263042695239388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39328,-0.0103329145806792,0.00923403416670894,-0.0284316215474288,0.00776579238607028,0.263163790988734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,41740,-0.0125325822819877,0.011236567712313,-0.0345562549981213,0.00949109043414587,0.264725572981567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41429,0.00575962106855693,0.00516814313570173,-0.00436993947741846,0.0158891816145323,0.265108392261931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39427,-0.0104320878743282,0.00937251400034828,-0.0288022153150108,0.00793803956635441,0.265711155205035
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39250,0.00612309618234906,0.00550685557618578,-0.00467034074697508,0.0169165331116732,0.266204415316032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39328,-0.00612531823844725,0.00551118510830999,-0.0169272410507348,0.00467660457384034,0.266406512797209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39406,0.00606516841327176,0.0054687196032213,-0.00465352200904198,0.0167838588355855,0.267426594765669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41465,-0.00855705788202117,0.00773339244025757,-0.023714507064926,0.00660039130088367,0.268527545185088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,41925,-0.00387893531356618,0.00351014542936076,-0.0107588203551133,0.0030009497279809,0.269151815283675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41636,0.00689166159383843,0.00623815858510027,-0.00533512923295809,0.019118452420635,0.269284437660303
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39600,0.0142934086364436,0.0129850171135684,-0.0111572249061504,0.0397440421790376,0.271024501114143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39250,-0.00468581214503716,0.00426006724398618,-0.0130355439432501,0.00366391965317576,0.271383763089165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,39600,-0.00623731725245113,0.00567198499456801,-0.0173544078418044,0.00487977333690217,0.271499572459604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39308,0.0104329322888368,0.0094924181840123,-0.00817220735182736,0.0290380719295009,0.271757638905822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39440,-0.00465291146047256,0.00423521258117311,-0.0129539281195719,0.00364810519862673,0.271955961826526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39334,-0.00518939220332125,0.00472786923788603,-0.0144560159095779,0.00407723150293537,0.272396151643484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39408,-0.00878938291093388,0.00803066971866582,-0.0245294955595189,0.00695072973765113,0.273770241063055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41534,0.00748522680658221,0.006853933579832,-0.00594848300988851,0.0209189366230529,0.274806545274802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,41728,0.00357954440634313,0.00327853366128005,-0.00284638156976577,0.010005470382452,0.274935510031398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41521,0.0082857357148502,0.00759044258828142,-0.0065915317581814,0.0231630031878818,0.27502881267386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,41715,-0.00482566065462341,0.00442206515190433,-0.0134929083523559,0.00384158704310908,0.27517477669372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,41836,-0.00320141868159244,0.0029364627152982,-0.0089568856035769,0.00255404824039203,0.275631848195031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,41925,0.00840435923924336,0.00773690992695373,-0.00675998421758595,0.0235687026960727,0.277380000721073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,41765,-0.00452871089790496,0.00417429991870418,-0.0127103387385652,0.00365291694275523,0.277984443740696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39625,0.0045083330831526,0.00415666105039727,-0.00363872257562606,0.0126553887419313,0.278120598567767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,41925,-0.00654358774957658,0.00603357171196122,-0.0183693883050206,0.00528221280586742,0.278149625227888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39122,0.00537395641437717,0.0049557886515587,-0.00433938934267788,0.0150873021714322,0.278221343760028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41414,0.00679455164713704,0.00627013495577904,-0.00549491286618989,0.019084016160464,0.278546067747488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41593,-0.00402569937027497,0.00371601059207622,-0.0113090801307444,0.00325768139019442,0.27867806313772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,41689,0.00876740911473402,0.00809953732901813,-0.00710768405014151,0.0246425022796096,0.279069001608992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,41765,0.0039987927281323,0.00369504027871041,-0.0032434862181401,0.0112410716744047,0.279181068848149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,39625,0.00841554618191141,0.00778319124267368,-0.006839508653729,0.0236706010175518,0.279611248918297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41465,0.0102710924387451,0.00950241621764245,-0.00835364334783413,0.0288958282253243,0.279765102193411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,41925,0.00485895933278322,0.00449636448381273,-0.00395391505548973,0.0136718337210562,0.27987604660374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39650,0.00224443525111878,0.00208636287914114,-0.00184483599199786,0.00633370649423541,0.282056051699617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39600,-0.0169728619179119,0.0157816443358181,-0.0479048848161154,0.0139591609802916,0.282182929358397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39259,0.0067727446180947,0.00629787373561762,-0.00557108790371584,0.0191165771399052,0.28221922698201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39313,0.00454948090062609,0.00423299865621767,-0.00374719646556054,0.0128461582668127,0.282503937327416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39427,0.00646588992789473,0.00602691690422916,-0.00534686720439443,0.0182786470601839,0.283368876719052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39259,0.00968806426313752,0.00904116970478295,-0.00803262835823706,0.0274087568845121,0.283946518940195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39427,-0.00757972002657269,0.00709589588350309,-0.0214876759582387,0.00632823590509337,0.285461490011684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39259,-0.00630156069211045,0.00590615248406362,-0.0178776195608751,0.00527449817665423,0.286019244980371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39328,0.00664028609842869,0.00622964113144273,-0.00556981051919906,0.0188503827160564,0.286484736898692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39241,0.00359262978395868,0.00337163457249069,-0.00301577397812307,0.0102010335460404,0.286653358468778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,39650,-0.00472966467263817,0.0044429168844269,-0.0134377817661149,0.00397845242083856,0.287107208124731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39250,-0.00512006024306983,0.00481060219040774,-0.014548840536269,0.00430872005012934,0.287204114247528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,41819,0.00293527757409346,0.00276080040853092,-0.00247589122662714,0.00834644637481406,0.287711574172471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,41728,0.0104716960003067,0.0098573265974224,-0.00884866413064118,0.0297920561312546,0.28810717961476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41534,-0.00915140692283803,0.00861976593061319,-0.0260461481468399,0.00774333430116383,0.288402183720064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,41692,0.00762634739989465,0.00718493083830134,-0.00645611704317597,0.0217088118429653,0.28851118426001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39250,0.00796865900265857,0.00751412949101221,-0.00675903479972535,0.0226963528050425,0.288945797077602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39600,-0.00344627394378023,0.00325112229285048,-0.00981847363776717,0.00292592575020671,0.289156075698368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41466,-0.00561664870290035,0.00529949619761798,-0.0160036612502316,0.00477036384443089,0.289234659696207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,39600,0.00429717327481895,0.00405733528430597,-0.00365520388242075,0.0122495504320586,0.289571942853003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39633,-0.00586349607940076,0.00554128468694571,-0.0167244140658143,0.00499742190701283,0.29001140591782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39655,0.00302129844160417,0.00285733732702163,-0.00257908271935823,0.00862167960256656,0.290360166681843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39250,-0.0113711696186498,0.0107572904897399,-0.0324554589785401,0.00971311974124042,0.290505291151993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39595,0.00696360993983722,0.00662402952838639,-0.0060194879358001,0.0199467078154745,0.293160033347143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39408,0.00990258519890225,0.00946669946825833,-0.00865214575888408,0.0284573161566886,0.295564061706827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,41758,0.00276119194806316,0.0026421411111018,-0.00241740462969636,0.00793978852582268,0.296015144674286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41534,0.00463495268330509,0.00444536408809667,-0.00407796092936438,0.0133478662959746,0.29713055503328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39400,0.0069946665332935,0.00670888175669653,-0.00615474170983169,0.0201440747764187,0.297157864639276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39328,0.00766077209979787,0.00736834957206691,-0.00678119306145327,0.022102737261049,0.29850909875708
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39600,-0.0133051670006021,0.0128285048800114,-0.0384490365654245,0.0118387025642203,0.299685733481428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39250,0.00453882629905572,0.00437963883406394,-0.00404526581570961,0.013122918413821,0.300063738539947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39259,0.00387494772277761,0.00374159544228618,-0.0034585793441033,0.0112084747896585,0.30039339116645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39427,0.00582055864525065,0.00562230871680175,-0.00519916643968077,0.0168402837301821,0.30057001850651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,41758,-0.00482819259653509,0.00466568150578448,-0.0139729283478727,0.0043165431548025,0.300766787064172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,39655,0.00269359551275082,0.00260658380288332,-0.00241530874090048,0.00780249976640213,0.301447999994961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39328,-0.00679676983895706,0.00657891106564886,-0.0196914355276288,0.0060978958497147,0.301573505751922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,41697,0.00656182548368012,0.00635652825581169,-0.0058969698977108,0.019020620865071,0.301952035560005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39308,-0.0101190009591015,0.00981349179795743,-0.0293534448830981,0.00911544296489503,0.302502425476859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41465,-0.00724804757128016,0.00703106045893158,-0.0210289260707861,0.00653283092822573,0.30262528312339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39408,0.0125788946949746,0.0122173294371983,-0.0113670710019341,0.0365248603918833,0.303223457288443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,41827,0.00467807200153185,0.00455302986249635,-0.004245866528961,0.0136020105320247,0.304221052230698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,41844,-0.00554053379274933,0.00539752539779934,-0.016119683572436,0.00503861598693738,0.304676982765299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39221,0.00594582841191502,0.00579428285154091,-0.00541096597710517,0.0173026228009352,0.304842216154735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,41836,0.0111467487117563,0.0108679820468298,-0.01015449610003,0.0324479935235427,0.305075206985123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39655,-0.00239684407969509,0.00234066196673464,-0.00698454153449499,0.00219085337510481,0.305856424841929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39259,0.00633109386855537,0.00618980100203475,-0.00580091609543275,0.0184631038325435,0.306412993754915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39615,-0.00252464020994754,0.00247888706842445,-0.00738325886405946,0.00233397844416438,0.308483132443212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,41925,0.00257185961948064,0.00252798950127648,-0.00238299980302126,0.00752671904198253,0.30900364271788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39250,-0.0064883358262863,0.00638447491582117,-0.0190019066612958,0.0060252350087232,0.30952499763557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39427,-0.0115851091041231,0.0114193592807805,-0.0339670532944528,0.0107968350862066,0.3103598367914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41466,0.0116221689823562,0.0114593521748949,-0.0108381612804377,0.0340824992451502,0.310502486905143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41466,-0.00729980963608838,0.0071994505283421,-0.0214107326716389,0.00681111339946213,0.310630531788235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39598,-0.00422512164226245,0.00417033100505323,-0.0123989704121668,0.00394872712764188,0.311016442837061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41465,-0.00394477536866124,0.00389920892970497,-0.011587224870883,0.00369767413356049,0.31170720329771
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39259,-0.0042692690225899,0.00422376668451674,-0.0125478517242427,0.00400931367906292,0.312148066415452
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41465,0.00513285719116498,0.00509886076738517,-0.00486090991290994,0.0151266242952399,0.314113539899971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39334,-0.00443450653081704,0.00440702401999401,-0.0130722736100053,0.00420326054837123,0.314324706945976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39633,0.00291664998442057,0.00291450134517682,-0.002795772652126,0.00862907262096715,0.316975813513698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39259,0.00339459382152156,0.00339880975409289,-0.0032670732965005,0.0100562609395436,0.317933840473521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39427,-0.00764752314796004,0.00767336846420239,-0.0226873253377967,0.00739227904187665,0.318965529649287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39221,-0.00925985619687525,0.00929473847140988,-0.0274775436008386,0.00895783120708813,0.319152798437534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39259,-0.00989321124739691,0.00993225069181747,-0.0293604226033592,0.00957400010856534,0.319239024882552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39625,-0.00323930887450847,0.00325529670654997,-0.00961969041934641,0.00314107267032948,0.319714978874519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,41765,-0.00416849121012334,0.0041966522822053,-0.0123939296832457,0.00405694726299904,0.320587083406474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,41865,-0.0120442516261966,0.0121307573214881,-0.0358205359763133,0.0117320327239202,0.320791959953885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41689,-0.00401713903912088,0.00404881566506547,-0.0119528177426492,0.00391853966440744,0.321129861328141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39589,0.00633265897072526,0.00639184363883187,-0.00619535456138521,0.0188606725028357,0.321834077163477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39427,0.00936555843050202,0.00946152684525849,-0.00917903418620462,0.0279101510472087,0.32226614775333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39408,0.0135075631812957,0.0136615287544892,-0.0132690331775033,0.0402841595400946,0.322817399798303
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,39598,-0.0146610757661537,0.0148316212298938,-0.0437310533767456,0.0144089018444382,0.322928980845715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,41689,0.00160818085704747,0.00162719866687601,-0.00158112853002951,0.00479749024412445,0.323017871905811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39250,-0.00709890830881321,0.00718992471970447,-0.021191160759434,0.00699334414180755,0.3234978701629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,39598,-0.00407270066579264,0.00412584353129132,-0.0121593539871236,0.00401395265553835,0.323605767578493
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39241,0.00651104629732239,0.00660033045578178,-0.0064256013960099,0.0194476939906547,0.32392359813864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41498,-0.00455137769032142,0.0046166760294897,-0.0136000627081212,0.00449730732747839,0.324222281595376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41465,0.00491404154846711,0.00498705693310598,-0.00486059004042062,0.0146886731373548,0.324466280664301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,41758,0.00564536664728105,0.0057383290538228,-0.00560175829821164,0.0168924915927737,0.325232074841698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39334,0.00415649610962786,0.00422632415974895,-0.00412709924348007,0.0124400914627358,0.325394488353682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39427,-0.00562497120402555,0.00572229001444332,-0.0168406596323345,0.00559071722428337,0.325632833795295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41466,-0.00764758096870299,0.00779996645109768,-0.0229355152128544,0.00764035327544845,0.326875904885302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41328,-0.00891009022271973,0.00909528638673714,-0.0267368515407245,0.00891667109528506,0.327283348333483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39334,-0.00959190404345196,0.00979673012509888,-0.0287934950886458,0.00960968700174184,0.327556390662008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39308,-0.00293060593430393,0.00299662765714136,-0.00880399614230101,0.00294278427369314,0.328112248276455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,41925,0.00777663760494935,0.00796919000926225,-0.00784297481320466,0.0233962500231034,0.329162517280926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41466,-0.00530539583737235,0.00546871483590845,-0.0160240769157529,0.00541328524100821,0.331997061965744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39328,0.0037952835330253,0.00391442158300294,-0.00387698276966046,0.0114675498357111,0.332285558920992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39334,-0.00648172472268058,0.00671855712987225,-0.0196500966972302,0.00668664725186902,0.334692022695596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,39600,-0.00235783607041481,0.00244763580214399,-0.00715520224261704,0.00243953010178742,0.335412326960337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39328,-0.00947548076924836,0.00984326495176803,-0.0287682800747137,0.00981731853621698,0.335751943534212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,41786,0.00593844729820667,0.0061790584890881,-0.00617250734040601,0.0180494019368193,0.336539513297865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39241,-0.00614302897255353,0.00639233853905381,-0.018672012509099,0.00638595456399192,0.336574661400134
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39600,-0.00497102164365996,0.00517440150123059,-0.0151128485860719,0.00517080529875201,0.336726662797436
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39259,0.00587139070597527,0.00611777776714743,-0.00611945371763369,0.0178622351295842,0.337214876682166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39241,0.00439627004705548,0.00458359040473401,-0.00458756714622317,0.0133801072403341,0.337513843778643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41465,0.00586336615125073,0.00613348155974371,-0.00615825770584694,0.0178849900083484,0.339110149391097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39334,0.00321202314857375,0.00336016891513785,-0.00337390792509643,0.00979795422224393,0.339138620178037
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,39655,0.00954235411123009,0.010000781775876,-0.0100591781694869,0.029143886391947,0.34002310763856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41511,0.00910101327710524,0.00953834150781621,-0.00959413607821454,0.027796162632425,0.340025332269667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39334,-0.0109156047949156,0.0114817506994401,-0.0334198361658182,0.0115886265759869,0.341782320762187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41534,-0.00521418954974128,0.00549449949931132,-0.0159834085683915,0.0055550294689089,0.342646717691053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,41891,0.00392254626405955,0.00415720671621576,-0.00422557889972333,0.0120706714278424,0.345415098735586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39314,-0.00868935569811489,0.00920953124758594,-0.0267400369433833,0.00936132554715354,0.345437443678208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,41740,0.00929354405893318,0.00986926515607698,-0.0100502156469777,0.0286373037648441,0.346381362056784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39600,0.00342840277742552,0.00365113788638926,-0.00372782747989743,0.0105846330347485,0.347753569164791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39328,-0.00710724134509158,0.00757506983886719,-0.0219543782292713,0.00773989553908811,0.348141678155048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,41758,-0.00447150856161777,0.00476813091220399,-0.0138170451495376,0.00487402802630206,0.348369222536689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,39598,0.00220791544989376,0.00235481621806605,-0.0024075243375157,0.00682335523730322,0.348461919434974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41466,-0.00609867408642136,0.00651151179659912,-0.0188612372077556,0.00666388903491291,0.348982553023409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,41802,0.0110776092564807,0.0118359480816049,-0.0121208489834649,0.0342760674964263,0.349326768184531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39427,-0.00749719085009507,0.00802790681367549,-0.023231888204899,0.00823750650470889,0.350380888588082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39259,-0.00593242475211578,0.00635656992582477,-0.0183913018067323,0.00652645230250077,0.350699386754655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,41740,0.00901137742579606,0.0096691011000081,-0.00994006073021982,0.0279628155818119,0.351365663888145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41465,0.00520232348305985,0.00559887895675134,-0.00577147927217278,0.0161761262382925,0.352817210850983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41447,-0.00607243439996728,0.00653829756564151,-0.0188874976286246,0.00674262882869009,0.353036861583548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41465,-0.00673667499085949,0.0072561325228923,-0.0209586947357284,0.00748534475400942,0.353211708529891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41865,-0.00279195391938094,0.00301162010045782,-0.00869472931627826,0.00311082147751639,0.353912010076151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41636,-0.00429280655386254,0.00463131676393877,-0.0133701874111825,0.00478457430345746,0.353991239551571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,41878,0.00344490198144227,0.00372176261106917,-0.00384975273625332,0.0107395566991378,0.354665336394153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39328,-0.00357375503204203,0.00386768907780095,-0.0111544256245319,0.00400691556044784,0.355505708007884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39308,-0.0101731913580648,0.0110174009611728,-0.0317672972419635,0.011420914525834,0.355832680344487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39583,0.00699893788651423,0.00758994648452298,-0.0078773572231508,0.0218752329961793,0.356479614872335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39408,-0.00833894667967014,0.00904623153204986,-0.0260695604824879,0.00939166712314759,0.356645960099576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",41758,-0.00383283227820088,0.00416296052968222,-0.011992234916378,0.00432657035997626,0.357224643180383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39259,-0.00429352724682203,0.00466381081724175,-0.0134345964486159,0.0048475419549718,0.357277559913101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,41717,-0.00381320652941489,0.00414229090066928,-0.0119320966947267,0.0043056836358969,0.357299743659581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,41716,-0.00886753725819238,0.00963371958651311,-0.0277496276477581,0.0100145531313733,0.357344815772164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39427,0.00418200972296015,0.00454352897733005,-0.00472330707260674,0.013087326518527,0.357367529858259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39250,0.00583477627784438,0.006340951696465,-0.00659348904722702,0.0182630416029158,0.357502895301648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,41698,-0.00249120663564583,0.00271029200875674,-0.00780337897280904,0.00282096570151738,0.358025992709587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39633,-0.00364656311390145,0.00397338206287394,-0.0114343919571344,0.00414126572933147,0.35877091605741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41466,0.00457085040354422,0.00498202055774055,-0.00519390988962726,0.0143356106967157,0.35891402422164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,41740,0.0118258484597323,0.0129284700792628,-0.0135139528956227,0.0371656498150873,0.360358744783738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39334,0.00326494363828521,0.00357653299488037,-0.00374506103168031,0.0102749483082507,0.36132642490358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39600,-0.00831447738773002,0.00912334303343392,-0.0261962297332605,0.00956727495780046,0.362135652908151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41689,-0.00462751854283637,0.00508421815459875,-0.0145925861258499,0.00533754904017717,0.362747994082032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39427,0.00406652457456117,0.00446988063305511,-0.00469444146622685,0.0128274906153492,0.362968641064835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,41802,0.00301251984299881,0.00331188952362145,-0.00347878362329923,0.00950382330929685,0.363046100685611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39259,-0.00804720008925016,0.0088610229508668,-0.0254148050729491,0.00932040489444877,0.363815806491474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39334,-0.00322425536694437,0.00355695980895218,-0.0101958965924906,0.00374738585860189,0.364710755030145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41521,-0.0136637817374975,0.0150873718117878,-0.0432350304886016,0.0159074670136066,0.365141409926519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,39633,0.00313061355746159,0.00345822030701736,-0.00364749824429244,0.00990872535921562,0.365343594251458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,41708,-0.00809768041339789,0.0089879633507895,-0.0257140885809453,0.00951872775414954,0.3676329462259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39598,0.00543842705217184,0.00603844035757523,-0.00639691604867562,0.0172737701530193,0.367802463704128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41465,0.0038994293740167,0.00433138516900888,-0.00459008555724071,0.0123889443052741,0.367991806273297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39427,-0.00631791274270605,0.00702131281782488,-0.0200796858656428,0.00744386038023072,0.368236437345377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,41769,0.0091473207637701,0.0101702238297047,-0.010786317942451,0.0290809594699912,0.368444490878293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39600,-0.00234271401927166,0.0026059913205543,-0.0074504570075581,0.00276502896901477,0.368687091151394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41646,0.00678619164295046,0.00756701647100505,-0.00804516064021944,0.0216175439261204,0.369835758890291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39589,-0.00504777002813321,0.00563723915853289,-0.0160967587788577,0.00600121872259125,0.370575274241966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39334,0.00435565719260373,0.00486588407541465,-0.00518147559520899,0.0138927899804164,0.370731257671933
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,41758,0.00430347298495521,0.0048127182610502,-0.00512945480670317,0.0137364007766136,0.371237881525661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39241,0.00574946683745107,0.00646531607101744,-0.00692255266174311,0.0184214863366453,0.373873504414917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39250,0.0037465275659453,0.00422360123324416,-0.00453173085121325,0.0120247859831039,0.375074294895315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39625,0.0094128804857139,0.0106475436519922,-0.0114563050721908,0.0302820660436186,0.37669258005343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41466,-0.00486115746802418,0.00550706455948636,-0.0156550040046174,0.00593268906856909,0.377407849425639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41534,-0.00422075847320778,0.00478623926794281,-0.0136017874383757,0.00516027049196013,0.377872805115572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39655,0.00269862123715524,0.00306141205951537,-0.00330174639949488,0.00869898887380536,0.378068803058983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39334,0.00969718276343508,0.0110301286188077,-0.011921869329428,0.0313162348562981,0.37933740953278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,41877,-0.00506955103964114,0.00578083822804495,-0.0163999939666092,0.00626089188732696,0.380525439419186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41689,0.0037143562393809,0.00423553449369254,-0.00458729136825649,0.0120160038470183,0.380529344318995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,41728,-0.00630534799085126,0.00719850732704157,-0.0204144223518527,0.00780372637015023,0.381087176769423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39334,0.00247748367059394,0.00282858633624004,-0.00306654554843654,0.00802151288962442,0.381118434166712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39308,-0.00413319589138727,0.0047219254990405,-0.0133881698695066,0.00512177808673212,0.381419440739044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,39650,-0.00202186150800821,0.00231470907813153,-0.00655869130114601,0.0025149682851296,0.382418266541905
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39427,-0.0047169422279377,0.00540116671259186,-0.0153032289846178,0.00586934452874236,0.382508523458875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41534,-0.00444590086383032,0.0051023140635181,-0.0144464364283258,0.00555463470066516,0.383579303554386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41465,-0.00836570054352066,0.00960476901465955,-0.0271910478122534,0.0104596467252121,0.38377343372393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39259,0.00570911963076992,0.00656287933186374,-0.00715412385968301,0.0185723631212228,0.384368740189737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,41740,-0.00456128437126543,0.00526099065550903,-0.0148728260560631,0.00575025731353226,0.385957271378459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39328,-0.00654311252350899,0.00755468535408588,-0.0213502958175173,0.00826407077049933,0.386454727476646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,41805,-0.00863278225247643,0.0099881445908365,-0.028209545650516,0.0109439811455631,0.387437221539199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41447,0.00329185920220893,0.00381227791764978,-0.00418020551638465,0.0107639239208025,0.387884906658268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41424,-0.00441491087583569,0.0051164172058068,-0.014443088599217,0.00561326684754563,0.388213480539888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41466,0.00636743117149129,0.00738567128745306,-0.00810848455191671,0.0208433468948993,0.388630385035427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39633,0.00241761688600374,0.00280562480855696,-0.0030814077387679,0.00791664151077538,0.388869393388761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,41805,0.00336377119380417,0.0039162573829488,-0.00431209327677547,0.0110396356643838,0.390397511914099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39600,-0.00708661013599206,0.00827620301580643,-0.0233079680469727,0.00913474777498854,0.391870725959661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39598,0.00987930469551976,0.0115657094135626,-0.012789485755063,0.0325480951461025,0.393018741286021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39655,0.00262670102157735,0.00308000457571799,-0.0034101079468299,0.0086635099899846,0.39377553279154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41502,-0.00335092361330093,0.00393702512534509,-0.0110674928589773,0.00436564563237544,0.394712455971074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39241,0.00539076238417469,0.00633884449342839,-0.00703337282294494,0.0178148975912943,0.395103544055543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,41925,0.00389378422517803,0.00458290458824971,-0.00508870876779141,0.0128762772181475,0.395544757144854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39259,0.00422980046102055,0.00498599704387477,-0.00554275374497401,0.0140023546670151,0.396269960547455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39328,-0.00204466177674118,0.00241224663577303,-0.00677266518285632,0.00268334162937397,0.396670093046673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39259,0.00493840967123453,0.00583685930734754,-0.00650183457116665,0.0163786539136357,0.397530957007003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39600,0.00716211036056559,0.00846934040781414,-0.00943779683875011,0.0237620175598813,0.397765584737519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41521,-0.00426365955747138,0.00504732933417679,-0.0141564250524579,0.00562910593751512,0.39827403189879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,39633,0.010368926247414,0.0123111087529434,-0.0137608469083551,0.034498699403183,0.399671065696798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,41758,-0.00559090046052411,0.0066432752943418,-0.018611720037434,0.00742991911638582,0.400033929151099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39241,0.007087632760627,0.00843087375128924,-0.00943687979189992,0.0236121453131539,0.40054838934627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41447,-0.00422852054781008,0.00504510263998545,-0.0141169217221816,0.0056598806265614,0.401965644862502
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41465,-0.0048657347549717,0.0058137490543043,-0.0162606829014081,0.00652921339146473,0.402644198022002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,39600,-0.00314073094839012,0.00375421659470923,-0.0104989954740202,0.00421753357723997,0.402842606549989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39328,-0.00532076182175877,0.00636088553914938,-0.0177880974784916,0.00714657383497401,0.402902822305975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,41815,0.00360904499583105,0.00431669638686884,-0.00485167992243188,0.012069769914094,0.403132641567101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41465,-0.00349090128901655,0.00418193893623068,-0.0116875016040287,0.00470569902599558,0.403870245149612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,41766,-0.00506757212900086,0.00608486017374835,-0.0169938980695476,0.00685875381154592,0.404963317807805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,41740,0.0039638031962258,0.0048144534925763,-0.00547252564922376,0.0134001320416754,0.41034484083535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,41861,-0.00388006855104602,0.0047140921380655,-0.0131196891416544,0.00535955203956236,0.410478074752646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41465,0.00315190157666169,0.00383664855121552,-0.00436792958372073,0.0106717327370441,0.411362680505675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,41826,0.0137694048239558,0.016760882461623,-0.0190819248008253,0.0466207344487369,0.411364786404582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41614,-0.00297850928186759,0.00362822756273963,-0.0100898353048373,0.00413281674110208,0.411702995432169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41521,0.00989958003359457,0.0120618416470687,-0.01374162959466,0.0335407896618492,0.411812162025715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39334,0.00272998855826031,0.00333814518421603,-0.00381277600280311,0.00927275311932373,0.413480410490038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41758,0.00314645595585906,0.00384796626220815,-0.00439555791806892,0.010688469829787,0.413547184190508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39308,-0.0068357077621036,0.00836908618763037,-0.0232391166898591,0.00956770116565192,0.414071955661963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,41805,-0.0033770549799157,0.00413685817997169,-0.0114852970126602,0.00473118705282882,0.414324274507164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39328,0.00425442173794296,0.00521428524502357,-0.00596557734230323,0.0144744208181892,0.41456596885706
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39328,0.00315382400946121,0.00387213883697086,-0.00443556811100167,0.0107432161299241,0.415381542602446
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,39600,0.00387636411386787,0.00476858074528039,-0.0054700541468817,0.0132227823746174,0.416294812127602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39334,-0.00149898110054412,0.00184529080996947,-0.00511575108808429,0.00211778888699605,0.416621553707972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,41788,0.0104261306207751,0.0128635404406396,-0.0147864086428785,0.0356386698844287,0.417657169632721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39250,-0.00435313923046787,0.00537489852566054,-0.0148879403407625,0.0061816618798268,0.418014793732791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39334,0.00258604396966392,0.00319936708642375,-0.00368471551972664,0.00885680345905447,0.41893661557139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39576,0.00317772509475446,0.00393248035212601,-0.00452993639541252,0.0108853865849214,0.419066965279687
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39427,0.00537285319587092,0.00665801420393639,-0.00767685464384441,0.0184225610355863,0.419698423950443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39427,0.00414957638544117,0.00515602359547844,-0.00595622986169657,0.0142553826325789,0.420951811427157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39334,-0.00177639726358619,0.00221030357260878,-0.00610859226589939,0.00255579773872702,0.421594249829548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,41736,-0.00232394342832503,0.00289370355535518,-0.00799560239682119,0.00334771554017113,0.421929450586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,39650,0.00161958553183018,0.00201671065030873,-0.00233316734277494,0.0055723384064353,0.421944181461801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39625,-0.0053475223611498,0.00665904188140561,-0.0183992444487048,0.0077041997264052,0.421964988985957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39328,-0.00700360573439288,0.00874404000259897,-0.0241419241394869,0.0101347126707011,0.423173901354089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,41740,-0.00478050916396338,0.00597370587896799,-0.0164889726867406,0.00692795435881388,0.423575484750336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,39625,-0.00560232511926936,0.00700823014150094,-0.0193384561966112,0.00813380595807248,0.42408020322036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39408,-0.00507883609413731,0.00635851434989113,-0.0175415242199239,0.00738385203164931,0.424455424197782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,41765,-0.00586683537527447,0.0073481424863202,-0.0202691946484621,0.00853552389791312,0.42464661475462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39241,0.00627893195138556,0.00788690493186403,-0.00917940171506794,0.0217372656178391,0.425979372624151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39427,0.00363178798181056,0.00457274675837142,-0.00533079566459743,0.0125943716282186,0.427082094935345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41765,0.00705019146972449,0.00888787390765228,-0.010370041389274,0.024470424328723,0.427653981991516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39334,0.0024953932634977,0.00314646834271966,-0.00367168468823283,0.00866247121522823,0.427750196990403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39250,0.00414120494884438,0.00523020727617191,-0.00611000131245257,0.0143924112101413,0.428503095703197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39334,-0.00735568339156927,0.00932988996364452,-0.0256422677203125,0.010930900937174,0.430480297991439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39334,-0.00557439064259562,0.00708025283127202,-0.0194516861918888,0.00830290490669754,0.431114759930852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41597,0.00473303813130137,0.00602052181984402,-0.00706718463559291,0.0165332608981957,0.431793470022417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39328,-0.00267704413776282,0.00340707769537404,-0.00935491642069595,0.00400082814517031,0.43204286822761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41281,0.00199923529537234,0.00254957494033321,-0.00299793158768074,0.00699640217842542,0.432969943592317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41521,0.00194003001919003,0.0024761158378692,-0.0029131570230336,0.00679321706141365,0.433349512395264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41521,0.00903341155816941,0.0115469691412753,-0.0135986479587302,0.031665471075069,0.434041550847816
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39334,-0.00305776954797099,0.00391485830057755,-0.010730891817103,0.004615352721161,0.434779876375948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39589,-0.00909581746876156,0.0116563914061126,-0.0319423446247424,0.0137507096872192,0.43521419507991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39600,-0.00711270243650083,0.00912940890924844,-0.0250063438986278,0.0107809390256261,0.435938863578597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39250,0.00516026655946972,0.00662657120052745,-0.00782781299356409,0.0181483461125035,0.436159925415717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41534,0.00546143593677395,0.00702238840780667,-0.00830244534252713,0.019225317216075,0.436749665526183
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41447,0.004514837120343,0.00580524110780076,-0.00686343545094649,0.0158931096916325,0.436749943387172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39334,-0.0037267025247,0.00479995911641519,-0.0131346223928738,0.00568121734347376,0.437528197508298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39427,0.00558243663992998,0.00720049722504758,-0.00853053792116327,0.0196954112010232,0.438188272985569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41686,-0.0037984270828829,0.00490162230820555,-0.0134056068069658,0.00580875264119998,0.438393469779141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39328,-0.00618565206028249,0.00798501792973736,-0.0218362872025677,0.00946498308200274,0.438559288790361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39589,0.00447217316117935,0.00577842150570424,-0.00685353299000096,0.0157978793123597,0.43898071037662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,41903,0.00251746183418953,0.00325299746108691,-0.00385841318954082,0.00889333685791988,0.439009663424596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,41925,0.00190366012858026,0.00246420525430318,-0.00292618216985396,0.00673350242701449,0.439817256132589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39433,0.00203581520781854,0.00264450374463036,-0.00314741213165697,0.00721904254729405,0.441418225077164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41534,-0.00234663704853716,0.00304918354566754,-0.00832303679804554,0.00362976270097122,0.441554102120688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39328,-0.0109187404450059,0.0142467671061742,-0.0388424039731072,0.0170049230830955,0.443454438915187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41521,-0.0048223014178701,0.00629224376588445,-0.0171550991990036,0.00751049636326342,0.443459348632076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,41865,-0.00264986468040104,0.00346386947197281,-0.00943904884546774,0.00413931948466566,0.444284374543587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41689,0.00570352846760725,0.00746307674614924,-0.00892410195484526,0.0203311588900598,0.444742265602343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40174,0.00256400553834481,0.00335851395219015,-0.00401868180794789,0.00914669288463751,0.445219851232357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39259,0.00265557071892502,0.00349258824203197,-0.00418990223545764,0.00950104367330768,0.447065428116424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39589,0.00394844788537623,0.00520278630781834,-0.00624901327794771,0.0141459090487002,0.447922521006674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39241,0.00534776103349122,0.00705352611594687,-0.00847715015376464,0.0191726722207471,0.448366930627413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39427,-0.00248013307361582,0.00327495079419229,-0.00889903663023272,0.00393877048300108,0.448884283450525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41666,0.00330097389078293,0.00438674285834065,-0.00529704211156474,0.0118989898931306,0.45177085281116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,39598,0.0076935365701906,0.0102539747869505,-0.0124042540122324,0.0277913271526136,0.453091309616007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41740,-0.00773465104728607,0.0103376118338398,-0.0279963702416121,0.0125270681470399,0.454350012342425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,41865,-0.00593859456870715,0.00795113844118449,-0.0215228259134287,0.00964563677601445,0.455145570812564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41466,-0.00234528539841906,0.0031449431468619,-0.00850937396626838,0.00381880316943025,0.455842822306182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39427,0.00581662310307457,0.00780165750773107,-0.00947462561207832,0.0211078718182275,0.455947941432342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41466,-0.00365428421464238,0.00490549619497752,-0.0132690567567983,0.00596048832751357,0.456323586127116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39598,-0.00432275612343736,0.00581146985041679,-0.0157132370302543,0.00706772478337955,0.456994125179398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39308,0.00171994792100806,0.00231801002769009,-0.00282335173326451,0.00626324757528063,0.458107666275141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39408,-0.0024486615140296,0.00330182371875638,-0.00892023600279211,0.00402291297473292,0.458340506340115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41636,-0.00554614608639333,0.00749067639813423,-0.0202278718267364,0.00913557965394977,0.459066662816328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41577,0.0047767074529761,0.00645219499865887,-0.0078695947443953,0.0174230096503475,0.459117507033407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39334,-0.00265767036442828,0.00359001617179613,-0.0096941020611487,0.00437876133229214,0.459137316966038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39328,-0.00346081094525261,0.00467774368292176,-0.0126291885637792,0.00570756667327403,0.459409504148027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,41805,0.0101487230786747,0.0137811349058094,-0.0168623013367117,0.037159747494061,0.461487348653019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41534,-0.00519214663084643,0.00705272940355142,-0.0190154962618072,0.00863120300011436,0.461628620572548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39250,0.00377064574387586,0.00513388526821274,-0.00629176938182111,0.0138330608695728,0.462683132548317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39562,-0.00359519501808635,0.00489596779377412,-0.0131912918938836,0.00600090185771092,0.462770937701337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39259,0.00762806844113808,0.0104117635095823,-0.0127789880376433,0.0280351249199194,0.463794487935421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,39598,-0.00547868237158861,0.00748156774195272,-0.0201425551458159,0.00918519040263871,0.464006768041965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,41862,-0.00534816366248825,0.00730766036120001,-0.0196711779704403,0.00897485064546376,0.46426867971006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39334,0.00220702713534823,0.00301689071777021,-0.00370607867148138,0.00812013294217784,0.464455050307646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39625,-0.00707042549403557,0.0096740867947403,-0.0260316356117266,0.0118907846236554,0.464878786162644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39258,-0.00440827144449934,0.00604691886457526,-0.0162602324190668,0.00744368953006816,0.466010843778297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41614,-0.0020198379300033,0.00277815395616305,-0.00746501968408288,0.00342534382407628,0.467212572634736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39250,0.00384506553362139,0.00528961349604685,-0.00652257691863043,0.0142127079858732,0.467297926499323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39328,-0.00394928343667326,0.00547614196477831,-0.0146825216876387,0.00678395481429223,0.470814561160432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,41862,0.00237498507182854,0.00330202743005636,-0.00409698869108192,0.00884695883473901,0.471999226555753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39427,0.00665172923146742,0.00926195436755492,-0.0115017013289402,0.0248051597918751,0.472663212729368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,41753,0.0148486454673042,0.0206869583820264,-0.0256977929614676,0.055395083896076,0.472906872915669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,39600,0.0121149505970915,0.016882018784921,-0.0209738062213537,0.0452037074155366,0.473004074830079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39600,-0.00166890416850591,0.00232626706797921,-0.00622838762174517,0.00289057928473335,0.473131900715294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39259,-0.00369178815397075,0.00518117834566916,-0.0138468977114823,0.00646332140354081,0.476147082945144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39600,-0.00350258129350778,0.00492023547240565,-0.0131462428194229,0.0061410802324073,0.476558707689856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39250,0.00303759824510271,0.00427900989943158,-0.00534926115778319,0.0114244576479886,0.477791965760676
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39250,0.00361227291547697,0.00509179418608451,-0.00636764368924866,0.0135921895202026,0.478073040547209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39259,-0.00268285528217995,0.00378327739402271,-0.0100980789744645,0.00473236841010457,0.478256072820611
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39250,-0.00481551012216688,0.00679851414248493,-0.0181405978414373,0.00850957759710359,0.47876328711046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,41865,0.00214105792725164,0.00302426637754797,-0.00378650417274239,0.00806862002724567,0.478982885241336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41780,-0.00172379446341314,0.00243685640996598,-0.00650003302694645,0.00305244410012017,0.47934007114854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39334,-0.00618105973163391,0.00874158096511899,-0.0233145584232671,0.0109524389599993,0.479527659226127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39308,0.00466854837201403,0.0066160804412892,-0.0082989692929128,0.0176360660369409,0.480429520258609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,41689,-0.0144986787942059,0.0205569310323659,-0.0547902636176431,0.0257929060292313,0.480639884320867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,41865,-0.00446966796820556,0.00634727992390985,-0.0169103366190689,0.00797100068265773,0.481329083576231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39250,0.00306072824187274,0.00437227028874286,-0.00550892152406326,0.0116303780078087,0.483922735814391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,39600,-0.0196319596037384,0.0280611638494926,-0.0746318407487439,0.0353679215412671,0.484183713645708
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39625,-0.00670191596343999,0.00958010010034057,-0.0254789121601075,0.0120750802332275,0.484212902753934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39241,0.00499667551294596,0.00714479442857939,-0.00900712156706964,0.0190004725929616,0.48435180227507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41534,-0.00320701800503857,0.00458802387358039,-0.0121995447972561,0.005785508787179,0.484566054810019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,41805,-0.00162841394692366,0.00233187429858341,-0.00619888757214715,0.00294205967829982,0.484984166554856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39334,-0.00427578037293533,0.00616932674930394,-0.0163676608015711,0.0078161000557004,0.488280101338873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39427,-0.00277387638103598,0.00402770749665211,-0.0106681830744741,0.00512043031240216,0.491027734818858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,41740,-0.00417473081719534,0.00606895727240339,-0.016069887071106,0.00772042543671531,0.491538783352125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39600,-0.00325400717001309,0.00473298889955721,-0.0125306654131452,0.00602265107311904,0.491771907602456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39427,0.00587936415938001,0.00855832835705821,-0.0108949594204541,0.0226536877392141,0.492112714835537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,41740,-0.00512148909745246,0.00747628323937172,-0.019775004246621,0.0095320260517161,0.493336163023676
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39589,-0.00480412621286792,0.00703385582684743,-0.0185904836334889,0.00898223120775304,0.494621000005709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39600,-0.0126455977687101,0.0185774070939424,-0.0490573156728372,0.0237661201354171,0.496077136822889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41798,-0.00423599882714423,0.00622382777393994,-0.0164347012640665,0.00796270360977805,0.496130297632565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39259,0.00452300198858163,0.00665940164978639,-0.00852942524499969,0.017575429222163,0.497031946390561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39334,0.00342907036054389,0.00505378797561172,-0.00647635407165508,0.0133344947927429,0.497459917483319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,41705,-0.00168611310251508,0.00248653313571645,-0.00655971804851932,0.00318749184348916,0.497721542261233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41750,0.00238455352222502,0.00352429887677393,-0.00452307227625189,0.00929217932070193,0.498669356349362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,41673,-0.00502042840182921,0.00742744077643231,-0.0195782123236365,0.00953735551997812,0.499097186635453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41740,-0.00619725298087516,0.00918647388061211,-0.0242027417868749,0.0118082358251246,0.499937809886612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41465,-0.00351080252328918,0.00520450332051738,-0.0137116290315032,0.0066900239849249,0.499961032130164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,41694,-0.00318965955435592,0.00472992166729986,-0.0124603060222636,0.00608098691355181,0.500095772268268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39334,0.00520246697966822,0.00775508786915055,-0.00999750524386686,0.0204024392032033,0.502333295450957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39589,0.00547036439935032,0.00816970091624842,-0.0105422493964966,0.0214829781951972,0.50313213777782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,41728,0.00288557952158129,0.00432733694666769,-0.00559600089388738,0.01136715993705,0.504895189007843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39250,0.0032218950285546,0.00483459898002552,-0.00625391897229543,0.0126977090294046,0.505154266314803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39589,-0.00329653392227843,0.00495374275102185,-0.0130058697142813,0.0064128018697244,0.505768186135603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41466,0.00278709415160131,0.00418958915429684,-0.00542450059082049,0.0109986888940231,0.505907113882468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39334,0.00254065196424567,0.00384443482393765,-0.00499444029067212,0.0100757442191635,0.508713152380972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41636,-0.00561203935166736,0.00853866465281691,-0.0223478220711885,0.0111237433678538,0.511031632917402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39600,-0.00295378196079862,0.00449577783480744,-0.0117655065170212,0.00585794259542397,0.511186663706377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,41802,0.0048642564275742,0.00740641449768418,-0.0096523159878868,0.0193808288430352,0.511344990069259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39427,-0.00376834876618455,0.00575000357959242,-0.0150383557821857,0.00750165824981658,0.512246965188235
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39334,0.00288074392204723,0.00439784447463303,-0.0057390312482335,0.011500519092328,0.512458983107791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39250,0.0038937883696781,0.00596696323804797,-0.00780145957689592,0.0155890363162521,0.514055486851952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,41752,-0.00220030303348002,0.00337260990483599,-0.00881061844695856,0.00441001237999853,0.514152208223737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39334,-0.00401207796281521,0.00615412699502326,-0.0160741668730608,0.00805001094743038,0.51445840757069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41447,0.00643917515738684,0.00990069628941905,-0.0129661895698745,0.0258445398846482,0.515461012322078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,39580,0.00600812816513805,0.00925203024824319,-0.0121258511214186,0.0241421074516947,0.516103245042453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39427,0.00193612831184664,0.00298821567845988,-0.00392077441793473,0.007793031041628,0.517049652052221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39328,0.00428761221999137,0.00665327195078727,-0.00875280080355168,0.0173280252435344,0.519306110057032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,41758,-0.0061804975133346,0.00961185859984139,-0.0250197403690237,0.0126587453423545,0.520230414813721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41585,0.00810947727851363,0.0126301881147456,-0.0166456914263878,0.0328646459834151,0.520838431056558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41521,0.00582747593573341,0.00907810004596836,-0.0119656001543646,0.0236205520258314,0.520932084101547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41465,-0.00399678077304416,0.00623466511945068,-0.0162167244071675,0.00822316286107919,0.52149654268324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,41925,-0.00225461653180532,0.00352185400535089,-0.00915745038229305,0.00464821731868242,0.522067322938389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39328,-0.00421473760258321,0.00660257198373553,-0.0171557786907048,0.00872630348553843,0.523260899024481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,41689,-0.0022504055024794,0.00352624285174897,-0.00916184149190739,0.00466103048694858,0.523362541086568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39250,-0.00441216570909619,0.00695584553690826,-0.0180456229614364,0.009221291543244,0.52589184383353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39327,0.00484620436361271,0.00767067079935702,-0.0101883104031271,0.0198807191303525,0.527541724872837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39259,-0.00304341590535366,0.00481789547081085,-0.0124864910281429,0.0063996592174356,0.527603076330182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39334,0.00379547791171613,0.00601677124046551,-0.00799739371959627,0.0155883495430285,0.52817401606547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39427,0.00279882157994319,0.00443974301588582,-0.00590307473119301,0.0115007178910794,0.528445098505003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39600,0.00708558476611364,0.0112441088727008,-0.0149528686243799,0.0291240381566071,0.528603164277663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39241,0.00285692980512826,0.00454042554981561,-0.00604230427251035,0.0117561638827669,0.529218077513409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,41840,-0.00414556139105824,0.00659646595350476,-0.0170746346599276,0.00878351187781109,0.529718804623887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39334,0.00148454337210793,0.00236271187902042,-0.00314637191077209,0.00611545865498795,0.529806524112652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39334,-0.00678885505674181,0.0108159715859076,-0.0279881593651207,0.0144104492516371,0.530233847022248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41534,-0.0032471918950229,0.00517735829536656,-0.0133948141539414,0.00690043036389555,0.530545193005481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39308,0.00262205464493602,0.00418896949376533,-0.00558832556284403,0.0108324348527161,0.531365903078082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39328,-0.00246408960963362,0.00394928223607225,-0.0102046827923352,0.00527650357306798,0.532684504809785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39308,-0.00173114861664893,0.00277562863692084,-0.00717138074501377,0.00370908351171591,0.532840503015027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39625,-0.00268032506322156,0.0043147123397835,-0.0111371612491972,0.00577651112275409,0.534476955033517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,41765,-0.00212733531172264,0.00342553169210462,-0.0088413774282477,0.00458670680480242,0.534594983753554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41415,0.00202961570155515,0.00327233950411137,-0.00438416972650313,0.00844340112961342,0.535114873134745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39082,-0.00472142298752973,0.00762526891430456,-0.0196669500595667,0.0102241040845072,0.535810466697941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39619,-0.00318183621849699,0.0051417834289744,-0.0132597317392868,0.00689605930229283,0.536048019600095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39250,0.00323291012991034,0.00523574955839215,-0.00702915900453827,0.013494979264359,0.536938991027779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,41765,0.00453461798855456,0.00735644788351451,-0.00988401986313388,0.018953255840243,0.537631927058225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39259,0.00504490399171663,0.00819521883489151,-0.0110177249246707,0.021107532908104,0.538177552911738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41585,-0.00452646596091678,0.00737293963489875,-0.0189774276453183,0.00992449572348477,0.539272597066385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39259,0.00229248988213902,0.00373720863818059,-0.00503243904869494,0.00961741881297299,0.539609745106046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,41703,-0.00576670854144507,0.0094423456105635,-0.0242737059381495,0.0127402888552594,0.541390000394833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,41805,0.00563065111703231,0.00923289909057262,-0.01246583110049,0.0237271333345546,0.54197399441294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39600,-0.00307712260346267,0.00505954415442106,-0.0129938291461279,0.0068395839392026,0.543079469773004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41466,-0.00430208133895412,0.00712411894269685,-0.0182653544666399,0.0096611917887317,0.545937023398833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,41764,0.00216429585590538,0.00358449498968296,-0.00486131432387322,0.00918990603568397,0.545991145211988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39576,0.00249239830284142,0.00413832721549036,-0.00561872303951968,0.0106035196452025,0.547005586296931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,41750,-0.00251051247320541,0.00417370006312343,-0.0106909645969273,0.00566993965051652,0.547512294087792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39427,0.00444068155246171,0.00739424135336617,-0.010052031500136,0.0189333946050594,0.54814602077471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39250,0.00207468886103818,0.00346582317718063,-0.00471832456623585,0.00886770228831221,0.549443321274881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41689,-0.00580062807171245,0.00970748606638926,-0.0248273007618354,0.0132260446184105,0.550156088203549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39314,-0.00288416905363163,0.00483226420376109,-0.0123554068930034,0.0065870687857401,0.55061569950328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",41758,-0.00493514544278605,0.00827198516075824,-0.0211482363578722,0.0112779454723001,0.550778349946435
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39250,0.00235091852636662,0.0039514446622281,-0.00539391301160045,0.0100957500643337,0.551888429981204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39259,0.00378860991938921,0.00637809573166895,-0.00871245771468193,0.0162896775534603,0.552522510958596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,41740,-0.00233182702798153,0.00392814617462143,-0.0100309935302395,0.00536733947427648,0.552776366628062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39250,-0.00428375284194478,0.00728487821466237,-0.018562114142683,0.00999460845879347,0.556522238191079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,41636,-0.00268460440079115,0.00456956228835302,-0.0116409464859631,0.00627173768438078,0.556880101322265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39334,-0.00391562751116384,0.00666631009077597,-0.0169815952890847,0.00915034026675706,0.556963870280447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39259,0.00212882045574869,0.00362442912967018,-0.00497506063840487,0.00923270154990224,0.556978883801371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39259,0.00616018758953241,0.0105099388065096,-0.0144392924712264,0.0267596676502912,0.557800750180789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39259,0.00584367926021289,0.00999937069481861,-0.0137550873016316,0.0254424458220574,0.558960431672981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39308,-0.0025810167655061,0.0044207862706286,-0.0112457578559382,0.00608372432492595,0.559342558291988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39598,-0.0028631412439834,0.00490474874819731,-0.0124764487904501,0.00675016630248333,0.559401294478985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39250,0.0029617411568959,0.00507953486716876,-0.00699414718275488,0.0129176294965467,0.55985630271747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41466,0.004613887630569,0.0079378882524245,-0.010944373344183,0.020172148605321,0.561082997559118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39427,-0.00248207972134891,0.00429379535418016,-0.010897918615542,0.00593375917284421,0.563234316269103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39334,-0.00265620745431322,0.00460799922706256,-0.0116878859393558,0.0063754710307294,0.564333951108537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39408,-0.00447774260346349,0.00782030420256822,-0.0198055388404972,0.0108500536335702,0.566941636397579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41466,-0.00379568778921523,0.00662921923327288,-0.0167889574864301,0.00919758190799962,0.566946318038267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39589,0.00617563978092342,0.0108054757575834,-0.01500309270394,0.0273543722657868,0.567652983611858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39308,0.00727046282115271,0.0127572227454672,-0.017733693759963,0.0322746194022684,0.568751016865223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,41911,0.00278974496494056,0.00491350054514579,-0.00684071610354519,0.0124202060334263,0.570199794657374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39328,-0.00339293305267436,0.00597950464726437,-0.0151127621613125,0.00832689605596382,0.570435907514972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39241,-0.00435572400726688,0.00767892266847117,-0.0194064124374704,0.0106949644229366,0.570569124081315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41465,0.00194203353915969,0.00342622961773139,-0.00477337651159384,0.00865744358991322,0.570850719217645
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,41689,-0.00260482024293615,0.0046001815876704,-0.0116211761547701,0.00641153566889784,0.571238366662993
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39598,0.0146501160833995,0.0260441685025756,-0.0363964541816487,0.0656966863484476,0.573779773328522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39598,0.00288043886830287,0.00516803429352105,-0.0072489083469984,0.0130097860836041,0.577295042724658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,41802,-0.00367339624744813,0.00661326644954255,-0.0166353984885515,0.00928860599365525,0.578590377668741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39250,-0.00232064055120422,0.0041801363674932,-0.0105137078314909,0.00587242672908246,0.578797532835588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41466,-0.00231039624182902,0.00416323815574306,-0.0104703430270854,0.00584955054342737,0.578937320641257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39241,0.00329050846009337,0.00593533671816896,-0.00834275150751779,0.0149237684277045,0.579321643727613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39250,0.00284120775996412,0.00514284762675045,-0.00723877358846677,0.012921189108395,0.580646136847334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41465,-0.00468560136175593,0.0085043816585627,-0.0213541894125388,0.011982986689027,0.581668466810777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39427,0.00343141692504526,0.00625979699666775,-0.00883778518842353,0.0157006190385141,0.583588235028748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39334,0.00345230994192585,0.00636243097534654,-0.00901805476975337,0.0159226746536051,0.587410562494416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39334,-0.00367103121036547,0.00678043776011074,-0.0169606892201825,0.00961862679945158,0.588232756200031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39259,0.00313194911283333,0.00580950292774469,-0.00825467662554625,0.0145185748512129,0.589823642019997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,41703,0.00604279258997715,0.0112131701089846,-0.0159350208236326,0.0280206060035869,0.589964076170528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,39589,0.0020381832994477,0.00378630472252136,-0.00538297395669417,0.00945934055558957,0.59037803423922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39308,-0.00427396652402006,0.00794421847772747,-0.0198446347403659,0.0112967016923258,0.590590230226499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,41692,0.00202041030345289,0.00376130389896503,-0.00535174533851856,0.00939256594542434,0.591168375685903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41534,0.00168273151845049,0.00313856367198086,-0.004468853278632,0.00783431631553297,0.591866174988702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41521,0.00287975302855717,0.00537390624426984,-0.00765310321021171,0.0134126092673261,0.592052750254885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,41865,-0.00396985161493239,0.00742687058250365,-0.0185265179566395,0.0105868147267748,0.592986979395683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41636,-0.00461999324705239,0.0086633279197184,-0.0216001159697005,0.0123601294755957,0.593847764284146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39393,0.00210616621512849,0.00395168761734843,-0.00563914151487444,0.00985147394513141,0.594059143186387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39633,0.00173836440498335,0.00326656878401202,-0.00466411041168021,0.0081408392216469,0.594620141851291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39334,-0.00317107368080072,0.00598341506843486,-0.014898567214933,0.0085564198533316,0.596138687321459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39241,0.00310510428605688,0.00585996309951132,-0.00838042338898532,0.0145906319610991,0.596202989760479
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39328,-0.00442768189935406,0.00835831536543381,-0.0208099800156043,0.0119546162168962,0.596307493511527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,41765,-0.00168722782088461,0.00319669381029464,-0.00795274768906211,0.00457829204729289,0.597644266986404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41466,-0.00301154301618715,0.00571937015510888,-0.0142215085202006,0.00819842248782626,0.598514146736727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,41802,-0.0039427558804205,0.00752387777099393,-0.0186895563115686,0.0108040445507276,0.600264787639954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,41747,-0.00433760710239863,0.00828382002567835,-0.0205738943527282,0.0118986801479309,0.600548900794965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39589,-0.00243535048363519,0.00466550345950205,-0.0115797372642592,0.00670903629698883,0.601687167668859
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39334,-0.0049687172857357,0.00957889111004458,-0.0237433438614231,0.0138059092899517,0.603969990194618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39259,-0.00271890819782803,0.00524476005686872,-0.0129986379092907,0.00756082151363466,0.604186705695989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39250,0.00238041908556437,0.00459765407882944,-0.00663098290894133,0.0113918210800701,0.604645937893783
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39259,0.00184157797960965,0.00356787148233431,-0.0051514501257656,0.0088346060849849,0.605756222699862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39250,-0.0026542444836713,0.00514602688745564,-0.0127404571830844,0.00743196821574176,0.606015150704821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41925,-0.00388950325528306,0.00754660908097488,-0.0186808570539938,0.0109018505434277,0.60628384767882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,41740,-0.00379950979707702,0.0074158430407558,-0.0183345621569584,0.0107355425628044,0.60841444238221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,39553,0.00157862622717649,0.00308739854415097,-0.00447267491935942,0.0076299273737124,0.609142388211535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,41614,-0.00283945480627272,0.00558117205036841,-0.0137785520249948,0.00809964241244937,0.610931883995214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41466,-0.00395366041407963,0.00777310696462349,-0.0191889500647417,0.0112816292365824,0.611018061482323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39259,-0.00403335538593989,0.00798757615365172,-0.0196890046470973,0.0116222938752175,0.613601860913311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,41786,-0.00177172625748637,0.00352064747022795,-0.00867219529913315,0.00512874278416042,0.614804824549672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39334,0.0029558328027926,0.00587623879073291,-0.0085615952270439,0.0144732608326291,0.614964459881535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39241,-0.00216001619789954,0.00431648148486768,-0.0106203199082402,0.0063002875124411,0.616795833095195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,39596,-0.00138072410507081,0.00275950106934905,-0.00678934620099495,0.00402789799085332,0.616836690845703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41465,0.00291218939875272,0.00583712200229236,-0.00852856972574031,0.0143529485232457,0.617852422331107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39589,0.00333393141678575,0.00670029069651023,-0.00979863834837429,0.0164665011819458,0.618789978114764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39259,0.00306592305224508,0.00617790795371286,-0.00904277653703212,0.0151746226415223,0.619712715621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41465,0.00675164126779603,0.0136244293037575,-0.0199522401675687,0.0334555227031607,0.620217535764019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,41740,0.00301282136374075,0.00608716610126597,-0.00891802419474055,0.014943666922222,0.620646183859669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41534,0.00257265898075779,0.00521085203137774,-0.00764061100074258,0.0127859289622582,0.621518134883932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41534,0.00733013728970458,0.0148653397352291,-0.0218059285913444,0.0364662031707536,0.621948483587269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39241,-0.00445773287162874,0.00905886145002829,-0.0222131013136842,0.0132976355704267,0.622669170237835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39250,0.00247172094088856,0.00502775207553521,-0.00738267312716045,0.0123261150089376,0.623001302841416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39241,0.0033076206750867,0.00673327779496363,-0.00988960380304202,0.0165048451532154,0.623270487577129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41521,-0.00123145026406832,0.00250716390798721,-0.00614549152372326,0.00368259099558661,0.623312705128424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39259,-0.00259292431920075,0.00528709871160152,-0.0129556377939397,0.00776978915553823,0.623843427308637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41459,0.00572543034002623,0.0116756190028788,-0.0171587829056162,0.0286096435856687,0.623877011341428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41865,-0.00246775112530889,0.00503652443746497,-0.0123393390227402,0.00740383677212246,0.62416249372442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41465,-0.0044989596743547,0.00918384522681027,-0.0224992963189028,0.0135013769701934,0.624228897565904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39250,0.00253870048862779,0.00518879902623297,-0.00763134560278883,0.0127087465800444,0.624663799891067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39625,0.00277209914125478,0.00567825968356439,-0.00835728983853141,0.013901488121041,0.625421290706521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39427,-0.00210640829682999,0.00433415337958331,-0.0106013489208133,0.0063885323271533,0.626975405900936
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41521,0.00397765036088145,0.00821255910869574,-0.0121189654921622,0.0200742662139251,0.628154574640402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41465,0.00843621081646958,0.0174268940197009,-0.0257205014621442,0.0425929230950833,0.628329192020666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39241,0.00329027527118811,0.0068020537930731,-0.0100417501632352,0.0166223007056114,0.628596031675477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39259,0.00270999410256984,0.00566390817590117,-0.00839126592219645,0.0138112541273361,0.632327550748494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41466,0.00574986424074014,0.0120201970332532,-0.0178097219444361,0.0293094504259164,0.632409065459025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39595,0.00102608518238275,0.00215045290336632,-0.00318880250821525,0.00524097287298074,0.633265928691897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,41838,-0.00325783344399202,0.00686403413537877,-0.0167113403493344,0.0101956734613504,0.635063022603112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39625,-0.00467619070588889,0.00988143260783746,-0.0240437986172503,0.0146914172054725,0.636058440417577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41466,-0.00756506801739568,0.0160611342515384,-0.039044891150411,0.0239147551156196,0.637636547548212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41534,-0.0028410999530054,0.00603826167183746,-0.0146760928298068,0.00899389292379602,0.637994195004318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41466,-0.00141559075179226,0.00300895299113137,-0.00731313861440974,0.00448195711082521,0.638034682772445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39250,0.00317908878852862,0.00676130425628285,-0.0100730675537858,0.016431245130843,0.638229842045693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,39598,-0.00497341617659541,0.010580992458861,-0.025712161395963,0.0157653290427722,0.63834072363675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39259,0.00265357447682365,0.00565235085907859,-0.00842503320697039,0.0137321821606177,0.638747711185559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,41802,0.00401301549910411,0.00857353422897738,-0.0127911115896916,0.0208171425878998,0.639742147839337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39334,0.00151089513267559,0.00323695427833287,-0.00483353525285682,0.00785532551820801,0.640677897394986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39600,0.00338490739235989,0.0072836562490742,-0.0108910588558255,0.0176608736405453,0.642136594028375
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41521,0.00157420358066724,0.00340743889132533,-0.00510437664633042,0.0082527838076649,0.644096083166086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39589,-0.00172566497257938,0.00374902688622112,-0.00907375766957277,0.00562242772441401,0.645312325699837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41598,0.0020179006632137,0.00438940963983259,-0.00658534223085817,0.0106211435572856,0.645724694294026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39241,0.00423951746502601,0.00923205433676461,-0.0138553090350326,0.0223343439650847,0.646087633315078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39600,-0.00822018914556004,0.0179394301411885,-0.0433814722222895,0.0269410939311694,0.64680410633453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39259,0.00294373803313231,0.0064310925455953,-0.00966120335623448,0.0155486794224991,0.647151958712685
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,39589,0.00131109895078082,0.00286520127062959,-0.00430469553965318,0.00692689344121481,0.64725319156462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,39600,-0.00161171413233894,0.00354387549001135,-0.00855771009276118,0.0053342818280833,0.649270315458041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41465,0.00235379232975682,0.00521371802161136,-0.00786509499260145,0.0125726796521151,0.651664664072867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39259,0.0032471888694346,0.00722334339727169,-0.0109105641892179,0.0174049419280871,0.653050593662004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41689,-0.00178141435879549,0.00396719525480481,-0.00955711705821293,0.00599428834062194,0.653412963243324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39408,-0.00126332393221935,0.00284094702264455,-0.00683158009660267,0.00430493223216397,0.656556975326481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,41765,-0.00617496988852926,0.013923614020929,-0.0334652533695502,0.0211153135924916,0.65741934993069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,41925,-0.0016505145550312,0.00374228415601666,-0.00898539150082386,0.00568436239076146,0.65918779961516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39408,-0.00499591915731284,0.0113309995641176,-0.0272046783029834,0.0172128399883577,0.659289008400189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,41765,-0.00381914368550775,0.00869682380750341,-0.0208649183482144,0.0132266309771989,0.660565598225153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39328,0.00367306335102224,0.00838657089389561,-0.0127646156010132,0.0201107423030576,0.661417116722296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41465,-0.00349786621122434,0.00800180081814004,-0.0191813958147788,0.0121856633923301,0.662020872664769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39328,0.00215232395180371,0.00493352336145085,-0.00751738183663996,0.0118220297402474,0.662653195347038
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,39589,-0.00216188250032316,0.00499690003871086,-0.0119558065761964,0.00763204157555012,0.665281373937291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41466,0.00352057283574696,0.0081395092702481,-0.0124328653339393,0.0194740110054332,0.665364315642794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41819,0.00527404848558393,0.012265069289178,-0.018765487321205,0.0293135842923729,0.667198576626975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41534,0.00333847975185339,0.00777705291988525,-0.0119045439711217,0.0185815034748285,0.667731628019601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39600,-0.0020197164694752,0.00473000191027683,-0.0112905202136178,0.00725108727466739,0.669386814206046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,39598,-0.00429137122089561,0.0100569024227544,-0.0240028999694943,0.0154201575277031,0.669599614441721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39250,-0.00150898771488174,0.0035554781993087,-0.0084777249855268,0.00545974955576332,0.671273922809909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39193,0.00157021944544116,0.00370755785283394,-0.00569659394611336,0.00883703283699568,0.671925581777437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39328,0.00128660238711529,0.00305091709091868,-0.00469319511108532,0.0072663998853159,0.673245120416246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41466,0.00153607299700021,0.00364315384908102,-0.00560450854719859,0.00867665454119902,0.67330013774081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41521,-0.00150306091417378,0.00356644910719236,-0.00849330116427081,0.00548717933592325,0.673437427539087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39625,-0.00451505973408047,0.0107490460862978,-0.0255831900632242,0.0165530705950633,0.674462351333366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41636,-0.00421166458990581,0.0100617227025026,-0.023932641086811,0.0155093119069994,0.675527919423571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39195,-0.0019868937155864,0.00474822233389639,-0.0112934094900233,0.00731962205885053,0.675626605297126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41534,-0.00152981304724154,0.00366700001973629,-0.00871713308592467,0.0056575069914416,0.676550888828179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39250,0.00206858607137849,0.00497989970910368,-0.00769201735846472,0.0118291895012217,0.677866920923242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39241,0.00248957944177482,0.00604208288712634,-0.0093529030169928,0.0143320619005424,0.680318452281829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41534,0.00417171055534345,0.010149123325401,-0.0157205711624424,0.0240639922731293,0.681048937550745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,41650,0.00205246942629923,0.00499727436260374,-0.0077421883244041,0.0118471271770026,0.681286232219464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41354,0.00549175102235101,0.0133762093260633,-0.0207256192567331,0.0317091213014351,0.6814012999957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39598,-0.00178993506149169,0.00436892728089029,-0.0103530325320367,0.00677316240905328,0.68203643509213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41689,-0.00373349575771139,0.00913456597069931,-0.021637245060282,0.0141702535448593,0.68275055958374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39408,-0.00262140384235237,0.00644183134269756,-0.0152473932740396,0.0100045855893348,0.68406410589044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,41855,-0.00110208427638902,0.00270865320438221,-0.00641104455697815,0.00420687600420011,0.684106095772183
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39408,0.00124423785516827,0.00306073387268297,-0.00475480053529034,0.00724327624562689,0.684371416833158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39650,0.000722990559867436,0.00178066622754489,-0.00276711524612054,0.00421309636585542,0.684733927733587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39241,0.00159573855103669,0.00393018647724169,-0.00610742694435703,0.00929890404643041,0.684735277235928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39328,0.00219768121775835,0.00542994046034798,-0.0084450020845237,0.0128403645200404,0.685681157833557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,41865,0.00282592106113605,0.00702529975579231,-0.0109436664602169,0.016595508582489,0.687507133281152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41465,-0.00338920570246228,0.00843293449107937,-0.0199177573049778,0.0131393459000533,0.687763484761509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39334,-0.00116201174800358,0.00289282214113027,-0.00683194314461891,0.00450791964861175,0.687921702945546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41786,-0.00328674610951948,0.0081914450274638,-0.0193419783633485,0.0127684861443096,0.688248973180534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39250,-0.00175687413079476,0.00437991217349192,-0.0103415019908389,0.0068277537292494,0.688339192019027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41689,0.00229261948187342,0.00574474265830068,-0.00896707612839591,0.0135523150921428,0.689839796732714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,41911,0.00255240874828344,0.00641652109743887,-0.0100239726026967,0.0151287900992636,0.69079357161064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39334,-0.00377904252612388,0.00952932873039438,-0.0224565268376969,0.0148984417854491,0.6916927229931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,39589,-0.00478561827087062,0.0121066113767328,-0.0285145765692669,0.0189433400275257,0.69263680377879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39427,-0.00193500556167122,0.00490056296327838,-0.0115401089696968,0.00767009784635439,0.69295861774995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39250,-0.00449835636177315,0.0114164491588607,-0.02687459671314,0.0178778839895937,0.693571118583935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41534,0.00244369119131815,0.00622921726381172,-0.00976557464575282,0.0146529570283891,0.694846673617705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39259,0.00383991155333531,0.00987820499647954,-0.0155213702397646,0.0232011933464352,0.697486878008523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39241,0.0021154882596158,0.00544590454384166,-0.00855848464631385,0.0127894611655454,0.697687200885297
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41617,0.00311550238188574,0.00803430870869334,-0.0126317426871532,0.0188627474509247,0.698189042938306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39241,-0.00240451062136095,0.00620697517680937,-0.0145701819679073,0.00976116072518542,0.698476385594598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39259,-0.00182139588566259,0.00471751280543491,-0.011067720984315,0.00742492921298984,0.699435937156823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,41683,0.00150126150947309,0.00392647669648912,-0.00619463281564558,0.00919715583459177,0.702213055293257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39328,0.00285999661167563,0.00749351932732768,-0.0118273012698866,0.0175472944932379,0.702719149926483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,41840,0.00285725492800256,0.00748689647182413,-0.0118170621567727,0.0175315720127779,0.702738918260896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,41708,-0.0032005471235736,0.00839018659065865,-0.0196453128412646,0.0132442185941174,0.702865782348316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39427,-0.00233370226285758,0.00613446223463924,-0.0143572482427505,0.00968984371703533,0.703637487225449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39625,-0.00127225009395079,0.00334608890720002,-0.00783058435206283,0.00528608416416126,0.703789401170617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39600,-0.00264693868457957,0.006972921145219,-0.0163138641292088,0.0110199867600497,0.70424779168441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39600,-0.00360437525357915,0.00952004552396781,-0.0222636644805561,0.0150549139733977,0.704985518229696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39328,-0.00430206906768141,0.0113810702761517,-0.0266089668089388,0.018004828673576,0.705436473274072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39266,-0.00139350856403935,0.00372018541838396,-0.00868507198407191,0.00589805485599321,0.707979994460224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,41836,-0.00129491515123669,0.00346239602067872,-0.00808121135176698,0.0054913810492936,0.708414810659054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39259,-0.00333577136221144,0.00892672372801484,-0.0208321498691205,0.0141606071446976,0.708647068209732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39250,-0.00233788026298776,0.00627680453098725,-0.0146404171437228,0.00996465661774725,0.709555232565175
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39533,0.00122913317380102,0.00331295706205798,-0.00526426266783263,0.00772252901543467,0.710638851519405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39427,-0.00166511124395341,0.0045035414254736,-0.0104920524378817,0.00716182994997485,0.711588116047315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41521,-0.0030599951218867,0.00830949823935733,-0.0193466116710271,0.0132266214272537,0.712690854286211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,41738,0.00367689178238189,0.0100066625894312,-0.0159361668929033,0.0232899504576671,0.713293502470356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,39636,-0.00140376385593841,0.0038280734274605,-0.00890678777376099,0.00609926006188416,0.713848018580443
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,39600,-0.00173641720870847,0.0047369603289445,-0.0110208594534397,0.00754802503602274,0.71394846797161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39308,-0.00350097492222039,0.00956284383513649,-0.0222441488390879,0.0152421989946471,0.714296301575008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,39625,0.00118138011347769,0.003251532533385,-0.00519162365195691,0.0075543838789123,0.716365168223833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,41765,0.00178478864855949,0.00494164736620322,-0.00790084018919882,0.0114704174863178,0.717976064759126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39241,0.00103121385698192,0.00286987885048014,-0.00459374868995916,0.00665617640392299,0.719360501268288
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41521,0.00131960728760775,0.00367529790845481,-0.00588397661296368,0.00852319118817917,0.71956526700633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39328,-0.00241683938624168,0.0067359139835506,-0.0156192307940009,0.0107855520215175,0.719752500928491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39600,0.00191113117272208,0.005329276251065,-0.00853425027936533,0.0123565126248095,0.719893828847805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41466,-0.00201334852509631,0.00565001059275163,-0.0130873692868895,0.00906067223669687,0.721588652466147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,41911,-0.00209659684300172,0.00594685262444966,-0.0137524279869231,0.00955923430091962,0.724427128994095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39328,0.00226801583546823,0.00648280859980806,-0.0104382890201556,0.014974320691092,0.72645753290524
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,39598,0.00319616344289314,0.00914904168595446,-0.0147359582615776,0.0211282851473639,0.726837706659932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41534,0.00234825622766886,0.00672258595231504,-0.0108280122388686,0.0155245246942063,0.726863425379824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39466,-0.00123003790198542,0.00352507052131962,-0.00813917612377189,0.00567910031980104,0.727141159505897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41465,-0.00296200504512657,0.00861081347527407,-0.0198391994566637,0.0139151893664106,0.730861933471586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41465,0.00276963575339273,0.008205407466531,-0.013312962881008,0.0188522343877935,0.735716976624241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,39600,0.00226158524419867,0.00671586660701867,-0.0109015133055579,0.0154246837939553,0.736309865308934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,41667,-0.00209969887542481,0.00626851838585514,-0.0143859949117009,0.0101865971608513,0.737661123449061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39570,0.00189745630861258,0.00568137211258376,-0.00923803303205158,0.0130329456492767,0.738402143660991
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39600,0.00133998857143428,0.00404059475036016,-0.00657957713927163,0.0092595542821402,0.740173834996322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41465,0.00301348555514916,0.00909259393768244,-0.0148079985627084,0.0208349696730067,0.740331157081231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39600,-0.00170952943159112,0.00519061413633845,-0.0118831331388145,0.00846407427563224,0.741897329316585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39328,-0.000970458197128465,0.00298514516313283,-0.00682134271686882,0.00488042632261189,0.745114896306668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39625,-0.00141175473696757,0.00434645625680204,-0.00993080900029957,0.00710729952636443,0.745334124054415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,41846,0.000781607135679042,0.00241359144619235,-0.00394903209885797,0.00551224637021605,0.746067520524762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39600,-0.0023070995835913,0.00716533026983271,-0.0163511469124634,0.0117369477452808,0.747473272670635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41466,0.00204163051309577,0.00637407611033999,-0.0104515586631706,0.0145348196893621,0.748744467558958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41614,-0.00138342083166673,0.00434554501955843,-0.00990068907000126,0.0071338474066678,0.750221676574097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,41689,0.000650533119215786,0.0020569787409133,-0.00338114521297429,0.00468221145140586,0.751812786962108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39250,-0.00146052853791211,0.00466242026543373,-0.0105988722581622,0.00767781518233801,0.754092731392257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39259,-0.00253576364952778,0.00812280481574457,-0.0184564610883871,0.0133849337893316,0.754911105624802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39655,0.00124094168394451,0.00399191036396809,-0.00658320262943293,0.00906508599732196,0.755909786474891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41617,-0.0010935375479157,0.00352605401670883,-0.00800460342066501,0.00581752832483362,0.756466543379171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,41805,0.00294277296274346,0.00951532826199194,-0.0157072704307607,0.0215928163562477,0.757123635702757
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39328,0.00346042362673309,0.0112157637436116,-0.0185224733107457,0.0254433205642119,0.757683436226643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39241,0.00129126141483094,0.00420987418289082,-0.00696009198363507,0.00954261481329695,0.759060914563107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,41765,0.00364243458114473,0.0119127826428525,-0.0197066193988461,0.0269914885611356,0.759793360859018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39241,-0.00303293956226909,0.00992023845264339,-0.0224766069294501,0.0164107278049119,0.759814286652113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41466,-0.00241815951563843,0.00791457386268271,-0.0179307242864965,0.0130944052552197,0.759965566202387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41534,0.00158086198488177,0.00518318509749969,-0.00857818080621762,0.0117399047759812,0.760372451437132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,39600,0.000990956742708874,0.00325534833796829,-0.00538952599970897,0.00737143948512672,0.760822208320454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39427,-0.0020768383613343,0.0068698354920283,-0.0155417159257098,0.0113880392030412,0.7624195220805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39598,0.000827541202987237,0.00274048134181683,-0.00454380222697376,0.00619888463294823,0.762681184185245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41408,-0.00207008462733558,0.00685869726279581,-0.0155131312624154,0.0113729620077442,0.762795004317709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41466,-0.00213988866917187,0.00709672287661899,-0.0160494655073451,0.0117696881690013,0.763013765623854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39328,0.00175028892676335,0.00583429359417376,-0.00968492651781722,0.0131855043713439,0.764182857156182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39259,0.00146159046427848,0.00489250406380166,-0.00812771750077277,0.0110508984293297,0.765143665324274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,41805,-0.000926391208896508,0.00312252531908499,-0.0070465408343031,0.00519375841651008,0.766715396537636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41466,-0.00104065975461672,0.00352218407015483,-0.00794414053212019,0.00586282102288675,0.767648302508881
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41534,-0.0012566577879629,0.00425335955593421,-0.00959324251759396,0.00707992694166815,0.767654399012807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39259,-0.0023132990292008,0.00787795610645783,-0.0177540929978582,0.0131274949394566,0.769037172056113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41877,0.000839075275541258,0.00285779379576713,-0.00476220056416231,0.00644035111524483,0.769060940144336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39427,-0.00137929095726494,0.00470009516217839,-0.0105914774751346,0.0078328955606047,0.769176026579909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39250,-0.00124722626692768,0.00425651070910289,-0.00958998725676934,0.00709553472291397,0.769515536493158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39241,-0.00194986842794774,0.00668006546748501,-0.0150427967442184,0.0111430598883229,0.77037365909444
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41740,0.00312701221622388,0.0107149462178629,-0.0178742823707875,0.0241283068032352,0.770416256742701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39250,0.00118932151030566,0.00420444891441276,-0.00705139836194334,0.00943004138255467,0.777280340515789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39328,0.00154478909050832,0.0054808614265611,-0.00919769930555144,0.0122872774865681,0.778062805656169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39427,0.0024383372869717,0.00865839220584499,-0.0145321114364845,0.0194087860104279,0.778243750277922
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39334,-0.00260003688273895,0.00928039728642198,-0.020789615564126,0.0155895417986481,0.779356781388802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39241,-0.00113161831425017,0.00406068003925495,-0.00909055119118987,0.00682731456268954,0.780498095452877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39334,0.000876445832987581,0.00317724586947776,-0.00535095607118883,0.00710384773716399,0.782667969931814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39334,0.000842940368998798,0.00307390457098562,-0.00518191259013301,0.00686779332813061,0.78391727190649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,41819,0.00081343604814502,0.00298511957292235,-0.00503739831478278,0.00666427041107282,0.785244174516588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,41694,-0.00111864851243861,0.00416346070090104,-0.00927903148620466,0.00704173446132743,0.78817834825449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41534,0.00138167632544232,0.00515896761663261,-0.00872990020315759,0.0114932528540422,0.788841904339988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41466,0.0011514837651239,0.00430719381575412,-0.00729061611375419,0.00959358364400198,0.789211932164941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,41765,-0.00116486644144759,0.00437711805477548,-0.00974401782880753,0.00741428494591236,0.790146071458258
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41465,-0.000898282738751435,0.00337893218867151,-0.00752098982854759,0.00572442435104472,0.790360448961232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39408,-0.00246242309281054,0.00941522077688355,-0.0209162558155023,0.0159914096298812,0.793683854553167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39241,-0.00101970552184723,0.00394591731376354,-0.00875370345682377,0.00671429241312932,0.796087473902994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41689,-0.00241833488169942,0.0093793624008286,-0.0208018851873235,0.0159652154239246,0.79653773075829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39328,-0.00181292246437916,0.00705479322761856,-0.0156403171905115,0.0120144722617532,0.797201142953178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,41612,0.000968882935373335,0.00377190813249851,-0.00642405700432374,0.00836182287507041,0.79728464600977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39600,-0.00150841798977633,0.0058761416194391,-0.013025655563877,0.0100088195843243,0.797413538501301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39420,0.00275028262178485,0.0107254765716581,-0.018271651458665,0.0237722167022347,0.797627395971191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39259,-0.00298030679100205,0.0117212738222017,-0.0259540034825174,0.0199933899005133,0.799295933020373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,39600,-0.00170540615025135,0.00673963929546412,-0.014915099169361,0.0115042868688583,0.800241134782246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41465,0.00136708051481165,0.00541208006248528,-0.00924059640765949,0.0119747574372828,0.800582923343002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41466,0.0013301863469266,0.00529850127603178,-0.00905487615409569,0.0117152488479489,0.801779811394635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39427,0.0020647613293605,0.008253941726115,-0.0141129644538249,0.0182424871125459,0.802472554512302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39334,0.0014647290396006,0.00587554776750595,-0.0100513445847111,0.0129808026639123,0.80313942764391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39250,-0.00175038893043185,0.00708519939357173,-0.0156373797418324,0.0121366018809687,0.804875336976911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39427,-0.00137545059278973,0.00557536589338328,-0.012303167743821,0.00955226655824149,0.805143997185571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39241,0.000890911286349868,0.00363044749061284,-0.0062247657952513,0.00800658836795104,0.806151574029619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,39650,-0.000719419887490071,0.00293977668049024,-0.00648138218125094,0.0050425424062708,0.806678380796842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,41849,-0.00109881703355766,0.00450757092436103,-0.00993365604530529,0.00773602197818996,0.807411618778336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41637,0.00153661650661768,0.00634329068452204,-0.0108962332350455,0.0139694662482809,0.808595842024315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39318,0.000940388042949145,0.0039213630033758,-0.00674548344366743,0.00862625952956572,0.810480957716638
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39427,-0.00176938515583421,0.00739774472778764,-0.016268964822298,0.0127301945106296,0.810971316087162
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41465,0.00342456541793542,0.0143597659669006,-0.0247205758771898,0.0315697067130606,0.811510008464964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39545,-0.00120924372723953,0.00510250965722185,-0.0112101626553943,0.00879167520091529,0.812668989003329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39328,0.000801865645552502,0.00338607195938778,-0.00583483539484755,0.00743856668595255,0.812806436215694
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41802,0.00183126071866863,0.00774880865576758,-0.0133564042466358,0.0170189256839731,0.813181800924823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41466,-0.000766843814729347,0.00326080893445444,-0.00715802932626005,0.00562434169680135,0.814080680429146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39598,0.00251119202786656,0.0107010178816125,-0.018462803020094,0.0234851870758271,0.814470391517996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39308,-0.00145411999748769,0.00619939679312846,-0.0136049377120195,0.0106966977170441,0.814556059963267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41562,-0.000856626564250283,0.00365606046510816,-0.00802250507586228,0.00630925194736171,0.814753324097322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,41808,-0.000685119240451493,0.00293882971598623,-0.00644522548378449,0.00507498700288151,0.81566674940422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39328,0.00104761264400983,0.00449602967120797,-0.00776460551155778,0.00985983079957745,0.81575933453113
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39334,-0.00158795609137772,0.00693273552537773,-0.0151761177211181,0.0120002055383626,0.818832958756008
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39427,-0.00172346915280836,0.00757977572446521,-0.0165798295727602,0.0131328912671434,0.820134641255269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39259,0.0028489907122365,0.0126494753096642,-0.0219439808947052,0.0276419623191783,0.821807782480088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,39589,-0.00187760113219832,0.00837074630980824,-0.0182842638994225,0.0145290616350258,0.822524074111722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39427,0.00134935080864751,0.00605929495173575,-0.0105268672967546,0.0132255689140496,0.823780161342821
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39381,0.00123221243419016,0.00556682590768608,-0.00967876634487455,0.0121431912132549,0.824824739695056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39625,-0.00169852405616293,0.00767711409884434,-0.0167456676898978,0.013348619577572,0.824905673569513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39589,0.00212145360971082,0.00962226156935617,-0.0167381790662273,0.0209810862856489,0.825506510477511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,41759,-0.000970302277614511,0.00440529084332889,-0.00960467233053913,0.00766406777531011,0.8256733396051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39230,0.00195238148033859,0.00887900828014656,-0.0154504747487487,0.0193552377094259,0.825963121371577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,39633,-0.00199878106183829,0.00914992918161723,-0.0199326422578081,0.0159350801341315,0.827084337311914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39589,0.000937531664136987,0.00431437162939936,-0.00751863672948576,0.00939370005775973,0.827975212153441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39259,-0.00128417567012509,0.00591029630497993,-0.0128683564278858,0.0103000050876356,0.827996082583508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,41758,0.00276796905485448,0.0127635798369492,-0.0222486474255659,0.0277845855352749,0.828317202775142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39328,0.000860171369239683,0.00396704874335167,-0.0069152441677296,0.00863558690620896,0.828345702963014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,41744,-0.00300662954106098,0.0138800404033962,-0.0302115087317175,0.0241982496495955,0.828511499016845
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39427,-0.000542441672270875,0.0025127060818417,-0.0054673455926806,0.00438246224813885,0.82908576236187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39328,-0.0012630482828545,0.00588220117052592,-0.0127921625770853,0.0102660660113763,0.829986787365878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,41758,0.000541130778385337,0.00252458283341424,-0.00440705157510658,0.00548931313187725,0.830281636884591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39420,0.00229437868460535,0.0108655870142096,-0.0190021718632454,0.0235909292324561,0.832766303482575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,41779,-0.00070154248197083,0.00332918913282141,-0.0072267531823008,0.00582366821835914,0.833105333819556
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39427,-0.000798021899262315,0.00384629327514336,-0.00833675671854329,0.00674071292001866,0.835640339760782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39589,-0.00106130057599506,0.00520241918272296,-0.0112580421741321,0.00913544102214194,0.838356215663672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39427,0.00163525208646419,0.0080548250465822,-0.0141522050048369,0.0174227091777653,0.839126950275166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41465,0.00114434065615715,0.00566414203058186,-0.0099573777237833,0.0122460590360976,0.83989452754491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39408,0.000537106631549988,0.00265887874241213,-0.00467429570357779,0.00574850896667777,0.839916666859383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",41805,-0.00237783676027115,0.0117784742485259,-0.0254636462873819,0.0207079727668396,0.840013755215005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39328,0.000786492209981399,0.00391908536491698,-0.00689491510525589,0.00846789952521869,0.840950576477789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",41758,0.000822483776110627,0.00410224063546557,-0.00721790786940189,0.00886287542162314,0.841095605978423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39250,-0.0009217379686622,0.00461211830012158,-0.0099614898369005,0.0081180138995761,0.841600672439691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39334,-0.000527933829860321,0.00265943922989963,-0.0057404347204636,0.00468456706074296,0.842647306445812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41636,-0.00213161119115459,0.0107540760399304,-0.0232096002294182,0.018946377847109,0.842880524174873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39334,-0.000916272758148878,0.00462608046592515,-0.00998339047136217,0.00815084495506441,0.842996583919552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39334,0.00108520569423118,0.00551412569155546,-0.00972248066121753,0.0118928920496799,0.843984121432425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41466,-0.00146128761431659,0.00743751008220027,-0.0160388073754291,0.0131162321467959,0.844241204764087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39241,0.00114167426196331,0.00581603925858607,-0.0102577626848654,0.012541111208792,0.844381026782243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,39600,-0.00218897276723948,0.01118017824163,-0.0241021221208342,0.0197241765863553,0.844777757009478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39241,0.00162868605132964,0.00835260214694161,-0.0147424141566759,0.0179997862593352,0.84540335931893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39535,0.00196198818193236,0.0102991018390775,-0.0182242514226596,0.0221482277865244,0.848920173401992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39427,-0.00150809592809956,0.00805393245368175,-0.0172938035373158,0.0142776116811167,0.851468417009042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39328,0.000952858593121544,0.00511807124056368,-0.00907856103838327,0.0109842782246264,0.852310790978005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39427,0.000789465191644441,0.00427161690965263,-0.00758290395127471,0.00916183433456359,0.853376444708903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,41925,-0.00175127680905002,0.00948377353124709,-0.0203394729302943,0.0168369193121943,0.853498268386188
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41466,-0.000937282309407626,0.00508897713328991,-0.0109116774906558,0.00903711287184059,0.853875999079747
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39427,-0.000788265214622115,0.00433083925386632,-0.0092767101522001,0.00770017972295587,0.855576625334639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,41877,-0.000815718175431585,0.00449097956730816,-0.00961803812735558,0.00798660177649241,0.855872109390893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41507,-0.00104784223218624,0.00576965841986572,-0.0123563727351231,0.0102606882707506,0.855889670894048
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39250,0.000974655097057701,0.00539385970993125,-0.00959730993440756,0.011546620128523,0.856608731298742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,41758,0.000682455860186012,0.00381532368731178,-0.00679557856694508,0.00816049028731711,0.858040699152801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,41758,0.000501108093466125,0.00280570619523311,-0.00499807604919077,0.00600029223612302,0.858252034511181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39334,0.00051290768034725,0.0028883375264693,-0.00514823387153258,0.00617404923222708,0.859057079999948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39427,0.00132734775294903,0.00749363020023686,-0.0133601674395152,0.0160148629454133,0.859409482669854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39259,0.00093049580706669,0.0054062875570746,-0.00966582780479952,0.0115268194189329,0.863351460525671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39241,0.00097139332368506,0.00566298217078539,-0.0101280517310543,0.0120708383784244,0.863807251831034
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39334,0.00127087112617527,0.00750411203304536,-0.0134371884585936,0.0159789307109442,0.86551932610912
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39334,-0.000695988641109943,0.0041227922064821,-0.00877666136581485,0.00738468408359497,0.865945440402081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39600,0.0015472843436774,0.00920559929615306,-0.0164956902767826,0.0195902589641374,0.866522816743501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39328,0.000758171868407232,0.00451909362121273,-0.00809925162916972,0.00961559536598418,0.866766772043228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39408,0.00066527622328045,0.00404834592111095,-0.007269481782097,0.0086000342286579,0.869472195594347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41534,-0.0020454670288888,0.0124694733412671,-0.0264856347777722,0.0223947007199947,0.869703820180071
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,41855,0.00105639887317146,0.00652668540960738,-0.011735904529659,0.0138487022760019,0.871419827916995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,39589,0.00182198772743166,0.0113131329706716,-0.0203517528950846,0.023995728349948,0.872056447352025
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39334,-0.000517773032783234,0.00323859032241314,-0.006865410064713,0.00582986399914653,0.872981722271455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41466,-0.000703198865414749,0.00450618358949486,-0.00953531870082468,0.00812892096999519,0.875994498280041
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39625,0.00179598626296769,0.0115680473891432,-0.020877386619753,0.0244693591456884,0.876623877479065
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39565,0.000632038772882551,0.00414040802865852,-0.00748316096328815,0.00874723850905325,0.878676056275294
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39221,0.000592735457109527,0.00390224001709911,-0.00705565497640473,0.00824112589062379,0.879271685061384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,41733,0.00108010909862985,0.00712318907798469,-0.0128813414942201,0.0150415596914798,0.879478891638195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39328,-0.000815227339718577,0.0054638980991515,-0.0115244676140555,0.00989401293461836,0.881396639822015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,39633,0.00148327767620081,0.0100044254442346,-0.0181253961944991,0.0210919515469007,0.882138590584904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39259,-0.0011837492198597,0.00811786977234631,-0.0170947739736585,0.0147272755339391,0.884066103352585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39259,0.000856181421360516,0.00592852502207681,-0.01076372762191,0.0124760904646311,0.88517370758982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39259,0.00154049672281447,0.010715746294397,-0.0194623660142037,0.0225433594598326,0.885692631403943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39522,0.00150988930519538,0.010656784961506,-0.0193774092193563,0.0223971878297471,0.887332717082843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,41802,0.000514113939611152,0.0036328272072422,-0.00660622738658356,0.00763445526580587,0.887462139692096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,41877,0.000441324084429716,0.00318674497297451,-0.00580469606260032,0.00668734423145975,0.889857312716708
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39328,0.000508793276532952,0.00368788322621831,-0.00671945784685494,0.00773704439992084,0.890271853879684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39169,0.00123977114749356,0.00899052382339811,-0.0163816555463667,0.0188611978413538,0.89032401902128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39259,0.000911716775643732,0.00665825538412032,-0.0121384637772321,0.0139618973285196,0.891088490246195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,39633,0.000633641650759291,0.00465977912125553,-0.00849952542690155,0.00976680872842013,0.891838743742632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,41925,0.000912988235561493,0.00681912824289904,-0.0124525031205206,0.0142784795916436,0.893494460952328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41765,0.000708095217450395,0.00533486427637436,-0.00974823876424335,0.0111644291991441,0.894409140122189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,41708,0.000942865197515982,0.00713609564025803,-0.0130438822573897,0.0149296126524217,0.89488650116164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,41847,0.000598359850830357,0.00453706996330519,-0.00829429727724781,0.00949101697890852,0.895079282151939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,39600,0.000520974464538712,0.00395503371035179,-0.00723089160775079,0.00827284053682821,0.895204689945165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39427,0.000636560831647436,0.00484882833029364,-0.00886714269572809,0.010140264359023,0.895555167120605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,41911,0.00051472089004294,0.0039540029734614,-0.0072351249379414,0.00826456671802728,0.896428229075672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39334,-0.000589786427706875,0.00453681798374552,-0.00948194967584808,0.00830237682043433,0.896568846959718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,41722,-0.000242498703122236,0.00187278808086462,-0.0039131633416169,0.00342816593537242,0.896975565922066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39408,0.00115026852308362,0.00900402172093626,-0.0164976140499514,0.0187981510961187,0.898348779336181
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39600,-0.000910374465226348,0.00712685758469121,-0.0148790153312211,0.0130582664007684,0.898358215256298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39334,0.000354093883587498,0.00279149645900446,-0.00511723917606124,0.00582542694323623,0.899063607137121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,39600,-0.00104846607063895,0.00851136844599333,-0.0177307482247859,0.015633816083508,0.901963491301434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,41802,0.00110553544737398,0.00902770151178855,-0.0165887595157316,0.0187998304104795,0.902536313145087
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,39589,-0.000558213540443775,0.0046021191165858,-0.00957836700895194,0.00846193992806439,0.903459683599055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41465,-0.000674302017057204,0.0056411512297248,-0.0117309584273178,0.0103823543932034,0.904855204203856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39385,0.00133679841270206,0.0112302080876771,-0.020674409439145,0.0233480062645491,0.905249096618355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41466,0.000652124970569101,0.00550487297432668,-0.0101374260591112,0.0114416760002494,0.905702486492238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41534,0.000389605889119235,0.00334167009573347,-0.00616006749851836,0.00693927927675683,0.907186636874632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39241,-0.000369766521262825,0.00319014291667731,-0.00662244663795035,0.0058829135954247,0.907726788909325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39589,-0.00104598721665209,0.00906856965210659,-0.018820383734781,0.0167284093014768,0.908176134383812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,39650,-0.000376339813852725,0.00329648451112792,-0.00683744945566345,0.006084769827958,0.909109873797882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39625,-0.000397348556260517,0.00349970333928591,-0.00725676710126091,0.00646206998873987,0.909606277974239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41350,-0.000311704161123647,0.00284134550899643,-0.00588074135875665,0.00525733303650936,0.912646637922325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39427,0.00052586738271451,0.00483291299241888,-0.00894664208242649,0.00999837684785551,0.913355516997879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39589,-0.000616945524893664,0.00576993681839197,-0.0119260216889419,0.0106921306391546,0.91485111487495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41617,-0.0010796959190842,0.0104786051225208,-0.021617761959225,0.0194583701210566,0.917934292674084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39361,-0.00094912144722662,0.00924601612033643,-0.019071313043086,0.0171730701486328,0.918241134954981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39334,0.000820408972737253,0.00799965929437374,-0.0148589232442353,0.0164997411897098,0.91831768665111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39476,0.000619639315195614,0.00606383998573188,-0.0112654870568389,0.0125047656872301,0.918610954890062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39250,0.00105452470641212,0.010591549513227,-0.0197049123395128,0.021813961752337,0.920693273737484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41636,-0.00108332366724613,0.0113309398786199,-0.0232919658293411,0.0211253184948489,0.923833719548618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39308,0.000539731209508809,0.00566828097696894,-0.0105700995053503,0.0116495619243679,0.924142217232296
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41866,-0.000354324208835956,0.00372335789358071,-0.00765210568025414,0.00694345726258223,0.92418715791094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39250,-0.000641735151995737,0.00706170564012368,-0.0144826782066381,0.0131992079026467,0.92759332572005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39600,0.000884052758720399,0.00979124298390144,-0.0183067834897264,0.0200748890071672,0.928058294418263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39328,-0.000281443575759152,0.00325136528571555,-0.00665411953576163,0.00609123238424332,0.931021557970207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41765,0.000291514983742262,0.00347623829453677,-0.0065219120735498,0.00710494204103433,0.933169557598124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39241,0.0005769660132788,0.00691121160064637,-0.0129690087239881,0.0141229407505457,0.933469371141578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39250,0.000338138619437949,0.00423467349396685,-0.00796182142873708,0.00863809866761298,0.936358068383122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39598,0.000326875514347267,0.00414954255866651,-0.00780622790063909,0.00845997892933362,0.937213923533573
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,39598,0.000224759928747765,0.00287406914891396,-0.00540841560312361,0.00585793546061914,0.937668247680546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39334,-0.000330196878238965,0.00447560741327687,-0.00910238740826163,0.00844199365178369,0.941189204945291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,39600,-0.000270237771088107,0.0037655357021609,-0.00765068774732347,0.00711021220514726,0.942789364816954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41689,-0.000863856494589811,0.0125840051971994,-0.0255285066811006,0.023800793691921,0.945271510247324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,41636,-0.000237861342023763,0.00352320822265141,-0.00714334945842052,0.006667626774373,0.946174577795433
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39334,-0.000303837653015154,0.0045301995062755,-0.00918302868531513,0.00857535337928482,0.946527722711156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41534,0.00029102079050777,0.00435489035410981,-0.00824456430354746,0.008826605884563,0.946721095277447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39408,-0.000491733424166225,0.0075687575668501,-0.0153264982551924,0.01434303140686,0.948200008854756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,39589,0.000395150159247701,0.0061663852413048,-0.0116909649137097,0.0124812652322051,0.948906634427108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41576,-0.000476498132030692,0.00754015590276224,-0.0152552037014447,0.0143022074373833,0.949612412970953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39427,0.000430656445079835,0.00684117670686923,-0.0129780499003839,0.0138393627905435,0.949806972746066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41465,-0.000529793374989216,0.00848226580528924,-0.0171550343533561,0.0160954476033777,0.950198325365873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,41877,-0.000736207865363653,0.0119470212599307,-0.0241523695348278,0.0226799538041005,0.950864216303628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39589,0.000293507739853042,0.00476860770277389,-0.00905296335758378,0.00963997883728987,0.950922325691441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39259,0.000491712129983209,0.00805931498464221,-0.0153045452399155,0.0162879694998819,0.951351072392468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39250,-0.00026177238397378,0.00434169884914801,-0.00877150212830389,0.00824795736035632,0.951923713668554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39598,0.000639524454017995,0.0107775810349438,-0.0204845343744718,0.0217635832825078,0.952683651385986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39334,-0.000188878748003795,0.00318727501486469,-0.00643593777713858,0.00605818028113099,0.952745916058092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,41911,-0.000295902124647543,0.00522276306775098,-0.0105325177374395,0.00994071348814438,0.954819882739332
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39334,0.000181054615668589,0.00325856058497803,-0.00620572413088834,0.00656783336222552,0.955691166966317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39241,0.000295673282312488,0.00562922275991932,-0.0107376033271294,0.0113289498917544,0.958111594232054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,39633,-0.000481345995406385,0.00920258258014469,-0.01851840785249,0.0175557158616772,0.958286190853268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39625,0.000197452011264914,0.00383298515741217,-0.00731519889726294,0.00771010291979277,0.958916959793825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41465,-0.000258377288458071,0.00502443343533178,-0.0101062668217084,0.00958951224479223,0.958988328612995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39328,0.000221124504317887,0.00433437683281812,-0.00827425408800564,0.00871650309664141,0.959313364902185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39334,0.000264778223278942,0.00528865859751298,-0.0101009926278465,0.0106305490744044,0.960071291593405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,41832,0.000310498100330904,0.00632056442082591,-0.0120778081644879,0.0126988043651497,0.96082037472838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,41689,-0.000156963526026173,0.00323124481690926,-0.00649020336716833,0.00617627631511599,0.961257301981371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,41815,-0.000142092887579974,0.00318599757230607,-0.00638664812929987,0.00610246235413992,0.964427468036907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41689,0.000265981770669971,0.0061296306355588,-0.0117480942750253,0.0122800578163652,0.965389087496355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39301,-0.000312060721631312,0.00720057243429605,-0.0144251826928516,0.0138010612495889,0.965432652525882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41802,0.000212713044989534,0.00492477140461502,-0.00943983890805591,0.00986526499803498,0.96554876014055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41490,0.00023037617799202,0.00535599985496159,-0.0102673835377327,0.0107281358937167,0.965692052048417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,41720,-0.000218356909519222,0.00518259036974721,-0.0103762340342237,0.0099395202151853,0.96639349450365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,39600,-0.000294980907713517,0.00708682266753904,-0.01418515333609,0.013595191520663,0.966799308403387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,41740,0.000285819186393464,0.00714153637373288,-0.013711592106123,0.0142832304789099,0.968076125961729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41689,-0.000349912538268186,0.0089963097142492,-0.0179826795781966,0.0172828545016602,0.968974601166553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,41689,-0.000117620033299138,0.00308903149909675,-0.00617212177152877,0.00593688170493049,0.969627133074365
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,41786,-0.00035117067246231,0.00939843237083886,-0.0187720981193065,0.0180697567743819,0.970194693474974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,41744,9.20062719463843e-05,0.00252602697375995,-0.00485900659662311,0.00504301914051588,0.970945378276318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41534,-0.000134122409792574,0.00374021013480406,-0.00746493427400853,0.00719668945442339,0.971394869349136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,41750,-0.000188674621488203,0.00551780900000292,-0.0110035802614939,0.0106262310185175,0.972723163605902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,41740,0.000250149550195274,0.00738239231266563,-0.0142193393826294,0.0147196384830199,0.97296967314718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39259,-0.000191457902262189,0.0056556909610288,-0.0112766121858786,0.0108936963813543,0.972995598836899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39334,-0.000172890273972433,0.00512423401203474,-0.0102163889375605,0.00987060838961566,0.973085324072098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39308,-0.000319360120244957,0.0098820081284034,-0.0196880960519156,0.0190493758114257,0.974219591201981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39241,-0.000220723185909512,0.00683324695926532,-0.0136138872260695,0.0131724408542505,0.974232328606803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39328,-0.000107055131642828,0.00338795763284261,-0.00674745209201434,0.00653334182872868,0.974792650335861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39408,-0.000120045778216232,0.00397868711554242,-0.00791827252467937,0.00767818096824691,0.975930269740114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41595,-0.000129957825593655,0.00440099333467418,-0.00875590476155506,0.00849598911036775,0.976442981925689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39589,-0.000184430329224527,0.00648332329300937,-0.0128917439835229,0.0125228833250738,0.977306249878795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39328,-0.000194136611082322,0.00726166910229468,-0.0144270080515799,0.0140387348294153,0.978672046087561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41534,0.000101149671054664,0.00389625237708445,-0.00753550498803085,0.00773780433014018,0.97928903775104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41534,-0.000131393513304603,0.00576607638900582,-0.011432903235756,0.0111701162091468,0.981820262267499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39308,-0.000185808017346137,0.00835911457555418,-0.0165696725854323,0.0161980565507401,0.982266342049885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39250,-0.000151255322268935,0.00706459291121239,-0.0139978574282452,0.0136953467837073,0.982918727997968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39308,5.38914265639157e-05,0.00254418459142189,-0.00493271037262299,0.00504049322575082,0.983100708201274
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39250,-0.000211299742807494,0.0109067154491873,-0.0215884620232147,0.0211658625375997,0.984543623664628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41466,0.000114583983692962,0.00600425058393253,-0.0116537471608148,0.0118829151282007,0.984774541904615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,41765,-0.000132775237952744,0.00726132366049223,-0.0143649696125175,0.014099419136612,0.985411558263291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41534,-4.95482503982632e-05,0.00338661772595745,-0.00668731899327486,0.00658822249247833,0.988327111993267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,39588,0.000140076040216198,0.0105130476364023,-0.0204654973271324,0.0207456494075648,0.989369527867536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39241,0.00010389272201067,0.00808884602718098,-0.0157502454912641,0.0159580309352854,0.98975253431104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39250,5.26012572449308e-05,0.00413492600678622,-0.00805185371605605,0.00815705623054592,0.989850455913267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39589,-4.97240888001365e-05,0.00404190610963088,-0.00797186006367665,0.00787241188607638,0.990184784523417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41534,-6.52869834594042e-05,0.00552878154867972,-0.0109016988188717,0.0107711248519529,0.990578528355013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41534,0.000109289086937143,0.0100029943580292,-0.0194965798548001,0.0197151580286743,0.991282944722681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41534,-5.4943643151591e-05,0.00522342654824866,-0.010292859677719,0.0101829723914158,0.991607610752457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39600,3.88511915551646e-05,0.003884374633451,-0.0075745230900088,0.00765222547311913,0.992019939512871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41466,5.39495102204784e-05,0.00596891285241231,-0.0116451196805076,0.0117530187009486,0.992788626704954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39250,-3.06474385937719e-05,0.00355939449039624,-0.0070070606397704,0.00694576576258285,0.993130224263568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39250,2.56438865571083e-05,0.00368295827258058,-0.00719295432770084,0.00724424210081505,0.994444624670232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,41758,2.31995488928143e-05,0.00366818556554248,-0.00716644415957045,0.00721284325735608,0.994953884844463
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,41765,-3.64923270000778e-05,0.0071213245174505,-0.0139942883812031,0.0139213037272029,0.995911436997407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39328,2.7310241445926e-05,0.00696106930019144,-0.0136163855869293,0.0136710060698211,0.996869754434184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39328,-1.15915734120047e-05,0.00392368508715147,-0.00770201434422889,0.00767883119740488,0.9976429024563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41437,-1.92100953953857e-05,0.0081486695213854,-0.0159906023573108,0.01595218216652,0.998119064002906
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39589,4.89030061732165e-06,0.00415088001723332,-0.00813083453315999,0.00814061513439463,0.999060005185853
